| Dokumendiregister | Sotsiaalministeerium |
| Viit | 1.5-8/1847-1 |
| Registreeritud | 11.07.2025 |
| Sünkroonitud | 14.07.2025 |
| Liik | Sissetulev kiri |
| Funktsioon | 1.5 Asjaajamine. Info- ja kommunikatsioonitehnoloogia arendus ja haldus |
| Sari | 1.5-8 Tervitus- ja tutvustuskirjad, kutsed ja kirjavahetus seminaridel, konverentsidel jt üritustel osalemiseks |
| Toimik | 1.5-8/2025 |
| Juurdepääsupiirang | Avalik |
| Juurdepääsupiirang | |
| Adressaat | WHO |
| Saabumis/saatmisviis | WHO |
| Vastutaja | Kärt Veliste (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Terviseala asekantsleri vastutusvaldkond, Tervishoiukorralduse osakond) |
| Originaal | Ava uues aknas |
20, AVENUE APPIA – CH-1211 GENEVA 27 – SWITZERLAND – TEL CENTRAL +41 22 791 2111 – FAX CENTRAL +41 22 791 3111 – WWW.WHO.INT
... ENCLS.: (2)
Ref.: C.L.22.2025
The World Health Organization (WHO) presents its compliments to Member States and Associate Members and has the pleasure of announcing that the 48th Expert Committee on Drug Dependence (ECDD) will meet from 20 to 22 October 2025 in Geneva, Switzerland. Given that WHO Expert Committee meetings are of a closed nature, this letter serves to notify Member
... States of the agenda of the 48th ECDD, which is in the Annex I file, attached for reference.
WHO is mandated by the 1961 and 1971 International Drug Control Conventions to make recommendations to the UN Secretary-General on the need for and level of international control of psychoactive substances based on the advice of its independent scientific advisory body, the ECDD. To assess whether or not a psychoactive substance should be placed under international control, the ECDD convenes annually to review the potential of that substance to cause dependence, abuse and harm to health, as well as any therapeutic applications. In order to perform this review and make evidence-based decisions, the ECDD conducts medical, scientific, and public health evaluations of the selected psychoactive substances using the best available information.
Although the meetings are of a closed nature, Member States and Associate Members are invited to contribute to the ECDD review process by joining the 48th ECDD Information Session on 20 October 2025. The Information Session will be held virtually and allow interested parties to learn about present and future activities of the ECDD Secretariat, and to present information concerning substances under review to the 48th Expert Committee for consideration in its deliberations. Registration information will be made available on the ECDD website in due course: https://www.who.int/news-room/events/detail/2025/10/20/default-calendar/forty-eighth- expert-committee-on-drug-dependence.
As in the past and in line with the publication “Guidance on the WHO review of psychoactive substances for international control” (EB126/2010/REC1, Annex 6),1 Member States and Associate Members can also contribute to the ECDD review process by providing up to date and accurate information concerning the substances under review in advance of the meeting. For this purpose, and as per previous practice, a questionnaire will be sent to Member States and Associate Members to gather country information on the legitimate use, harmful use, status of national control and potential impact of international control for each substance under evaluation.
1 https://apps.who.int/gb/ebwha/pdf_files/EB126-REC1/B126_REC1-en.pdf#page=90.
Page 2
C.L.22.2025
... Annex II to this Circular Letter contains a list of national focal points officially designated by Member States and Associate Members in previous years who provide country information to the ECDD through the Member States questionnaire referred to above. If the focal point information requires changes or amendments, Member States and Associate Members are invited to inform the WHO ECDD Secretariat by email to [email protected] by 18 July 2025 with the subject “48ECDD Focal Point: (Country Name)”.
If the individual on the list is still the official focal point for completing the ECDD Member State questionnaire this year and if no additions or amendments to focal point details are made by 18 July 2025, the focal point from the list will be given further instructions and direct access to online questionnaires by the WHO Secretariat. Results of the questionnaires will be prepared as a report as part of the 48th ECDD substance review process.
In addition to the questionnaire, Member States and Associate Members are also encouraged to provide any additional relevant information (unpublished or published) on substances to be reviewed by the 48th ECDD by emailing [email protected] with the subject “Ref: C.L.22.2025”.
All recommendations made by the 47th ECDD, held in October 2024, were accepted by the 68th UN Commission on Narcotic Drugs and all technical reports and recommendations made by the ECDD are available online through the recently launched ECDD Information Repository (https://ecddrepository.org/en).
The World Health Organization takes this opportunity to renew to Member States and Associate Members the assurance of its highest consideration.
GENEVA, 11 July 2025
48th WHO EXPERT COMMITTEE ON DRUG DEPENDENCE
Provisional Agenda
----
Information Meeting (Virtual)
20 October 2025
10:00-13:00 CEST
1. Welcome and opening of the meeting
2. WHO presentations 2.1 Expert Committee on Drug Dependence 2.2 Science Division 2.3 Gender, Equity, and Human Rights 2.4 Traditional medicine
3. Presentations and statements from participants
48th WHO EXPERT COMMITTEE ON DRUG DEPENDENCE
Geneva, Switzerland
Provisional Agenda
----
Closed Session
20–22 October 2025
1. Procedural matters and updates 1.1 Opening of meeting and welcoming remarks 1.2 Introduction of participants 1.3 Statement of confidentiality 1.4 Declarations of interest 1.5 Election of Chair, Vice-Chair, and Rapporteur 1.6 Adoption of agenda
2. Updates on priorities from international agencies 2.1 Briefings from international agencies on their work on the public health dimension of the
world drug problem 2.1.1 WHO 2.1.2 UNODC 2.1.3 INCB
2.2 Updates on ECDD meeting recommendations and outcomes 2.2.1 Recommendations and outcomes of the 47th ECDD 2.2.2 Updates on substance surveillance
3. Critical reviews: Recommendations on the scope of international control 3.1 Coca leaf1
3.1.1 Coca leaf
3.2 Synthetic cannabinoids2 3.2.1 MDMB-FUBINACA
3.3 Novel synthetic opioids2 3.3.1 N-pyrrolidino isotonitazene (Isotonitazepyne) 3.3.2 N-Desethyl etonitazene
4. Finalization of meeting report
1 There has been a notification from a Party to the 1961 or the 1971 Convention concerning the scheduling of a
substance. 2 Information was brought to WHO’s attention that a substance is clandestinely manufactured, or especially serious risk
to public health and society, and of no recognized therapeutic use by any Party.
Annex II: List of focal points designated by Member States in previous years
Country Name Focal Point Job title Institution Email Last update
Afghanistan
Albania Linda Ternova Specialist
Regulation Sector of Pharmaceutical Market and Medical Devices Ministry of Health and Social Protection, Albania
Algeria Ghrieb Houria Doctor
Narcotics, Psychotropics and Chemical Precursors, General Direction of Pharmacy and Health Equipment, Algerian Health Ministry
Andorra Carla Lobaco Valls Technical Officer Department of Health Resources and Medicines [email protected]
Andorra Carme Pallarés Papaseit Department of Health Resources and Medicines [email protected]
Angola Ana Da Conceição Mamede General Director, National Institute for combating Drugs
Ministry of Health [email protected]
Antigua and Barbuda
Argentina G. Rebaldería Pharmacist
Director of Surveillance of Substances Subject to Special Control Argentinian Ministry of Health [email protected]
Armenia Hasmik Martirosyan Armenian Ministry of Health [email protected]
Australia
Narcotics Control Section Office of Drug Control Australian Government Department of Health and Aged Care
[email protected] 7/10/2024
Australia [email protected]
Austria Raphael Bayer Head of Division
Section VI, Department 6 Federal Ministry of Social Affairs, Health, Care and Consumer Protection
Azerbaijan Telman Suleyman Oglu Mammadhassanov [email protected]
Bahamas
Bahrain Samar Yousef Salem Senior Pharmacist Ministry of Health [email protected]
Bangladesh Habibur Rahman Khan Additional Secretary Health Services Division, Ministry of Health & Family Welfare [email protected]
Barbados Lindsay Bynoe Assistant Director for Drug Regulation Ministry of Health [email protected]
Belarus Aleksey Kralko Ministry of Health [email protected]
Belgium Lies Gremeaux Head of Unit illicit Drugs, Reitox National Focal Point
Epidemiology and Public Health, Sciensano, Ministry of Health
Belize
Benin Saturnin Bognon State-certified Pharmacist, Head of Pharmaceutical Establishments Department
Pharmaceutical Establishments Department [email protected]
Bhutan Dil Kumar Subba Department of Public Health, Ministry of Health [email protected]
Bolivia (Plurinational State of) H.E. Amb. Maira Mariela Macdonal Permanente Representative of the Plurinational State of Bolivia
[email protected]; [email protected] 7/27/2024
Bosnia and Herzegovina [email protected]; [email protected]
Annex II: List of focal points designated by Member States in previous years
Country Name Focal Point Job title Institution Email Last update
Bosnia and Herzegovina Sabina Šahman Department for Health, Ministr of the Civill Affairs of Bosnia and Herzegovina
Botswana Vivian Sebako Chief Pharmacist Department of Clinical Services, Ministry of Health and Wellness [email protected]
Brazil Renata de Morais Souza, Moema Luisa Silva Macedo Manager
Management of Controlled Products GPCON/GGMON/DIMON/ANVISA Controlled Substances Office Brazilian Health Regulatory Agency – ANVISA
Brazil Natalia Jorge e Costa International Affairs Office, Brazilian Health Regulatory Agency - ANVISA, AINTE/ GADIP/ANVISA
Brunei Darussalam Hajah Zanatul ‘Aini Haji Zainin (Ms) Acting Director of Pharmaceutical Services Department of Pharmaceutical Services, Ministry of Health [email protected]
Bulgaria Slaveyka Nikolova Chief Expert at the Health Promotion Department Health Promotion and Prophylaxis of the Diseases and Addictions Directorate
Bulgaria Alexander Panayotov Head of the National Focus Center Department
Mental Health and Addiction Prevention Directorate, National Center for Public Health and Analysis
Burkina Faso [email protected]
Burundi Israël Nimubona [email protected]
Cabo Verde Raquel Lopes Commission for the Coordination of Alcohol and Other Drugs, Ministerio da Saude e da Seguranca Social
[email protected] 8/30/2024
Cambodia Chhit Sophal Director Department of Mental and Substance Abuse, Ministry of Health [email protected]
Cameroon Ketchozo Loko Wilfried [email protected]
Canada
International Relations Unit, Office of Drug Policy and Science, Controlled Substances Directorate, Health Canada, Government of Canada
[email protected] 4/26/2024
Central African Republic
Chad Haoua Haroun Saker Deputy Director of Pharmacy and Medicine Ministry of Public Health [email protected]
Chile Javiera Erazo Leiva Advisor Department of Mental Health/DIPRECE, Ministry of Health [email protected]
China Zhendong HUA Deputy Director National Narcotics Laboratory [email protected]
China Yan ZHENG Official Office of National Narcotics Control Commission [email protected]
China Peng XU Senior Expert National Narcotics Laboratory [email protected]
Annex II: List of focal points designated by Member States in previous years
Country Name Focal Point Job title Institution Email Last update
Colombia Oscar Ricardo Santana
Observatorio de Drogas de Colombia Dirección de Políticas de Drogas y Actividades Relacionadas Ministerio de Justicia y del Derecho
[email protected]; [email protected] 7/16/2024
Colombia Nubia Esperanza Bautista Coordinadora del Grupo Convivencia Social y Ciudadanía
Dirección de Promoción y Prevención – Ministerio de Salud y Protección Social
Colombia Germán Andrés Calderón Velásquez Coordinador Grupo Interno de Trabajo de Asuntos Relacionados con las Drogas
Ministerio de Relaciones Exteriores [email protected]; [email protected]
Comoros
Cook Islands Tereapii Uka Central Policy and Planning Office [email protected]
Costa Rica Marchena Vasquez [email protected]
Côte d'Ivoire Ernest Zotoua [email protected]
Croatia Lidija Vugrinec Head of National Information Unit in the Field of Drugs and Behavioural Addictions and Internal Relations Department
Croation Institute of Public Health [email protected] 8/30/2024
Cuba
Cyprus John Kkolos Pharmacist Pharmaceutical Services, Ministry of Health [email protected]
Czechia Vlastimil Brandejs Inspectorate Department, Narcotic and Psychotropic Substances Ministry of Health
Democratic People's Republic of Korea Kim Jong Guk
Democratic Republic of the Congo Ghislaine Mbelu Kanyunya [email protected]
Denmark Kari Gragaasen Chief Consultant Head of Focal Point, Prevention, National Board of Health [email protected]
Djibouti
Dominica Laura Esprit Chief Medical Office Ministry of Health, Wellness and New Health Investment [email protected]
Dominica Anna Royer-Edmund Chief Pharmacist Ministry of Health, Wellness and New Health Investment [email protected]
Dominican Republic [email protected]
Dominican Republic Francisca Dalia Castillo Sanchez Head of the Assistive Technology Department
General Directorate of Medicines, Food and Health Products (DIGEMAPS), Ministry of Public Health
Ecuador Gabriel Ordonez Guzman Director nacional de Estrategias de Prevencion Y Control para Enfermedades no Transmisibles
Salud Mental Y Fenomeno Socioeconomico de las Drogas [email protected] 7/24/2024
Egypt Dr Samah Abdeleazik Kandil Ministry of Health and Population [email protected]; [email protected] 7/16/2024
El Salvador José Mauricio Bermúdez Recinos Focal Point of the Ministry of Health of El Salvador
Health Technology Department, Ministry of Health [email protected]
Equatorial Guinea
Annex II: List of focal points designated by Member States in previous years
Country Name Focal Point Job title Institution Email Last update
Eritrea Michael Girmay Haile [email protected]
Estonia Olga Kamp Inspector of pharmacovigilance, drugs and psychotropic substances, and the precursors
State Agency of Medicines, Ministry of Health [email protected]
Eswatini
Ethiopia Baharu Zewdie Moya [email protected]
Fiji Ilisabeta May Pesamino Chief Pharmacist Pharmaceutical & Biomedical Services/Ministry of Health & Medical Services
Finland Katja Pihlainen Finnish Medicines Agency, Ministry of Health [email protected]
France Luciano Amato Acting Head of Department
Regulation of narcotics and psychotropic substances, National Agency for the Safety of Medicines and Health Products
Gabon Okouyi Ndakissa
Directorate of Medicines and Pharmacy Ministry of Health [email protected]
Gambia
Georgia Ekaterine Paposhvili Senior Specialist
Division of Legal Circulation of Narcotic Drugs, LEPL State Regulation Agency for Medical Activities Ministry of Labour, Health and Social Affairs of Georgia
Germany Annette Hinze
Division 122 - Narcotics Law, Traffic in Narcotics, International Narcotic Drug Affairs Federal Ministry of Health
Ghana Martha Gyansa-Lutterodt Director Pharmaceutical Services, Ministry of Health [email protected]
Greece Dr Foteini Koulouri Head of General Directorate of Public Health and Quality of Life
Hellenic Ministry of Health [email protected] ; [email protected] 7/16/2024
Greece Avgerinos Nikolaos Psychiatrist, Programs Implementation Director
OKANA - Organisation Against Drugs Greece
[email protected] ; [email protected]
Greece Ms Anastasia Petroulia Legal Advisor to the Minister of Health Hellenic Ministry of Health [email protected]; [email protected] Will also attend the 47th ECDD meeting
Grenada
Guatemala José Miguel Solares Estrada Department of Regulation and Control of Related Pharmaceutical Products [email protected] 8/30/2024
Guatemala Alicia Elena Morgan Durán Section of Psychotropics, Narcotics, Imports and Exports [email protected] 8/30/2024
Guinea
Guinea-Bissau
Guyana
Haiti Marie Judith Robuste Roche Ministry of Health [email protected]
Honduras Alex Virgilio Santos Moreno General Director of the Honduran Institute for the Prevention of Alcoholism
Honduran Institute for the Prevention of Alcoholism, Drug Addiction and Drug Dependence (IHADFA)
Annex II: List of focal points designated by Member States in previous years
Country Name Focal Point Job title Institution Email Last update
Hungary Tímea Kahlesz Deputy Head of Department EMMI Pharmaceutical and Medical Technology Department [email protected]
Iceland Bjarni Sigurðsson Ministry of Health [email protected]
India Dr Anju Dhawan Professor and Head Department of Psychiatry, National Drug Dependence Treatment Centre, All India Institute of Medical Sciences
[email protected] 7/24/2024
Indonesia Agusdini Banun Saptaningsih Director of Pharmaceutical Production and Distribution
Directorate General of Pharmaceutical Care and Medical Devices, [email protected]
Iran (Islamic Republic of) Mina Azhoogh [email protected]
Iraq Emad Abdulrazzaq Abdulghani Ministry of Health [email protected]
Ireland Conor Brennan Department of Health [email protected]
Ireland Alan Bell Department of Health [email protected]
Israel Paola Rosca Head of the Addiction Treatment Department Ministry of Health [email protected]
Israel Tal Lavy
The Competent Authority for Narcotics, Psychotropics and Precursors Pharmaceutical Administration
Italy Pietro Canuzzi Head of Office 7, Central Narcotic Office Ministry of Health - Directorate general of Health Prevention [email protected] 7/26/2024
Jamaica Dr Jacquiline Bisasor McKenzie Chief Medical Officer Ministry of Health & Wellness [email protected] 7/5/2024
Jamaica Ms Uki Atkinson Research Analyst National Council on Drug Abuse (NCDA) [email protected] 7/5/2024
Japan Compliance and Narcotics Division, Pharmaceutical Safety and Environmental Health Bureau
Jordan Malak AlMahirah
Head of Narcotics, Psychotropic Substances and Chemical Precursors Department, Jordan Food and Drug Administration
Kazakhstan Prilutskaya Marina Republican Scientific and Practical Center of Mental Health [email protected]
Kenya Anthony Toroitich [email protected]
Kenya Simon Njuguna [email protected]
Kiribati Biribo Kararaiti Chief Pharmacist Ministry of Health and Medical Services [email protected]
Kuwait Ali Abdulmohsen Jaragh Head Control of Licenses for Narcotic Drugs and Psychotropic Substances Department
[email protected] 7/24/2024
Kyrgyzstan Kanyshai Damirbek Drug Trafficking Control Department, Ministry of Foreign Affairs [email protected]
Annex II: List of focal points designated by Member States in previous years
Country Name Focal Point Job title Institution Email Last update
Lao People's Democratic Republic Khatthanaphone Phandoangsy Head of Health Promotion and Nutrition Unit Department of Hygiene and Health Promotion, Ministry of Health [email protected]
Latvia Linda Veisberga Ministry of Health [email protected]
Lebanon Marie-Therese Matar Head of Narcotics Department Ministry of Public Health [email protected]
Lesotho Masello Sello [email protected]
Liberia Dr. Moses Ziah II Director Mental Health Unit Ministry of Health, Republic of Liberia [email protected]; [email protected]
Libya
Lithuania Rima Mačiūnienė Head of Drug Precursors Control and Risk Assessment Division
Drug Precursors Control and Risk Assessment Division, Drug, Tobacco and Alcohol Control Department
Luxembourg Alain Origer National Drug Coordinator Ministry of Health [email protected]
Madagascar Maximine Ravaoarimanana Director of Pharmacy Laboratories and Traditional Medicine [email protected]; [email protected]
Malawi Michael Udedi Assistant Director of Clinical Services (Mental Health and Substance Abuse) [email protected]
Malaysia Rohaida Binti Zakaria Senior Principal Assistant Director Pharmaceutical Services Division, Ministry of Health [email protected]
Maldives Aishath Mohamed Deputy Director General, Pharmaceuticals
Medicine and Therapeutic Goods Division, Maldives Food and Drug Authority [email protected]
Mali Mahamadou Ousmane Maiga [email protected]
Malta Victor P. Pace
Office of the Superintendence of Public Health, Department for Health Regulation [email protected]
Marshall Islands Julia Alfred Ministry of Health [email protected]
Mauritania Hamoud Fadel Yamohomed Director of Pharmacy and Laboratories Ministry of Health [email protected]
Mauritius Nitish Raj Sokool Officer-in-Charge Harm Reduction Unit, Ministry of Health and Wellness [email protected]
Mauritius Anil Jhugroo Advisor on Substance Abuse Ministry of Health and Wellness [email protected]
Mexico Angélica Juárez Ramírez Specialized Reviewer COFEPRIS representative, Federal Committee for Protection from Sanitary Risks
Micronesia (Federated States of) Benido Victor [email protected]
Monaco Isabelle Kessedjian Head of Division Pharmacy Inspector, Health Products Division [email protected]
Mongolia Luvsandagva Purevdorj [email protected]
Montenegro Jasna Sekulic Ministry of Health [email protected]
Morocco Hassan Elkarimi [email protected]
Annex II: List of focal points designated by Member States in previous years
Country Name Focal Point Job title Institution Email Last update
Morocco Jallal Toufiq
Professor of Psychiatry, Rabat Faculty of Medicine, Director of the National Centre on Drug Abuse Prevention, Treatment and Research, Director of the Moroccan Observatory on Drugs and Drugs Addictions
Mozambique Flavio Mandlate [email protected]
Myanmar Nanda Myo Aung Wan Program Manager/ Consultant Psychiatrist Drug Dependency Treatment and Research Unit, Ministry of Health and Sport
Namibia Ester Mvula Senior Pharmacist Ministry of Health & Social Services [email protected]
Nauru Richard Leona Chief Surgeon Ministry of Health [email protected]
Nepal
Netherlands Matthijs Geilenkirchen Nutrition, Health Protection and Prevention Department, Ministry of Health, Welfare and Sport
[email protected] 29 April 2024
New Zealand Group mail to be cc'ed [email protected] 7/10/2024
New Zealand Tania Jones Regulatory Practice and Analysis, Medsafe
[email protected] Confirmed 10/7/24
Nicaragua Karla Vanessa Delgado Martinez Director of Pharmacy Ministry of Health [email protected]
Niger Haoua Na Allah Alou [email protected]
Nigeria Wosilat Abdulhameed Deputy Director Federal Ministry of Health [email protected] 8/30/2024
Niue
North Macedonia
Norway Anne S. Onsgård Sagabråten Narcotic Drugs Control, Norwegian Medicines Agency [email protected]
Oman Dr. Mohammed Al-Rubaie, [email protected] 7/10/2024
Oman Dr Mahmood Al Abri [email protected] 7/10/2024
Oman Directorate General of Pharmaceutical Affairs and Drug control, Ministry of Health
Oman Drug Safety Center, Ministry of Health, Sultanate of Oman [email protected] 8/30/2024
Pakistan Rizwan Taj Professor Ministry of Health [email protected]
Palau Clarette Matlab Chief Pharmacist
Division of Ancillary Services, Bureau of Hospital and Clinical Services, Ministry of Health
Palau [email protected]
Palau Marla Ito [email protected]
Panama Dr Ricardo Goti, coordinateur du Programme de Santé Mentale
Ministère de la Santé du Panama [email protected] 7/16/2024
Annex II: List of focal points designated by Member States in previous years
Country Name Focal Point Job title Institution Email Last update
Papua New Guinea Vicky Wari Program Manager-Non Communicable Diseases
Public Health Division, National Department of Health [email protected]
Paraguay Blanca Galeano [email protected] 8/30/2024
Paraguay Zaira Francesca Stumpfs Bigarella [email protected]
Peru Judith Castañeda Alcántara Head of Functional Unit of Controlled Products
DIGEMID – General Directorate of Medicines, Supplies and Drugs [email protected] 7/26/2024
Philippines
Poland Michał Kidawa Polish Reitox Focal Point
Information Centre for Drugs and Drug Addiction (CINN) National Bureau for Drug Prevention [email protected]
Portugal Graça Vilar Director of Planning and Intervention Services Directorate
Intervention Service for Addictive Behaviours and Addictions General Directorate for Intervention on Addictive Behaviours and Dependencies SICAD
Puerto Rico
Qatar Majid Ali Al Abdulla Senior Consultant Psychiatrist
Director of addiction and CL at Hamad Medical Corporation Deputy Chairman of Mental Health Services, Hamad Medical Corporation
Republic of Korea Sang Hun Yeon Narcotics Policy Division of Ministry of Food and Drug Safety [email protected] 7/16/2024
Republic of Moldova Oleg Costachi
Standing Committee on Drugs Control, Agency for Medicines and Medical Devices
Romania Camelia Bunaciu Senior Advisor Ministry of Health [email protected]
Russian Federation Alyona Ryzova Deputy Head of the Unit for regulatory and leg Department for regulation of medicines and medical devices, Ministry of Health
[email protected] 7/11/2024
Rwanda
Saint Kitts and Nevis puerto rico
Saint Lucia Charlotte Emmanuel Coordinator of the Substance Abuse Advisory Council Secretariat
Substance Abuse Advisory Council Secretariat, Ministry of Health and Wellness [email protected]
Saint Lucia Paul Caleb Programme Officer
Substance Abuse Advisory Council Secretariat, Ministry of Health and Wellness [email protected]
Saint Vincent and the Grenadines
Samoa Robert Thomsen Assistant Chief Executive Officer HSPQA, Medical and Allied Division [email protected]
San Marino Claudio Muccioli Health Authority Director Health Authority [email protected]
Sao Tome and Principe
Annex II: List of focal points designated by Member States in previous years
Country Name Focal Point Job title Institution Email Last update
Saudi Arabia Adnan Alshammary
Administration of controlled preparations, Executive Management for Regulatory Affairs, Controlled Products Department, Regulatory Affairs Directorate, Drug Sector
Senegal Moussa DIALLO Pharmacist Inspector Pharmaceutical Regulatory Agency, Ministry of Health and Social Action [email protected]
Serbia Nataša Savić
Monitoring Centre for Drugs and Drug Addiction, Sector for Medicines and Medical Devices, Psychoactive Controlled Substances and Precursors, Ministry of Health
Seychelles
Sierra Leone
Singapore Ong Lay Tin Personal Assistant to Director (International Cooperation)
Senior Executive (International Cooperation) Public Health Group, Ministry of Health
[email protected] 04/07/2024 confiming no changes
Slovakia Peter Koreň Reitox National Focal Point
National Monitoring Centre for Drugs, Department of Anti-Drug Strategy Coordination and Drug Monitoring, Ministry of Health of the Slovak Republic
[email protected] 04/07/2024 confirming no changes
Slovenia Joze Hren Secretary Directorate of Public Health, Ministry of Health [email protected]
Solomon Islands Paul Orotaloa Head of Mental Health Services National Mental Health Service, Ministry of Health and Medical Services
Solomon Islands Stephen Araitewa Director Mental Health National Mental Health Service, Ministry of Health and Medical Services
Somalia
South Africa MG Molewa Ministry of Health [email protected]
South Sudan Moses Malual Deng Director General of Pharmaceuticals and Medical Supplies
Ministry of Health [email protected]
Spain Manuel Ibarra Head of Department Inspection & Enforcement
Spanish Agency of Medicines and Medical Products (AEMPS) [email protected]
Spain Lidia Fernandez Matellano
Narcotics and Psychotropic Substances Area, Pharmaceutical Inspection and Enforcement Department, Spanish Agency of Medicines and Medical Products (AEMPS)
Sri Lanka S.C. Wickramasinghe Deputy Director General (NCD) Ministry of Health [email protected]
Sudan
Annex II: List of focal points designated by Member States in previous years
Country Name Focal Point Job title Institution Email Last update
Suriname
Sweden Annika Borg
Ministry of Health and Social Affairs, Division for Public Health and Health Care [email protected] 4/8/2024
Switzerland Lucien Colliander
Federal Department of Home Affairs, Federal Office of Public Health, Division of International Affairs, Global Health Section
Switzerland Monika Joos Head of Division Narcotics Swissmedic, Swiss Agency for Therapeutic Products [email protected]
Syrian Arab Republic Ahmed Al-Salama Mental Health Directorate, Ministry of Health [email protected]
Tajikistan Salim Abdulazizov [email protected]
Thailand Sujinart Chantharakul Pharmacist
Narcotics Control Division (Standards and Regulations Sub-Division), Food and Drug Administration, Ministry of Public Health
Thailand Saranya Chavanich Pharmacist
Narcotics Control Division (Standards and Regulations Sub-Division), Food and Drug Administration, Ministry of Public Health
Thailand Korapin Na Ranong Expert on Narcotics Epidemiology
Narcotics Control Division Food and Drug Administration, Ministry of Public Health [email protected]
Thailand Raththar Benchapalanont Pharmacist
Narcotics Control Division Food and Drug Administration, Ministry of Public Health
Timor-Leste Soares Henriques Regulatory Affairs Pharmacist
Pharmacovigilance and Medicine Control Department, National Directorate for Pharmaceutical and Medicines, Ministry of Health
Togo Mouhoudine Yerima Centre National de Pharmacovigilance (CNPV)
[email protected]; [email protected]
Tokelau
Tonga Melenaite Mahe Principal Pharmacist Central Pharmacy and Medical Store, Old Vaiola, Ministry of Health [email protected]
Trinidad and Tobago Anesa Doodnath-Siboo Principal Pharmacist Ministry of Health [email protected]
Tunisia
Türkiye Elif Inci ERGONUL Head of Pharmacovigilance and Controlled Substances Department
Turkish Medicines and Medical Devices Agency, Ministry of Health
[email protected]; [email protected] 7/24/2024
Turkmenistan
Tuvalu
Uganda Hafsa Lukwata Head of Mental Health and Control of Substance Abuse
Mental Health and Control of Substance Abuse Division, Ministry of Health [email protected]
Annex II: List of focal points designated by Member States in previous years
Country Name Focal Point Job title Institution Email Last update
Ukraine Deputy Director Institute of Psychiatry, Forensic Psychiatric Examination and Drug Monitoring,
Ukraine Irina Pinchuk Director
Institute of Psychiatry of Taras Shevchenko National University of Kyiv, International Technology Transfer Center - Ukraine Head of ISSUP Ukraine National Chapter
Ukraine Yulia YACHNYK Clinical Psychologist Institute of Psychiatry, Taras Shevchenko National University of Kyiv
United Arab Emirates Alia Bin Hussain Head of Regulating Controlled substances Product & Precursor Chemicals Drug Department, Ministry of Health and Prevention
United Kingdom of Great Britain and Northern Ireland
Alberto Oteo Project Manager Drugs Research and Surveillance
Addiction and Inclusion Directorate, Office for Health Improvement & Disparities, Department of Health and Social Care
United Republic of Tanzania Suma Jairo Pharmacist Pharmaceutical Service Unit, Ministry of Health [email protected]
United States of America Edward Hawkins Senior Pharmacologist and International Drug Control Liaison
Center for Drug Evaluation and research, U.S. Food and Drug Administration
Uruguay Lorena Quintana Coordinator of the Addiction Prevention and Treatment Program
Ministry of Public Health [email protected] 8/2/2024
Uzbekistan Dr Azizbek Khamrakulov Head, Department of Inpatient and Specialized Care
Ministry of Health [email protected]
Uzbekistan Mr Zarif Ashurov Director Specialized Scientific and Mental Health Medical Center [email protected]
Vanuatu Jerry Iaruel Tafea Provincial Health Administrator Lenakel Health Office, Ministry of Health [email protected]
Venezuela (Bolivarian Republic of)
Viet Nam Mhin Tam Nguyen Regulatory Affair Consultant Ministry of Health [email protected]
Yemen
Zambia Nita Besa Head Clinical Care Chainama Hospital [email protected]
Zimbabwe Eneti Siyame Mental Health Manager Ministry of Health and Child Care [email protected]
Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga. |
20, AVENUE APPIA – CH-1211 GENEVA 27 – SWITZERLAND – TEL CENTRAL +41 22 791 2111 – FAX CENTRAL +41 22 791 3111 –WWW.WHO.INT
Ref.: C.L.22.2025 2025-22خ.د.
تةل أ ه ححححح و والأعضححححح المنت ححححح إلى الدول الأعضححححح تع ته)المنظمة( منظمة الصحححححعة الة لم ة هدي ت تشرين 22 إلى 20 م والأ ة الث م تةقد اجتم عه ( الخ ا لجنة) لاعتم د على الأدو ة المةن ة الخ ا لجنة أ
تةقد في جل حححححح ت للمنظمة الت ةة الخ ا لجنة لنظ إلى أ اجتم ع ت و . ححححححو حححححح ا جن ف، في 2025 أكتوبر /الأول للجنة والأ ة الث م الاجتم ع أعم ل جدول الأعضحححححح الدول إخط هو الدو ي الخط ب الغ ض م هذا فإ ،مغلقة لل جوع إل ه. الأول الملعق ملف في الوا د الخ ا
إلى توصحححححححححححححح ح ت تقحد 1971و 1961الاتةح ي ت الحدول ت لم اي حة المخحد ات لةح مي المنظمحة ملل ةحة موجحبو
اللاز ، الم اي ة وم حححححححححتو الدول ة للم اي ة الت ث نة ححححححححح ن ة مواد إخضححححححححح ع إلى الع جة شححححححححح المتعدة للأم الة الأم ة إلى ا ححتن دا نة حح ن ة م دة إخضحح ع تة ل إذا م ولتق . الخ ا لجنة أي الم ححتقلة، الا ححتشحح ة الةلم ة ته ه ئ مشححو إ ح ة أو الإدم في الم دة هذه بت ح اعتم ل لا حتة اض حنو اجتم ع الخ ا لجنة تةقد ،لا أ الدول ة للم اي ة الت ث
ل ن ت، م ححندة ي ا ات واتخ ذ الا ححتة اض هذا لإج ا و .الةلاج ة تط ق ته ع فضححلا لصححعة، ه إضحح ا أو ه ا ححتةم ل م حححححتة نة الت ث النة ححححح ن ة المواد م منتق ة لمجموعة الة مة الصحححححعة منظو وم وعلم ط تق م الخ ا لجنة تج ي
.المت عة المةلوم ت فضلفي ذلك إلى دعو الدول الأعضحح والأعضحح المنت حح فإ ، مغلقةتُةقد في جل حح ت اجتم ع ت لجنة الخ ا مع أ و
تشححح 20الجل حححة الإعلام ة لاجتم ع لجنة الخ ا الث م والأ ة و لمشححح لة في الإ حححه في عمل ة الا حححتة اض الع ل ة نشحطة الأ. و حتُةقد هذه الجل حة الإعلام ة افت اضح و حتت للأط اف المهتمة الاطلاع على 2025 الأول/ ألتو
لجنحة الخ ا إلى الاجتمح ع الثح م والأ ة لالمواد ي حد الا ححححححححححححححتة اض ع مةلومح ت وتقحد مح نحة لجنحة الخ ا ، والمق لحة لأ الإللت وني في الويت المن ب:نظ ف ه أثن مداولاته. و تتُ ح مةلوم ت الت ج ل على مويع اللجنة لي ل
https://www.who.int/news-room/events/detail/2025/10/20/default-calendar/forty-eighth-
expert-committee-on-drug-dependence.
المنظمة للمواد النة ححححححح ن ة الت ث م أجل لا حححححححتة اضت "إ شححححححح دامع وعلى غ ا المم حححححححة ال ححححححح قة وات ححححححح ي
والأعضحححح المنت حححح مل للدول الأعضحححح 1،(6، الملعق 1/ ححححجلات /126/2010ت ) إخضحححح عه للم اي ة الدول ة" المواد ي د ع دي قة معد ثة و قد مةلوم ت م خلال ت ،في عمل ة الا حتة اض التي تج ه لجنة الخ ا وا حهم أ أ ضح
ا ححححت إلى الدول الأعضحححح ححححل على المم ححححة ال حححح قة، ححححُ ، وج الغ ض لهذاو الا ححححتة اض ي ل انةق د الاجتم ع. ه تا ححتةم لا م ع ث للتق الخ ضححةة المواد م م دة لل ع ل لدا الخ صححة المةلوم ت لجمع المنت حح والأعضحح
ة مش وعةال .عل ه الدول ة لم اي ةوالأث المعتمل ل ش نه المة وضة الوطن ة الضوا ط وع لة وا تةم لاته الض م الدول الأعضححححححح حححححححم الذ عُ نوا لملعق الث ني هذا الخط ب الدو ي ي ئمة م حححححححصولي الاتصححححححح ل ت د و
دو لجنة الخ ا لمةلوم ت الخ صححة ل لدا م خلال الا ححت والأعضحح المنت حح في ال ححنوات ال حح قة والذ زو ه إلى الدول الأعضحح والمُشحح إل ه أعلاه ذا ايتضححت المةلوم ت الخ صححة م ححصول أو م ححصولي الاتصحح ل إدخ ل .المُوج وا
1 http://apps.who.int/gb/ebwha/pdf_files/EB126-REC1/B126_REC1-ar.pdf#page=95.
(2الم فق ت: )
...
...
...
C.L.22.2025 2025-22خ.د. Page 2 2الصةعة
ذلك ع ط ق لة إ لاغ أم نة لجنة الخ ا إلى و مدعو والأعض المنت الدول تغ ات أو تةد لات عل ه ، فإ مع ذل "م ححححححححححححصول 2025تموز/ يوليو 18، في موعد أيصحححححححححححح ه ecddsecretariat@who.int الةنوا : إلىإللت ون ة
.والأ ة المةن ة: )ا ال لد(" في موضوع ال لة الث م الاتص ل لاجتم ع لجنة الخ ا ذاو لجنة ا حت لا حتلم ل حمي اتصح ل م حصول صحةة ا مةتمدلا زال الق ئمة على ا حمه الوا د الشحخ ل ا
ه الخ ا ه الخ صححححححة ال ن ت على تةد لات أو إضحححححح ف ت أي إدخ ل ُ طلب ل م و الة هذا الأعضحححححح لدولإلى ا الموج على المد جهذا الاتصحححح ل م ححححصولإلى إضحححح ف ة تةل م ت المنظمة أم نة ف ححححت ححححل ،2025 يوليو /تموز 18 و علول ة الوصححححححول له وتت الق ئمة إط في تق في الا ححححححت ن ت نت ئج إعداد و حححححح ج ي. الإللت ون ة الا ححححححت ن ت إلى م شحححححح .والأ ة الث م الخ ا لجنة اجتم ع في المواد ا تة اض عمل ة
ضححححححححح فة أ ضححححححححح على تقد أي مةلوم ت و والأعضححححححححح المنت ححححححححح ع الدول الأعضححححححححح إلى الا حححححححححت ، تُشحححححححححج وا
إلى إ ح له والأ ة المواد التي حت حتة ضحه لجنة الخ ا في اجتم عه الث م ع )منشحو ة أو غ منشحو ة( إضح ف ة الإشحححح ة في موضححححوع ال حححح لة إلى م جع هذا الخط ب الدو ي مع [email protected]عنوا ال د الإللت وني
".2025-22خ.د. " أي
وال ححححت على جم ع التوصحححح ت الصحححح د ة ع الث منة دو ته في لجنة المخد ات الت ةة للأم المتعدة ويد وافقت . وجم ع التق التقن ة والتوصحححححححححح ت 2024المةقود في تشحححححححححح الأول/ ألتو والأ ة ال حححححححححح عاجتم ع لجنة الخ ا
(https://ecddrepository.org/en)م ححتودع مةلوم ت لجنة الخ ا فيعلى الإنت نت مت عة الصحح د ة ع لجنة الخ ا ا . الذي أُطلق مصخ
وتغتن منظمة الصححعة الة لم ة هذه الة صححة للي تة ب مجددا للدول الأعضحح والأعضحح المنت حح ع أ ححمى
ع ات التقد والاعت ا .
2025 ول و / تموز 11 ، جن ف
للجنة الخبراء التابعة للمنظمة والمعنية بالاعتماد على الأدوية والأربعون الثامن الاجتماع
جدول الأعمال المؤقت
----
( افتراضيا المعقودة علامية )الإجلسة ال
2025 تشرين الأول/ أكتوبر 20
وروبا أ الصيفي لوسط توقيت الب 13:00إلى الساعة 10:00من الساعة
ترحيب وافتتاح الاجتماعالكلمة -1
عروض منظمة الصحة العالمية -2 لجنة الخبراء المعنية بالاعتماد على الأدوية )لجنة الخبراء( 2-1 شعبة العلوم 2-2 الإنسان وحقوق والإنصاف الجنسين بين المساواة 2-3 الطب التقليدي 2-4
وبياناتهمعروض المشاركين -3
للجنة الخبراء التابعة للمنظمة والمعنية بالاعتماد على الأدوية الثامن والأربعون جتماع الا جنيف، سويسرا
جدول الأعمال المؤقت ----
جلسة مغلقة
2025 أكتوبر /الأول تشرين 20-22
محدّثةالمعلومات الجرائية و الإمسائل ال -1 الترحيبكلمة الاجتماع و افتتاح 1-1 تقديم المشاركين 1-2 بيان السرية 1-3 المصالح إعلانات 1-4 الرئيس والمقررنائب انتخاب الرئيس و 1-5 اعتماد جدول الأعمال 1-6
والمقدمة من الوكالات الدوليةثة عن الأولويات المعلومات المحدّ -2 المرتبط ببُعد الصحة العامة لمشكلة المخدرات العالميةإحاطات من الوكالات الدولية بشأن عملها 2-1
منظمة الصحة العالمية 2-1-1 مكتب الأمم المتحدة المعني بالمخدرات والجريمة 2-1-2 الهيئة الدولية لمراقبة المخدرات 2-1-3
ونتائجهاثة عن اجتماعات لجنة الخبراء التابعة للمنظمة معلومات محد 2-2
والأربعين للجنة الخبراء السابعالتوصيات والحصائل المنبثقة عن الاجتماع 2-2-1 ترصد المواد عن محد ثة معلومات 2-2-2
الدولية المراقبة نطاق بشأن التوصيات: الناقدة الاستعراضات -3 1ورقة الكوكا 3-1
الكوكاورق 3-1-1 2الاصطناعية القنب شبائه 3-2
3-2-1 MDMB-FUBINACA
الأفيونات الاصطناعية الجديدة 3-3 (إيزوتونيتازيبين) إزوتونيتازينبيروليدينو –ن 3-3-1 ديزيثيل إيتونيتازين –ن 3-3-2
وضع الصيغة النهائية لتقرير الاجتماع -4
.إشعاراً بشأن جدولة إحدى المواد 1971أو اتفاقية عام 1961اتفاقية عام قدم أحد الأطراف في 1
لُفت انتباه المنظمة إلى معلومات تفيد بأن هناك مادة تصنننننننع في السننننننر أو تنطوي بوجه خا على خطر شننننننديد يتهدد الصننننننحة 2 العامة والمجتمع وليس لها أي فائدة علاجية معروفة لدى أي طرف.
ي ي السنوات السابقة : الملحق الثان
قائمة بأسماء مسؤولي الاتصال الذين عينتهم الدول الأعضاء ف
ياسم مسؤول الاتصالالبلد يالمؤسسةاللقب الوظيف
ون يد الإلكبر آخر تحديثالبر
أفغانستان
Linda TernovaSpecialist ألبانيا
Regulation Sector of Pharmaceutical
Market and Medical Devices
Ministry of Health and Social
Protection, Albania
Ghrieb HouriaDoctorالجزائر
Narcotics, Psychotropics and
Chemical Precursors, General
Direction of Pharmacy and Health
Equipment, Algerian Health Ministry
Carla Lobaco VallsTechnical Officerأندورا Department of Health Resources and
Medicines [email protected]
Carme Pallarés Papaseitأندورا Department of Health Resources and
Medicines [email protected]
Ana Da Conceição Mamede أنغولا General Director, National Institute for
combating Drugs Ministry of Health [email protected]
أنتيغوا وبربودا
ن G. RebalderíaPharmacistالأرجنتي
Director of Surveillance of Substances
Subject to Special Control
Argentinian Ministry of Health [email protected]
Hasmik MartirosyanArmenian Ministry of [email protected]أرمينيا
اليا أستر
Narcotics Control Section
Office of Drug Control
Australian Government Department
of Health and Aged Care
[email protected]/10/2024
اليا [email protected]أستر
Raphael BayerHead of Divisionالنمسا
Section VI, Department 6
Federal Ministry of Social Affairs,
Health, Care and Consumer
Protection
Telman Suleyman Oglu [email protected]أذربيجان
جزر البهاما
Samar Yousef SalemSenior PharmacistMinistry of [email protected] البحرين
Habibur Rahman KhanAdditional Secretaryبنغلاديش Health Services Division,
Ministry of Health & Family Welfare [email protected]
Lindsay BynoeAssistant Director for Drug RegulationMinistry of [email protected]بربادوس
Aleksey KralkoMinistry of [email protected] بيلاروس
Lies Gremeauxبلجيكا Head of Unit illicit Drugs, Reitox National
Focal Point
Epidemiology and Public Health,
Sciensano,
Ministry of Health
ن بلت
ن Saturnin Bognonبين State-certified Pharmacist, Head of
Pharmaceutical Establishments Department
Pharmaceutical Establishments
Department [email protected]
Dil Kumar Subbaبوتان Department of Public Health,
Ministry of Health [email protected]
H.E. Amb. Maira Mariela Macdonalدولة بوليفيا المتعددة القوميات Permanente Representative of the
Plurinational State of Bolivia [email protected]; [email protected]/27/2024
[email protected]; [email protected]البوسنة والهرسك
ي ي السنوات السابقة : الملحق الثان
قائمة بأسماء مسؤولي الاتصال الذين عينتهم الدول الأعضاء ف
ياسم مسؤول الاتصالالبلد يالمؤسسةاللقب الوظيف
ون يد الإلكبر آخر تحديثالبر
Šahman Sabinaالبوسنة والهرسك
Department for Health, Ministr of the
Civill Affairs of Bosnia and
Herzegovina
Vivian SebakoChief Pharmacistبوتسوانا Department of Clinical Services,
Ministry of Health and Wellness [email protected]
ازيل Renata de Morais Souza, Moema Luisa Silva MacedoManagerالتر
Management of Controlled Products
GPCON/GGMON/DIMON/ANVISA
Controlled Substances Office
Brazilian Health Regulatory Agency –
ANVISA
ازيل Natalia Jorge e Costaالتر
International Affairs Office, Brazilian
Health Regulatory Agency - ANVISA,
AINTE/ GADIP/ANVISA
دار السلام ي (Ms)Acting Director of Pharmaceutical Services Zainin Haji ‘Aini Zanatul Hajahبرونن
Department of Pharmaceutical
Services, Ministry of Health [email protected]
Slaveyka Nikolova Chief Expert at the Health Promotionبلغاريا
Department Health Promotion and
Prophylaxis of the Diseases and
Addictions Directorate
Alexander Panayotovبلغاريا Head of the National Focus Center
Department
Mental Health and Addiction
Prevention Directorate, National
Center for Public Health and Analysis
[email protected]بوركينا فاسو
Israël [email protected]بوروندي
دي Raquel Lopesكابو فت
Commission for the Coordination of
Alcohol and Other Drugs, Ministerio
da Saude e da Seguranca Social
[email protected]/30/2024
Chhit SophalDirectorكمبوديا Department of Mental and Substance
Abuse, Ministry of Health [email protected]
ون Ketchozo Loko [email protected]الكامت
كندا
International Relations Unit, Office of
Drug Policy and Science, Controlled
Substances Directorate, Health
Canada, Government of Canada
[email protected]/26/2024
جمهورية أفريقيا الوسطى
Haoua Haroun SakerDeputy Director of Pharmacy and MedicineMinistry of Public [email protected]تشاد
Javiera Erazo LeivaAdvisorشيلي Department of Mental
Health/DIPRECE, Ministry of Health [email protected]
ن Zhendong HUADeputy DirectorNational Narcotics [email protected]الصي
ن Yan ZHENGOfficialالصي Office of National Narcotics Control
Commission [email protected]
ن Peng XUSenior ExpertNational Narcotics [email protected]الصي
ي ي السنوات السابقة : الملحق الثان
قائمة بأسماء مسؤولي الاتصال الذين عينتهم الدول الأعضاء ف
ياسم مسؤول الاتصالالبلد يالمؤسسةاللقب الوظيف
ون يد الإلكبر آخر تحديثالبر
Oscar Ricardo Santanaكولومبيا
Observatorio de Drogas de Colombia
Dirección de Políticas de Drogas y
Actividades Relacionadas
Ministerio de Justicia y del Derecho
[email protected]; [email protected] 7/16/2024
Nubia Esperanza Bautistaكولومبيا Coordinadora del Grupo Convivencia Social
y Ciudadanía
Dirección de Promoción y Prevención
– Ministerio de Salud y Protección
Social
Germán Andrés Calderón Velásquezكولومبيا Coordinador Grupo Interno de Trabajo de
Asuntos Relacionados con las Drogas Ministerio de Relaciones Exteriores
جزر القمر
Tereapii UkaCentral Policy and Planning [email protected]جزر كوك
Marchena [email protected]كوستاريكا
Ernest [email protected]كوت ديفوار
Lidija Vugrinecكرواتيا
Head of National Information Unit in the
Field of Drugs and Behavioural Addictions
and Internal Relations Department
Croation Institute of Public [email protected]/30/2024
كوبا
ص John KkolosPharmacistقتر Pharmaceutical Services, Ministry of
Health [email protected]
Vlastimil Brandejsتشيكيا
Inspectorate Department, Narcotic
and Psychotropic Substances
Ministry of Health
Kim Jong Gukجمهورية كوريا الشعبية الديمقراطية
Ghislaine Mbelu [email protected]جمهورية الكونغو الديمقراطية
Kari GragaasenChief Consultantالدانمرك Head of Focal Point, Prevention,
National Board of Health [email protected]
ي جيبونر
Laura EspritChief Medical Officeدومينيكا Ministry of Health, Wellness and New
Health Investment [email protected]
Anna Royer-EdmundChief Pharmacistدومينيكا Ministry of Health, Wellness and New
Health Investment [email protected]
[email protected]الجمهورية الدومينيكية
Francisca Dalia Castillo Sanchezالجمهورية الدومينيكية Head of the Assistive Technology
Department
General Directorate of Medicines,
Food and Health Products
(DIGEMAPS), Ministry of Public Health
Gabriel Ordonez Guzmanإكوادور
Director nacional de Estrategias de
Prevencion Y Control para Enfermedades no
Transmisibles
Salud Mental Y Fenomeno
Socioeconomico de las Drogas [email protected]/24/2024
Dr Samah Abdeleazik Kandil Ministry of Health and [email protected]; [email protected]/16/2024مصر
José Mauricio Bermúdez Recinosالسلفادور Focal Point of the Ministry of Health of El
Salvador
Health Technology Department,
Ministry of Health [email protected]
غينيا الاستوائية
ي ي السنوات السابقة : الملحق الثان
قائمة بأسماء مسؤولي الاتصال الذين عينتهم الدول الأعضاء ف
ياسم مسؤول الاتصالالبلد يالمؤسسةاللقب الوظيف
ون يد الإلكبر آخر تحديثالبر
يا Michael Girmay [email protected]إريتر
Olga Kampإستونيا Inspector of pharmacovigilance, drugs and
psychotropic substances, and the precursors
State Agency of Medicines, Ministry
of Health [email protected]
ي إسواتينن
Baharu Zewdie [email protected]إثيوبيا
ي Ilisabeta May PesaminoChief Pharmacistفيجر
Pharmaceutical & Biomedical
Services/Ministry of Health & Medical
Services
Katja Pihlainen فنلندا Finnish Medicines Agency, Ministry of
Health [email protected]
Luciano AmatoActing Head of Departmentفرنسا
Regulation of narcotics and
psychotropic substances,
National Agency for the Safety of
Medicines and Health Products
Okouyi Ndakissaغابون
Directorate of Medicines and
Pharmacy
Ministry of Health [email protected]
غامبيا
Ekaterine PaposhviliSenior Specialistجورجيا
Division of Legal Circulation of
Narcotic Drugs, LEPL State Regulation
Agency for Medical Activities
Ministry of Labour, Health and Social
Affairs of Georgia
Annette Hinzeألمانيا
Division 122 - Narcotics Law, Traffic
in Narcotics, International Narcotic
Drug Affairs
Federal Ministry of Health
Martha Gyansa-LutterodtDirectorغانا Pharmaceutical Services, Ministry of
Health [email protected]
Dr Foteini Koulouriاليونان Head of General Directorate of Public
Health and Quality of Life Hellenic Ministry of [email protected] ; [email protected]/16/2024
Avgerinos Nikolaosاليونان Psychiatrist, Programs Implementation
Director
OKANA - Organisation Against Drugs
Greece [email protected] ; [email protected]
اءMs Anastasia Petroulia Legal Advisor to the Minister of HealthHellenic Ministry of [email protected]; [email protected]اليونان للجنة الختر ن الاجتماع السابع والأربعي ً أيضا ستحصرن
غرينادا
José Miguel Solares Estradaغواتيمالا Department of Regulation and Control of
Related Pharmaceutical Products [email protected]/30/2024
Alicia Elena Morgan Duránغواتيمالا Section of Psychotropics, Narcotics, Imports
and Exports [email protected]/30/2024
غينيا
بيساو-غينيا
غيانا
ي Marie Judith Robuste RocheMinistry of [email protected]هاينر
Alex Virgilio Santos Morenoهندوراس General Director of the Honduran Institute
for the Prevention of Alcoholism
Honduran Institute for the
Prevention of Alcoholism, Drug
Addiction and Drug Dependence
(IHADFA)
ي ي السنوات السابقة : الملحق الثان
قائمة بأسماء مسؤولي الاتصال الذين عينتهم الدول الأعضاء ف
ياسم مسؤول الاتصالالبلد يالمؤسسةاللقب الوظيف
ون يد الإلكبر آخر تحديثالبر
Tímea Kahlesz Deputy Head of Departmentهنغاريا EMMI Pharmaceutical and Medical
Technology Department [email protected]
Bjarni SigurðssonMinistry of [email protected]أيسلندا
Dr Anju DhawanProfessor and Headالهند
Department of Psychiatry, National
Drug Dependence Treatment Centre,
All India Institute of Medical Sciences
[email protected]/24/2024
Agusdini Banun Saptaningsihإندونيسيا Director of Pharmaceutical Production and
Distribution
Directorate General of
Pharmaceutical Care and Medical
Devices,
Mina [email protected]جمهورية إيران الإسلامية
Emad Abdulrazzaq AbdulghaniMinistry of [email protected]العراق
Conor BrennanDepartment of [email protected]أيرلندا
Alan BellDepartment of [email protected]أيرلندا
Paola RoscaHead of the Addiction Treatment DepartmentMinistry of [email protected]إسرائيل
Tal Lavyإسرائيل
The Competent Authority for
Narcotics, Psychotropics and
Precursors
Pharmaceutical Administration
Pietro CanuzziHead of Office 7, Central Narcotic Officeإيطاليا Ministry of Health - Directorate
general of Health Prevention [email protected]/26/2024
Dr Jacquiline Bisasor McKenzieChief Medical OfficerMinistry of Health & [email protected]/5/2024جامايكا
Ms Uki AtkinsonResearch Analystجامايكا National Council on Drug Abuse
(NCDA) [email protected]/5/2024
اليابان
Compliance and Narcotics Division,
Pharmaceutical Safety and
Environmental Health Bureau
Malak AlMahirahالأردن
Head of Narcotics, Psychotropic
Substances and Chemical Precursors
Department,
Jordan Food and Drug Administration
Prilutskaya Marinaكازاخستان Republican Scientific and Practical
Center of Mental Health [email protected]
Anthony Toroitich [email protected]كينيا
Simon Njuguna [email protected]كينيا
ي يبانر Biribo KararaitiChief Pharmacistكت
Ministry of Health and Medical
Services [email protected]
Ali Abdulmohsen JaraghHeadالكويت
Control of Licenses for Narcotic Drugs
and Psychotropic Substances
Department
[email protected]/24/2024
ستان ن غت Kanyshai Damirbekقت Drug Trafficking Control Department,
Ministry of Foreign Affairs [email protected]
ي ي السنوات السابقة : الملحق الثان
قائمة بأسماء مسؤولي الاتصال الذين عينتهم الدول الأعضاء ف
ياسم مسؤول الاتصالالبلد يالمؤسسةاللقب الوظيف
ون يد الإلكبر آخر تحديثالبر
Khatthanaphone PhandoangsyHead of Health Promotion and Nutrition Unitجمهورية لاو الديمقراطية الشعبية Department of Hygiene and Health
Promotion, Ministry of Health [email protected]
Linda VeisbergaMinistry of [email protected]لاتفيا
Marie-Therese MatarHead of Narcotics DepartmentMinistry of Public [email protected]لبنان
Masello [email protected]ليسوتو
يا Dr. Moses Ziah IIDirector Mental Health UnitMinistry of Health, Republic of [email protected]; [email protected]ليتر
ليبيا
Mačiūnienė Rimaليتوانيا Head of Drug Precursors Control and Risk
Assessment Division
Drug Precursors Control and Risk
Assessment Division,
Drug, Tobacco and Alcohol Control
Department
غ Alain OrigerNational Drug CoordinatorMinistry of [email protected]لكسمتر
Maximine RavaoarimananaDirector of PharmacyLaboratories and Traditional [email protected]; [email protected]مدغشقر
Michael Udediملاوي Assistant Director of Clinical Services
(Mental Health and Substance Abuse) [email protected]
يا ن Rohaida Binti ZakariaSenior Principal Assistant Directorمالت Pharmaceutical Services Division,
Ministry of Health [email protected]
Aishath MohamedDeputy Director General, Pharmaceuticalsملديف
Medicine and Therapeutic Goods
Division,
Maldives Food and Drug Authority [email protected]
Mahamadou Ousmane [email protected]مالي
Victor P. Paceمالطة
Office of the Superintendence of
Public Health,
Department for Health Regulation [email protected]
Julia AlfredMinistry of [email protected]جزر مارشال
Hamoud Fadel YamohomedDirector of Pharmacy and LaboratoriesMinistry of [email protected]موريتانيا
Nitish Raj SokoolOfficer-in-Chargeموريشيوس Harm Reduction Unit, Ministry of
Health and Wellness [email protected]
Anil JhugrooAdvisor on Substance AbuseMinistry of Health and [email protected]موريشيوس
Angélica Juárez RamírezSpecialized Reviewerالمكسيك
COFEPRIS representative, Federal
Committee for Protection from
Sanitary Risks
يا الموحدة ن Benido Victor [email protected]ولايات ميكرونت
Isabelle KessedjianHead of Divisionموناكو Pharmacy Inspector, Health Products
Division [email protected]
Luvsandagva [email protected]منغوليا
Jasna SekulicMinistry of [email protected]الجبل الأسود
Hassan Elkarimi [email protected]المغرب
ي ي السنوات السابقة : الملحق الثان
قائمة بأسماء مسؤولي الاتصال الذين عينتهم الدول الأعضاء ف
ياسم مسؤول الاتصالالبلد يالمؤسسةاللقب الوظيف
ون يد الإلكبر آخر تحديثالبر
Jallal Toufiqالمغرب
Professor of Psychiatry, Rabat Faculty of
Medicine,
Director of the National Centre on Drug
Abuse Prevention, Treatment and Research,
Director of the Moroccan Observatory on
Drugs and Drugs Addictions
Flavio [email protected]موزامبيق
Nanda Myo Aung WanProgram Manager/ Consultant Psychiatristميانمار
Drug Dependency Treatment and
Research Unit,
Ministry of Health and Sport
Ester MvulaSenior PharmacistMinistry of Health & Social [email protected]ناميبيا
Richard Leona Chief SurgeonMinistry of [email protected] ناورو
نيبال
Matthijs Geilenkirchenهولندا
Nutrition, Health Protection and
Prevention Department,
Ministry of Health, Welfare and Sport
[email protected] April 2024
Group mail to be cc'[email protected]/10/2024نيوزيلندا
Tania Jonesنيوزيلندا
Regulatory Practice and Analysis,
Medsafe
10/7/24جرى تأكيده بتاري خ
Karla Vanessa Delgado MartinezDirector of PharmacyMinistry of [email protected]نيكاراغوا
Haoua Na Allah [email protected]النيجر
يا Wosilat AbdulhameedDeputy DirectorFederal Ministry of [email protected]/30/2024نيجت
نيوي
مقدونيا الشمالية
وي ج Anne S. Onsgård Sagabråtenالتن Narcotic Drugs Control,
Norwegian Medicines Agency [email protected]
Dr. Mohammed Al-Rubaie, [email protected]/10/2024عمان
Dr Mahmood Al Abri [email protected]/10/2024عمان
عمان
Directorate General of
Pharmaceutical Affairs and Drug
control,
Ministry of Health
عمان Drug Safety Center, Ministry of
Health, Sultanate of Oman [email protected]/30/2024
Rizwan TajProfessorMinistry of [email protected]باكستان
Clarette MatlabChief Pharmacistبالاو
Division of Ancillary Services,
Bureau of Hospital and Clinical
Services,
Ministry of Health
[email protected]بالاو
Marla [email protected]بالاو
,Dr Ricardo Gotiبنما coordinateur du Programme de Santé
Mentale Ministère de la Santé du Panama [email protected]/16/2024
ي ي السنوات السابقة : الملحق الثان
قائمة بأسماء مسؤولي الاتصال الذين عينتهم الدول الأعضاء ف
ياسم مسؤول الاتصالالبلد يالمؤسسةاللقب الوظيف
ون يد الإلكبر آخر تحديثالبر
Vicky Wariبابوا غينيا الجديدة Program Manager-Non Communicable
Diseases
Public Health Division, National
Department of Health [email protected]
Blanca [email protected]/30/2024باراغواي
Zaira Francesca Stumpfs [email protected]باراغواي
و Judith Castañeda Alcántara بت Head of Functional Unit of Controlled
Products
DIGEMID – General Directorate of
Medicines, Supplies and Drugs [email protected]/26/2024
ن الفلبي
Polish Reitox Focal Point Kidawa Michał بولندا
Information Centre for Drugs and
Drug Addiction (CINN)
National Bureau for Drug Prevention [email protected]
تغال ر Graça Vilarال Director of Planning and Intervention
Services Directorate
Intervention Service for Addictive
Behaviours and Addictions
General Directorate for Intervention
on Addictive Behaviours and
Dependencies
SICAD
بورتوريكو
Majid Ali Al AbdullaSenior Consultant Psychiatristقطر
Director of addiction and CL at
Hamad Medical Corporation
Deputy Chairman of Mental Health
Services,
Hamad Medical Corporation
Sang Hun Yeonجمهورية كوريا Narcotics Policy Division of Ministry
of Food and Drug Safety [email protected]/16/2024
Oleg Costachiجمهورية مولدوفا
Standing Committee on Drugs
Control,
Agency for Medicines and Medical
Devices
Camelia BunaciuSenior AdvisorMinistry of [email protected]رومانيا
Alyona RyzovaDeputy Head of the Unit for regulatory and legaالاتحاد الروسي regulation of pharmaceutical activities, regulation of narcotic drugs and psychotropic substances
Department for regulation of
medicines and medical devices,
Ministry of Health
[email protected]/11/2024
رواندا
puerto ricoسانت كيتس ونيفس
Charlotte Emmanuelسانت لوسيا Coordinator of the Substance Abuse
Advisory Council Secretariat
Substance Abuse Advisory Council
Secretariat,
Ministry of Health and Wellness [email protected]
Paul CalebProgramme Officerسانت لوسيا
Substance Abuse Advisory Council
Secretariat,
Ministry of Health and Wellness [email protected]
سانت فنسنت وجزر غرينادين
Robert ThomsenAssistant Chief Executive OfficerHSPQA, Medical and Allied [email protected]ساموا
Claudio MuccioliHealth Authority DirectorHealth [email protected]سان مارينو
ي وبرينسينر سان تومي
ي ي السنوات السابقة : الملحق الثان
قائمة بأسماء مسؤولي الاتصال الذين عينتهم الدول الأعضاء ف
ياسم مسؤول الاتصالالبلد يالمؤسسةاللقب الوظيف
ون يد الإلكبر آخر تحديثالبر
Adnan Alshammaryالمملكة العربية السعودية
Administration of controlled
preparations,
Executive Management for
Regulatory Affairs,
Controlled Products Department,
Regulatory Affairs Directorate,
Drug Sector
Moussa DIALLOPharmacist Inspectorالسنغال Pharmaceutical Regulatory Agency,
Ministry of Health and Social Action [email protected]
Savić Natašaصربيا
Monitoring Centre for Drugs and
Drug Addiction, Sector for Medicines
and Medical Devices, Psychoactive
Controlled Substances and
Precursors, Ministry of Health
سيشيل
اليون ست
Ong Lay Tinسنغافورة Personal Assistant to Director (International
Cooperation)
Senior Executive (International
Cooperation)
Public Health Group,
Ministry of Health
[email protected]/07/2024 بتاري خ ات جرى تأكيد عدم إدخال أي تغيت
KoreňReitox National Focal Point Peterسلوفاكيا
National Monitoring Centre for Drugs,
Department of Anti-Drug Strategy
Coordination and Drug Monitoring,
Ministry of Health of the Slovak
Republic
[email protected]/07/2024 بتاري خ ات جرى تأكيد عدم إدخال أي تغيت
Joze HrenSecretaryسلوفينيا Directorate of Public Health, Ministry
of Health [email protected]
Paul OrotaloaHead of Mental Health Servicesجزر سليمان
National Mental Health Service,
Ministry of Health and Medical
Services
Stephen Araitewa Director Mental Healthجزر سليمان
National Mental Health Service,
Ministry of Health and Medical
Services
الصومال
MG MolewaMinistry of [email protected]جنوب أفريقيا
Moses Malual Dengجنوب السودان Director General of Pharmaceuticals and
Medical Supplies Ministry of [email protected]
Manuel Ibarraأسبانيا Head of Department Inspection &
Enforcement
Spanish Agency of Medicines and
Medical Products (AEMPS) [email protected]
Lidia Fernandez Matellanoأسبانيا
Narcotics and Psychotropic
Substances Area,
Pharmaceutical Inspection and
Enforcement Department,
Spanish Agency of Medicines and
Medical Products (AEMPS)
S.C. Wickramasinghe Deputy Director General (NCD)Ministry of [email protected]سري لانكا
السودان
ي ي السنوات السابقة : الملحق الثان
قائمة بأسماء مسؤولي الاتصال الذين عينتهم الدول الأعضاء ف
ياسم مسؤول الاتصالالبلد يالمؤسسةاللقب الوظيف
ون يد الإلكبر آخر تحديثالبر
سورينام
Annika Borgالسويد
Ministry of Health and Social Affairs,
Division for Public Health and Health
Care [email protected]/8/2024
Lucien Collianderسويسرا
Federal Department of Home Affairs,
Federal Office of Public Health,
Division of International Affairs,
Global Health Section
Monika JoosHead of Division Narcoticsسويسرا Swissmedic, Swiss Agency for
Therapeutic Products [email protected]
Ahmed Al-Salamaالجمهورية العربية السورية Mental Health Directorate,
Ministry of Health [email protected]
Salim [email protected]طاجيكستان
Sujinart ChantharakulPharmacistتايلند
Narcotics Control Division (Standards
and Regulations Sub-Division),
Food and Drug Administration,
Ministry of Public Health
Saranya ChavanichPharmacistتايلند
Narcotics Control Division (Standards
and Regulations Sub-Division),
Food and Drug Administration,
Ministry of Public Health
Korapin Na RanongExpert on Narcotics Epidemiologyتايلند
Narcotics Control Division
Food and Drug Administration,
Ministry of Public Health [email protected]
Raththar BenchapalanontPharmacistتايلند
Narcotics Control Division
Food and Drug Administration,
Ministry of Public Health
ي- تيمور Soares HenriquesRegulatory Affairs Pharmacistليشنر
Pharmacovigilance and Medicine
Control Department, National
Directorate for Pharmaceutical and
Medicines, Ministry of Health
Mouhoudine Yerimaتوغو Centre National de
Pharmacovigilance (CNPV) [email protected]; [email protected]
توكيلاو
Melenaite MahePrincipal Pharmacist تونغا Central Pharmacy and Medical Store,
Old Vaiola, Ministry of Health [email protected]
Anesa Doodnath-SibooPrincipal PharmacistMinistry of [email protected]ترينيداد وتوباغو
تونس
Elif Inci ERGONUL تركيا Head of Pharmacovigilance and Controlled
Substances Department
Turkish Medicines and Medical
Devices Agency, Ministry of Health [email protected]; [email protected]/24/2024
تركمانستان
توفالو
Hafsa Lukwataأوغندا Head of Mental Health and Control of
Substance Abuse
Mental Health and Control of
Substance Abuse Division,
Ministry of Health [email protected]
ي ي السنوات السابقة : الملحق الثان
قائمة بأسماء مسؤولي الاتصال الذين عينتهم الدول الأعضاء ف
ياسم مسؤول الاتصالالبلد يالمؤسسةاللقب الوظيف
ون يد الإلكبر آخر تحديثالبر
Deputy Directorأوكرانيا
Institute of Psychiatry, Forensic
Psychiatric Examination and Drug
Monitoring,
Irina PinchukDirectorأوكرانيا
Institute of Psychiatry of Taras
Shevchenko National University of
Kyiv,
International Technology Transfer
Center - Ukraine
Head of ISSUP Ukraine National
Chapter
Yulia YACHNYKClinical Psychologistأوكرانيا
Institute of Psychiatry, Taras
Shevchenko National University of
Kyiv
Alia Bin HussainHead of Regulating Controlled substancesالإمارات العربية المتحدة
Product & Precursor Chemicals Drug
Department,
Ministry of Health and Prevention
يطانيا العظمى وأيرلندا الشمالية Alberto Oteoالمملكة المتحدة لتر Project Manager Drugs Research and
Surveillance
Addiction and Inclusion Directorate,
Office for Health Improvement &
Disparities,
Department of Health and Social Care
انيا المتحدة ن Suma JairoPharmacistجمهورية تتن Pharmaceutical Service Unit, Ministry
of Health [email protected]
Edward Hawkinsالولايات المتحدة الأمريكية Senior Pharmacologist and International
Drug Control Liaison
Center for Drug Evaluation and
research,
U.S. Food and Drug Administration
Lorena Quintanaأورغواري Coordinator of the Addiction Prevention and
Treatment Program Ministry of Public [email protected]/2/2024
Dr Azizbek Khamrakulovأوزبكستان Head, Department of Inpatient and
Specialized Care Ministry of [email protected]
Mr Zarif AshurovDirectorأوزبكستان Specialized Scientific and Mental
Health Medical Center [email protected]
Jerry IaruelTafea Provincial Health Administratorفانواتو Lenakel Health Office,
Ministry of Health [email protected]
ويلا البوليفارية ن جمهورية فتن
Mhin Tam NguyenRegulatory Affair ConsultantMinistry of [email protected]فييت نام
اليمن
Nita Besa Head Clinical CareChainama [email protected] زامبيا
Eneti SiyameMental Health ManagerMinistry of Health and Child [email protected]زمبابوي
20, AVENUE APPIA – CH-1211 GENEVA 27 – SWITZERLAND – TEL CENTRAL +41 22 791 2111 – FAX CENTRAL +41 22 791 3111 – WWW.WHO.INT
… 内附：(2)
World Health Organization
…
Ref.: C.L.22.2025
世界卫生组织（世卫组织）谨向各会员国和准会员致意，并宣布药物依赖问题专家
委员会第四十八次会议将于 2025 年 10 月 20 日至 22 日在瑞士日内瓦举行。鉴于世卫组织
专家委员会会议属于非公开会议，本函旨在向会员国通报这次会议的议程（载于附件
一，供参考）。
1961 年和 1971 年《国际药物管制公约》授权世卫组织根据其独立科学咨询机构，即
药物依赖问题专家委员会的建议，就精神活性物质国际管制的必要性和程度向联合国秘
书长提出建议。为评估某种精神活性物质是否应受国际管制，药物依赖问题专家委员会
每年召开会议，审查有关物质导致依赖、滥用和健康危害的可能性，以及任何治疗用
途。为了进行审查并做出循证决策，药物依赖问题专家委员会利用现有最佳信息对选定
的精神活性物质进行医学、科学和公共卫生评估。
虽然这些会议属于非公开性质，但仍邀请会员国和准会员参加 2025 年 10 月 20 日举
行的药物依赖问题专家委员会第四十八次会议的信息通报会议，为药物依赖问题专家委
员会的审查进程做出贡献。此次信息通报会议将以虚拟方式举行，旨在让有关各方了解
药物依赖问题专家委员会秘书处当前和未来的活动，并向专家委员会第四十八次会议提
交受审查物质的相关信息，供其审议。注册信息将适时公布在药物依赖问题专家委员会
网站上：https://www.who.int/news-room/events/detail/2025/10/20/default-calendar/forty-eighth- expert-committee-on-drug-dependence。
同过去一样，并根据《世卫组织审查受国际管制的精神活性物质指导方针》
（EB126/2010/REC1，附件 6）1这一出版物的要求，各会员国和准会员也可以通过在会议
之前提供有关受审查物质的最新准确信息，为药物依赖问题专家委员会的审查进程做出
贡献。为此，并按照以往惯例，将向会员国和准会员发送一份调查问卷，收集各国有关
每种被评价物质的合法使用、有害使用、国家管制状况和国际管制的可能影响的信息。
1 http://apps.who.int/gb/ebwha/pdf_files/EB126-REC1/B126_REC1-ch.pdf#page=94.
Page 2 C.L.22.2025
… 该通函附件二载有会员国和准会员往年正式指定的国家联络人名单，这些联络人将
通过上述会员国调查问卷向药物依赖问题专家委员会提供国家信息。如果联络人的信息
需要修改或修正，请会员国和准会员在 2025 年 7 月 18 日之前通过电子邮件
（[email protected] ）告知世卫组织药物依赖问题专家委员会秘书处，并在邮件主
题栏注明“48ECDD Focal Point：（Country Name）”。
如果名单上的人员仍然是今年填写药物依赖问题专家委员会会员国调查问卷的正式
联络人，且在 2025 年 7 月 18 日之前没有收到对联络人详情进行补充或修正的意见，世卫
组织秘书处将向清单中的联络人发送更多指导，并直接向其提供在线问卷。这次问卷结
果将作为药物依赖问题专家委员会第四十八次会议物质审查进程的一部分编制成报告。
除调查问卷外，还鼓励各会员国和准会员向 [email protected] 发送主题为“Ref: C.L.22.25”的电子邮件，提供与药物依赖问题专家委员会第四十八次会议将审查的物质有
关的任何其他补充信息（未公布或已公布）。
2024 年 10 月举行的药物依赖问题专家委员会第四十七次会议所提全部建议均已被联
合国麻醉药品委员会第六十八届会议接受，药物依赖问题专家委员会编写的所有技术报告
和提出的所有建议可通过最近启动的药物依赖问题专家委员会信息库(https://ecddrepository. org/en) 在线查阅。
世界卫生组织借此机会重申对各会员国和准会员的最崇高敬意。
2025 年 7 月 11 日于日内瓦
世卫组织药物依赖问题专家委员会第四十八次会议
临时议程
----
信息通报会议（虚拟）
2025 年 10 月 20 日
欧洲中部夏令时 10:00-13:00
1. 欢迎和会议开幕
2. 世卫组织介绍情况
2.1 药物依赖问题专家委员会
2.2 科学部门
2.3 性别、公平和人权
2.4 传统医学
3. 与会者的介绍和发言
世卫组织药物依赖问题专家委员会第四十八次会议
瑞士日内瓦
临时议程
----
非公开会议
2025 年 10 月 20-22 日
1. 程序事项和最新情况
1.1 会议开幕和欢迎辞
1.2 介绍与会者
1.3 保密声明
1.4 利益申报
1.5 选举主席、副主席和报告员
1.6 通过议程
2. 国际机构关于重点事项的最新情况
2.1 国际机构简介其针对世界毒品问题的公共卫生影响所开展的工作
2.1.1 世卫组织
2.1.2 联合国毒品和犯罪问题办公室
2.1.3 国际麻醉品管制局
2.2 药物依赖问题专家委员会会议的最新建议和结果
2.2.1 药物依赖问题专家委员会第四十七次会议的建议和结果
2.2.2 物质监测情况更新
3. 严格审查：关于国际管制范围的建议
3.1 古柯叶 1
3.1.1 古柯叶
3.2 合成大麻素 2
3.2.1 MDMB-FUBINACA
3.3 新型合成类阿片药物 2
3.3.1 N-pyrrolidino isotonitazene (Isotonitazepyne)
3.3.2 N-Desethyl etonitazene
4. 完成会议报告定稿
1 具有一个《1961 年公约》或《1971 年公约》缔约方关于将一种物质列入管制附表的通知书。 2 世卫组织获得有关信息，一种物质系私下生产，对公众健康和社会具有特别严重的风险，且没有任何缔约方
承认其治疗用途。
附件二：会员国往年指定的联络人名单
国家 联络人姓名 职称 机构 电子邮件 上一次更新日期
阿富汗
阿尔巴尼亚 Linda Ternova Specialist Regulation Sector of Pharmaceutical Market and Medical Devices
Ministry of Health and Social Protection, Albania
阿尔及利亚 Ghrieb Houria Doctor Narcotics, Psychotropics and Chemical Precursors, General Direction of Pharmacy and
Health Equipment, Algerian Health Ministry
安道尔 Carla Lobaco Valls Technical Officer Department of Health Resources and Medicines [email protected]
安道尔 Carme Pallarés Papaseit Department of Health Resources and Medicines, [email protected]
安哥拉 Ana Da Conceição Mamede General Director, National Institute for
combating Drugs
Ministry of Health [email protected]
安提瓜和巴布达
阿根廷 G. Rebaldería Pharmacist Director of Surveillance of Substances Subject to Special Control
Argentinian Ministry of Health
亚美尼亚 Hasmik Martirosyan Armenian Ministry of Health [email protected]
澳大利亚 Narcotics Control Section
Office of Drug Control
Australian Government Department of Health and Aged Care
[email protected] 2024年7月10日
澳大利亚 [email protected]
奥地利 Raphael Bayer Head of Division Section VI, Department 6
Federal Ministry of Social Affairs, Health, Care and Consumer Protection
阿塞拜疆 Telman Suleyman Oglu
Mammadhassanov
巴哈马
巴林 Samar Yousef Salem Senior Pharmacist Ministry of Health [email protected]
孟加拉国 Habibur Rahman Khan Additional Secretary Health Services Division,
Ministry of Health & Family Welfare
巴巴多斯 Lindsay Bynoe Assistant Director for Drug Regulation Ministry of Health [email protected]
白俄罗斯 Aleksey Kralko Ministry of Health [email protected]
比利时 Lies Gremeaux Head of Unit illicit Drugs, Reitox
National Focal Point
Epidemiology and Public Health, Sciensano,
Ministry of Health
伯利兹
贝宁 Saturnin Bognon State-certified Pharmacist, Head of
Pharmaceutical Establishments
Department
Pharmaceutical Establishments Department [email protected]
不丹 Dil Kumar Subba Department of Public Health, Ministry of Health [email protected]
多民族玻利维亚国 H.E. Amb. Maira Mariela
Macdonal
Permanente Representative of the Plurinational State of Bolivia [email protected]; contact@mission-
bolivia.ch
2024年7月27日
波斯尼亚和黑塞哥维那 [email protected];
波斯尼亚和黑塞哥维那 Sabina Šahman Department for Health, Ministr of the Civill Affairs of Bosnia and Herzegovina [email protected]
博茨瓦纳 Vivian Sebako Chief Pharmacist Department of Clinical Services, Ministry of Health and Wellness [email protected]
巴西 Renata de Morais Souza, Moema
Luisa Silva Macedo
Manager Management of Controlled Products
GPCON/GGMON/DIMON/ANVISA
Controlled Substances Office
Brazilian Health Regulatory Agency – ANVISA
附件二：会员国往年指定的联络人名单
国家 联络人姓名 职称 机构 电子邮件 上一次更新日期
巴西 Natalia Jorge e Costa International Affairs Office, Brazilian Health Regulatory Agency - ANVISA, AINTE/
GADIP/ANVISA
文莱达鲁萨兰国 Hajah Zanatul ‘Aini Haji Zainin
(Ms)
Acting Director of Pharmaceutical
Services
Department of Pharmaceutical Services, Ministry of Health [email protected]
保加利亚 Slaveyka Nikolova Chief Expert at the Health Promotion Department Health Promotion and Prophylaxis of the Diseases and Addictions Directorate [email protected]
保加利亚 Alexander Panayotov Head of the National Focus Center
Department
Mental Health and Addiction Prevention Directorate, National Center for Public Health
and Analysis
布基纳法索 [email protected]
布隆迪 Israël Nimubona [email protected]
佛得角 Raquel Lopes Commission for the Coordination of Alcohol and Other Drugs, Ministerio da Saude e da
Seguranca Social
[email protected] 2024年8月30日
柬埔寨 Chhit Sophal Director Department of Mental and Substance Abuse, Ministry of Health [email protected]
喀麦隆 Ketchozo Loko Wilfried [email protected]
加拿大 International Relations Unit, Office of Drug Policy and Science, Controlled Substances
Directorate, Health Canada, Government of Canada
[email protected] 2024年4月26日
中非共和国
乍得 Haoua Haroun Saker Deputy Director of Pharmacy and
Medicine
Ministry of Public Health [email protected]
智利 Javiera Erazo Leiva Advisor Department of Mental Health/DIPRECE, Ministry of Health [email protected]
中国 Zhendong HUA Deputy Director National Narcotics Laboratory [email protected]
中国 Yan ZHENG Official Office of National Narcotics Control Commission [email protected]
中国 Peng XU Senior Expert National Narcotics Laboratory [email protected]
哥伦比亚 Oscar Ricardo Santana Observatorio de Drogas de Colombia
Dirección de Políticas de Drogas y Actividades Relacionadas
Ministerio de Justicia y del Derecho
2024年7月16日
哥伦比亚 Nubia Esperanza Bautista Coordinadora del Grupo Convivencia
Social y Ciudadanía
Dirección de Promoción y Prevención – Ministerio de Salud y Protección Social [email protected]
哥伦比亚 Germán Andrés Calderón Velá
squez
Coordinador Grupo Interno de Trabajo
de Asuntos Relacionados con las
Drogas
Ministerio de Relaciones Exteriores [email protected];
科摩罗
库克群岛 Tereapii Uka Central Policy and Planning Office [email protected]
哥斯达黎加 Marchena Vasquez [email protected]
科特迪瓦 Ernest Zotoua [email protected]
克罗地亚 Lidija Vugrinec Head of National Information Unit in
the Field of Drugs and Behavioural
Addictions and Internal Relations
Department
Croation Institute of Public Health [email protected] 2024年8月30日
古巴
塞浦路斯 John Kkolos Pharmacist Pharmaceutical Services, Ministry of Health [email protected]
捷克 Vlastimil Brandejs Inspectorate Department, Narcotic and Psychotropic Substances
Ministry of Health
朝鲜民主主义人民共和国 Kim Jong Guk
附件二：会员国往年指定的联络人名单
国家 联络人姓名 职称 机构 电子邮件 上一次更新日期
刚果民主共和国 Ghislaine Mbelu Kanyunya [email protected]
丹麦 Kari Gragaasen Chief Consultant Head of Focal Point, Prevention, National Board of Health [email protected]
吉布提
多米尼克 Laura Esprit Chief Medical Office Ministry of Health, Wellness and New Health Investment [email protected]
多米尼克 Anna Royer-Edmund Chief Pharmacist Ministry of Health, Wellness and New Health Investment [email protected]
多米尼加共和国 [email protected]
多米尼加共和国 Francisca Dalia Castillo Sanchez Head of the Assistive Technology
Department
General Directorate of Medicines, Food and Health Products (DIGEMAPS), Ministry of
Public Health
厄瓜多尔 Gabriel Ordonez Guzman Director nacional de Estrategias de
Prevencion Y Control para
Enfermedades no Transmisibles
Salud Mental Y Fenomeno Socioeconomico de las Drogas [email protected] 2024年7月24日
埃及 Dr Samah Abdeleazik Kandil Ministry of Health and Population [email protected];
2024年7月16日
萨尔瓦多 José Mauricio Bermúdez Recinos Focal Point of the Ministry of Health
of El Salvador
Health Technology Department,
Ministry of Health
赤道几内亚
厄立特里亚 Michael Girmay Haile [email protected]
爱沙尼亚 Olga Kamp Inspector of pharmacovigilance, drugs
and psychotropic substances, and the
precursors
State Agency of Medicines, Ministry of Health [email protected]
斯威士兰
埃塞俄比亚 Baharu Zewdie Moya [email protected]
斐济 Ilisabeta May Pesamino Chief Pharmacist Pharmaceutical & Biomedical Services/Ministry of Health & Medical Services [email protected]
芬兰 Katja Pihlainen Finnish Medicines Agency, Ministry of Health [email protected]
法国 Luciano Amato Acting Head of Department Regulation of narcotics and psychotropic substances,
National Agency for the Safety of Medicines and Health Products
加蓬 Okouyi Ndakissa Directorate of Medicines and Pharmacy
Ministry of Health
冈比亚 格鲁吉亚 Ekaterine Paposhvili Senior Specialist Division of Legal Circulation of Narcotic Drugs, LEPL State Regulation Agency for
Medical Activities
Ministry of Labour, Health and Social Affairs of Georgia
德国 Annette Hinze Division 122 - Narcotics Law, Traffic in Narcotics, International Narcotic Drug Affairs
Federal Ministry of Health
加纳 Martha Gyansa-Lutterodt Director Pharmaceutical Services, Ministry of Health [email protected]
希腊 Dr Foteini Koulouri Head of General Directorate of Public
Health and Quality of Life
Hellenic Ministry of Health [email protected] ; [email protected] 2024年7月16日
希腊 Avgerinos Nikolaos Psychiatrist, Programs Implementation
Director
OKANA - Organisation Against Drugs Greece [email protected] ;
希腊 Ms Anastasia Petroulia Legal Advisor to the Minister of
Health
Hellenic Ministry of Health [email protected];
还将出席药物依赖 问题专家委员会第 四十七次会议
格林纳达
附件二：会员国往年指定的联络人名单
国家 联络人姓名 职称 机构 电子邮件 上一次更新日期
危地马拉 José Miguel Solares Estrada Department of Regulation and Control
of Related Pharmaceutical Products
[email protected] 2024年8月30日
危地马拉 Alicia Elena Morgan Durán Section of Psychotropics, Narcotics,
Imports and Exports
[email protected] 2024年8月30日
几内亚
几内亚比绍
圭亚那
海地 Marie Judith Robuste Roche Ministry of Health [email protected]
洪都拉斯 Alex Virgilio Santos Moreno General Director of the Honduran
Institute for the Prevention of
Alcoholism
Honduran Institute for the Prevention of Alcoholism, Drug Addiction and Drug
Dependence (IHADFA)
匈牙利 Tímea Kahlesz Deputy Head of Department EMMI Pharmaceutical and Medical Technology Department [email protected]
冰岛 Bjarni Sigurðsson Ministry of Health [email protected]
印度 Dr Anju Dhawan Professor and Head Department of Psychiatry, National Drug Dependence Treatment Centre, All India
Institute of Medical Sciences
Anju Dhawan <[email protected]> 2024年7月24日
印度尼西亚 Agusdini Banun Saptaningsih Director of Pharmaceutical Production
and Distribution
Directorate General of Pharmaceutical Care and Medical Devices, [email protected]
伊朗伊斯兰共和国 Mina Azhoogh [email protected]
伊拉克 Emad Abdulrazzaq Abdulghani Ministry of Health [email protected]
爱尔兰 Conor Brennan Department of Health [email protected]
爱尔兰 Alan Bell Department of Health [email protected]
以色列 Paola Rosca Head of the Addiction Treatment
Department
Ministry of Health [email protected]
以色列 Tal Lavy The Competent Authority for Narcotics, Psychotropics and Precursors
Pharmaceutical Administration
意大利 Pietro Canuzzi Head of Office 7, Central Narcotic
Office
Ministry of Health - Directorate general of Health Prevention [email protected] 2024年7月26日
牙买加 Dr Jacquiline Bisasor McKenzie Chief Medical Officer Ministry of Health & Wellness [email protected] 2024年7月5日
牙买加 Ms Uki Atkinson Research Analyst National Council on Drug Abuse (NCDA) [email protected] 2024年7月5日
日本 Compliance and Narcotics Division,
Pharmaceutical Safety and Environmental Health Bureau
约旦 Malak AlMahirah Head of Narcotics, Psychotropic Substances and Chemical Precursors Department,
Jordan Food and Drug Administration
哈萨克斯坦 Prilutskaya Marina Republican Scientific and Practical Center of Mental Health [email protected]
肯尼亚 Anthony Toroitich [email protected]
肯尼亚 Simon Njuguna [email protected]
基里巴斯 Biribo Kararaiti Chief Pharmacist Ministry of Health and Medical Services [email protected]
科威特 Ali Abdulmohsen Jaragh Head Control of Licenses for Narcotic Drugs and Psychotropic Substances Department [email protected] 2024年7月24日
吉尔吉斯斯坦 Kanyshai Damirbek Drug Trafficking Control Department,
Ministry of Foreign Affairs
老挝人民民主共和国 Khatthanaphone Phandoangsy Head of Health Promotion and
Nutrition Unit
Department of Hygiene and Health Promotion, Ministry of Health [email protected]
拉脱维亚 Linda Veisberga Ministry of Health [email protected]
黎巴嫩 Marie-Therese Matar Head of Narcotics Department Ministry of Public Health [email protected]
莱索托 Masello Sello [email protected]
附件二：会员国往年指定的联络人名单
国家 联络人姓名 职称 机构 电子邮件 上一次更新日期
利比里亚 Dr. Moses Ziah II Director Mental Health Unit Ministry of Health, Republic of Liberia [email protected]; [email protected]
利比亚
立陶宛 Rima Mačiūnienė Head of Drug Precursors Control and
Risk Assessment Division
Drug Precursors Control and Risk Assessment Division,
Drug, Tobacco and Alcohol Control Department
卢森堡 Alain Origer National Drug Coordinator Ministry of Health [email protected]
马达加斯加 Maximine Ravaoarimanana Director of Pharmacy Laboratories and Traditional Medicine [email protected];
马拉维 Michael Udedi Assistant Director of Clinical Services
(Mental Health and Substance Abuse)
马来西亚 Rohaida Binti Zakaria Senior Principal Assistant Director Pharmaceutical Services Division, Ministry of Health [email protected]
马尔代夫 Aishath Mohamed Deputy Director General,
Pharmaceuticals
Medicine and Therapeutic Goods Division,
Maldives Food and Drug Authority
马里 Mahamadou Ousmane Maiga [email protected]
马耳他 Victor P. Pace Office of the Superintendence of Public Health,
Department for Health Regulation
马绍尔群岛 Julia Alfred Ministry of Health [email protected]
毛里塔尼亚 Hamoud Fadel Yamohomed Director of Pharmacy and Laboratories Ministry of Health [email protected]
毛里求斯 Nitish Raj Sokool Officer-in-Charge Harm Reduction Unit, Ministry of Health and Wellness [email protected]
毛里求斯 Anil Jhugroo Advisor on Substance Abuse Ministry of Health and Wellness [email protected]
墨西哥 Angélica Juárez Ramírez Specialized Reviewer COFEPRIS representative, Federal Committee for Protection from Sanitary Risks [email protected]
密克罗尼西亚联邦 Benido Victor [email protected]
摩纳哥 Isabelle Kessedjian Head of Division Pharmacy Inspector, Health Products Division [email protected]
蒙古 Luvsandagva Purevdorj [email protected]
黑山 Jasna Sekulic Ministry of Health [email protected]
摩洛哥 Hassan Elkarimi [email protected]
摩洛哥 Jallal Toufiq Professor of Psychiatry, Rabat Faculty
of Medicine,
Director of the National Centre on
Drug Abuse Prevention, Treatment and
Research,
Director of the Moroccan Observatory
on Drugs and Drugs Addictions
莫桑比克 Flavio Mandlate [email protected]
缅甸 Nanda Myo Aung Wan Program Manager/ Consultant
Psychiatrist
Drug Dependency Treatment and Research Unit,
Ministry of Health and Sport
纳米比亚 Ester Mvula Senior Pharmacist Ministry of Health & Social Services [email protected]
瑙鲁 Richard Leona Chief Surgeon Ministry of Health [email protected]
尼泊尔
荷兰王国 Matthijs Geilenkirchen Nutrition, Health Protection and Prevention Department,
Ministry of Health, Welfare and Sport
[email protected] 2024年4月29日
新西兰 Group mail to be cc'ed [email protected] 2024年7月10日
新西兰 Tania Jones Regulatory Practice and Analysis,
Medsafe
[email protected] 2024年10月7日确认
附件二：会员国往年指定的联络人名单
国家 联络人姓名 职称 机构 电子邮件 上一次更新日期
尼加拉瓜 Karla Vanessa Delgado Martinez Director of Pharmacy Ministry of Health [email protected]
尼日尔 Haoua Na Allah Alou [email protected]
尼日利亚 Wosilat Abdulhameed Deputy Director Federal Ministry of Health [email protected] 2024年8月30日
纽埃
北马其顿
挪威 Anne S. Onsgård Sagabråten Narcotic Drugs Control,
Norwegian Medicines Agency
阿曼 Dr. Mohammed Al-Rubaie, [email protected] 2024年7月10日
阿曼 Dr Mahmood Al Abri [email protected] 2024年7月10日
阿曼 Directorate General of Pharmaceutical Affairs and Drug control,
Ministry of Health
阿曼 Drug Safety Center, Ministry of Health, Sultanate of Oman [email protected] 2024年8月30日
巴基斯坦 Rizwan Taj Professor Ministry of Health [email protected]
帕劳 Clarette Matlab Chief Pharmacist Division of Ancillary Services,
Bureau of Hospital and Clinical Services,
Ministry of Health
帕劳 Marla Ito [email protected]
巴拿马 Dr Ricardo Goti, coordinateur du Programme de Santé
Mentale
Ministère de la Santé du Panama [email protected] 2024年7月16日
巴布亚新几内亚 Vicky Wari Program Manager-Non Communicable
Diseases
Public Health Division, National Department of Health [email protected]
巴拉圭 Blanca Galeano [email protected] 2024年8月30日
巴拉圭 Zaira Francesca Stumpfs Bigarella [email protected]
秘鲁 Judith Castañeda Alcántara Head of Functional Unit of Controlled
Products
DIGEMID – General Directorate of Medicines, Supplies and Drugs [email protected] 2024年7月26日
菲律宾
波兰 Michał Kidawa Polish Reitox Focal Point Information Centre for Drugs and Drug Addiction (CINN)
National Bureau for Drug Prevention
葡萄牙 Graça Vilar Director of Planning and Intervention
Services Directorate
Intervention Service for Addictive Behaviours and Addictions
General Directorate for Intervention on Addictive Behaviours and Dependencies
SICAD
波多黎各
卡塔尔 Majid Ali Al Abdulla Senior Consultant Psychiatrist Director of addiction and CL at Hamad Medical Corporation
Deputy Chairman of Mental Health Services,
Hamad Medical Corporation
大韩民国 Sang Hun Yeon Narcotics Policy Division of Ministry of Food and Drug Safety [email protected] 2024年7月16日
摩尔多瓦共和国 Oleg Costachi Standing Committee on Drugs Control,
Agency for Medicines and Medical Devices
罗马尼亚 Camelia Bunaciu Senior Advisor Ministry of Health [email protected]
俄罗斯联邦 Alyona Ryzova Deputy Head of the Unit for regulatory
and legal regulation of pharmaceutical
activities, regulation of narcotic drugs
and psychotropic substances
Department for regulation of medicines and medical devices,
Ministry of Health
[email protected] 2024年7月11日
卢旺达
附件二：会员国往年指定的联络人名单
国家 联络人姓名 职称 机构 电子邮件 上一次更新日期
圣基茨和尼维斯 puerto rico
圣卢西亚 Charlotte Emmanuel Coordinator of the Substance Abuse
Advisory Council Secretariat
Substance Abuse Advisory Council Secretariat,
Ministry of Health and Wellness
圣卢西亚 Paul Caleb Programme Officer Substance Abuse Advisory Council Secretariat,
Ministry of Health and Wellness
圣文森特和格林纳丁斯
萨摩亚 Robert Thomsen Assistant Chief Executive Officer HSPQA, Medical and Allied Division [email protected]
圣马力诺 Claudio Muccioli Health Authority Director Health Authority [email protected]
圣多美和普林西比
沙特阿拉伯 Adnan Alshammary Administration of controlled preparations,
Executive Management for Regulatory Affairs,
Controlled Products Department,
Regulatory Affairs Directorate,
Drug Sector
塞内加尔 Moussa DIALLO Pharmacist Inspector Pharmaceutical Regulatory Agency,
Ministry of Health and Social Action
塞尔维亚 Nataša Savić Monitoring Centre for Drugs and Drug Addiction, Sector for Medicines and Medical
Devices, Psychoactive Controlled Substances and Precursors, Ministry of Health
塞舌尔
塞拉利昂
新加坡 Ong Lay Tin Personal Assistant to Director
(International Cooperation)
Senior Executive (International Cooperation)
Public Health Group,
Ministry of Health
[email protected] 2024年4月7日确认无变
化
斯洛伐克 Peter Koreň Reitox National Focal Point National Monitoring Centre for Drugs,
Department of Anti-Drug Strategy Coordination and Drug Monitoring,
Ministry of Health of the Slovak Republic
[email protected] 2024年4月7日确认无变
化
斯洛文尼亚 Joze Hren Secretary Directorate of Public Health, Ministry of Health [email protected]
所罗门群岛 Paul Orotaloa Head of Mental Health Services National Mental Health Service, Ministry of Health and Medical Services [email protected]
所罗门群岛 Stephen Araitewa Director Mental Health National Mental Health Service, Ministry of Health and Medical Services [email protected]
索马里
南非 MG Molewa Ministry of Health [email protected]
南苏丹 Moses Malual Deng Director General of Pharmaceuticals
and Medical Supplies
Ministry of Health [email protected]
西班牙 Manuel Ibarra Head of Department Inspection &
Enforcement
Spanish Agency of Medicines and Medical Products (AEMPS) [email protected]
西班牙 Lidia Fernandez Matellano Narcotics and Psychotropic Substances Area,
Pharmaceutical Inspection and Enforcement Department,
Spanish Agency of Medicines and Medical Products (AEMPS)
斯里兰卡 S.C. Wickramasinghe Deputy Director General (NCD) Ministry of Health [email protected]
苏丹
苏里南
瑞典 Annika Borg Ministry of Health and Social Affairs,
Division for Public Health and Health Care
[email protected] 2024年4月8日
瑞士 Lucien Colliander Federal Department of Home Affairs, Federal Office of Public Health, Division of
International Affairs, Global Health Section
附件二：会员国往年指定的联络人名单
国家 联络人姓名 职称 机构 电子邮件 上一次更新日期
瑞士 Monika Joos Head of Division Narcotics Swissmedic, Swiss Agency for Therapeutic Products [email protected]
阿拉伯叙利亚共和国 Ahmed Al-Salama Mental Health Directorate,
Ministry of Health
塔吉克斯坦 Salim Abdulazizov [email protected]
泰国 Sujinart Chantharakul Pharmacist Narcotics Control Division (Standards and Regulations Sub-Division),
Food and Drug Administration,
Ministry of Public Health
泰国 Saranya Chavanich Pharmacist Narcotics Control Division (Standards and Regulations Sub-Division),
Food and Drug Administration,
Ministry of Public Health
泰国 Korapin Na Ranong Expert on Narcotics Epidemiology Narcotics Control Division
Food and Drug Administration,
Ministry of Public Health
泰国 Raththar Benchapalanont Pharmacist Narcotics Control Division
Food and Drug Administration,
Ministry of Public Health
东帝汶 Soares Henriques Regulatory Affairs Pharmacist Pharmacovigilance and Medicine Control Department, National Directorate for
Pharmaceutical and Medicines, Ministry of Health
多哥 Mouhoudine Yerima Centre National de Pharmacovigilance (CNPV) [email protected];[email protected]
托克劳
汤加 Melenaite Mahe Principal Pharmacist Central Pharmacy and Medical Store, Old Vaiola, Ministry of Health [email protected]
特立尼达和多巴哥 Anesa Doodnath-Siboo Principal Pharmacist Ministry of Health [email protected]
突尼斯
土耳其 Elif Inci ERGONUL Head of Pharmacovigilance and
Controlled Substances Department
Turkish Medicines and Medical Devices Agency, Ministry of Health [email protected] ,
2024年7月24日
土库曼斯坦
图瓦卢
乌干达 Hafsa Lukwata Head of Mental Health and Control of
Substance Abuse
Mental Health and Control of Substance Abuse Division,
Ministry of Health
乌克兰 Deputy Director Institute of Psychiatry, Forensic Psychiatric Examination and Drug Monitoring, [email protected]
乌克兰 Irina Pinchuk Director Institute of Psychiatry of Taras Shevchenko National University of Kyiv,
International Technology Transfer Center - Ukraine
Head of ISSUP Ukraine National Chapter
乌克兰 Yulia YACHNYK Clinical Psychologist Institute of Psychiatry, Taras Shevchenko National University of Kyiv [email protected]
阿拉伯联合酋长国 Alia Bin Hussain Head of Regulating Controlled
substances
Product & Precursor Chemicals Drug Department,
Ministry of Health and Prevention
大不列颠及北爱尔兰联合 王国
Alberto Oteo Project Manager Drugs Research and
Surveillance
Addiction and Inclusion Directorate,
Office for Health Improvement & Disparities,
Department of Health and Social Care
坦桑尼亚联合共和国 Suma Jairo Pharmacist Pharmaceutical Service Unit, Ministry of Health [email protected]
美利坚合众国 Edward Hawkins Senior Pharmacologist and
International Drug Control Liaison
Center for Drug Evaluation and research,
U.S. Food and Drug Administration
乌拉圭 Lorena Quintana Coordinator of the Addiction
Prevention and Treatment Program
Ministry of Public Health [email protected] 2024年8月2日
附件二：会员国往年指定的联络人名单
国家 联络人姓名 职称 机构 电子邮件 上一次更新日期
乌兹别克斯坦 Dr Azizbek Khamrakulov Head, Department of Inpatient and
Specialized Care
Ministry of Health [email protected]
乌兹别克斯坦 Mr Zarif Ashurov Director Specialized Scientific and Mental Health Medical Center [email protected]
瓦努阿图 Jerry Iaruel Tafea Provincial Health Administrator Lenakel Health Office,
Ministry of Health
委内瑞拉玻利瓦尔共和国
越南 Mhin Tam Nguyen Regulatory Affair Consultant Ministry of Health [email protected]
也门
赞比亚 Nita Besa Head Clinical Care Chainama Hospital [email protected]
津巴布韦 Eneti Siyame Mental Health Manager Ministry of Health and Child Care [email protected]
20, AVENUE APPIA – CH-1211 GENEVA 27 – SWITZERLAND – TEL CENTRAL +41 22 791 2111 – FAX CENTRAL +41 22 791 3111 – WWW.WHO.INT
... ENCLS.: (2)
Ref.: C.L.22.2025
The World Health Organization (WHO) presents its compliments to Member States and Associate Members and has the pleasure of announcing that the 48th Expert Committee on Drug Dependence (ECDD) will meet from 20 to 22 October 2025 in Geneva, Switzerland. Given that WHO Expert Committee meetings are of a closed nature, this letter serves to notify Member
... States of the agenda of the 48th ECDD, which is in the Annex I file, attached for reference.
WHO is mandated by the 1961 and 1971 International Drug Control Conventions to make recommendations to the UN Secretary-General on the need for and level of international control of psychoactive substances based on the advice of its independent scientific advisory body, the ECDD. To assess whether or not a psychoactive substance should be placed under international control, the ECDD convenes annually to review the potential of that substance to cause dependence, abuse and harm to health, as well as any therapeutic applications. In order to perform this review and make evidence-based decisions, the ECDD conducts medical, scientific, and public health evaluations of the selected psychoactive substances using the best available information.
Although the meetings are of a closed nature, Member States and Associate Members are invited to contribute to the ECDD review process by joining the 48th ECDD Information Session on 20 October 2025. The Information Session will be held virtually and allow interested parties to learn about present and future activities of the ECDD Secretariat, and to present information concerning substances under review to the 48th Expert Committee for consideration in its deliberations. Registration information will be made available on the ECDD website in due course: https://www.who.int/news-room/events/detail/2025/10/20/default-calendar/forty-eighth- expert-committee-on-drug-dependence.
As in the past and in line with the publication “Guidance on the WHO review of psychoactive substances for international control” (EB126/2010/REC1, Annex 6),1 Member States and Associate Members can also contribute to the ECDD review process by providing up to date and accurate information concerning the substances under review in advance of the meeting. For this purpose, and as per previous practice, a questionnaire will be sent to Member States and Associate Members to gather country information on the legitimate use, harmful use, status of national control and potential impact of international control for each substance under evaluation.
1 https://apps.who.int/gb/ebwha/pdf_files/EB126-REC1/B126_REC1-en.pdf#page=90.
Page 2
C.L.22.2025
... Annex II to this Circular Letter contains a list of national focal points officially designated by Member States and Associate Members in previous years who provide country information to the ECDD through the Member States questionnaire referred to above. If the focal point information requires changes or amendments, Member States and Associate Members are invited to inform the WHO ECDD Secretariat by email to [email protected] by 18 July 2025 with the subject “48ECDD Focal Point: (Country Name)”.
If the individual on the list is still the official focal point for completing the ECDD Member State questionnaire this year and if no additions or amendments to focal point details are made by 18 July 2025, the focal point from the list will be given further instructions and direct access to online questionnaires by the WHO Secretariat. Results of the questionnaires will be prepared as a report as part of the 48th ECDD substance review process.
In addition to the questionnaire, Member States and Associate Members are also encouraged to provide any additional relevant information (unpublished or published) on substances to be reviewed by the 48th ECDD by emailing [email protected] with the subject “Ref: C.L.22.2025”.
All recommendations made by the 47th ECDD, held in October 2024, were accepted by the 68th UN Commission on Narcotic Drugs and all technical reports and recommendations made by the ECDD are available online through the recently launched ECDD Information Repository (https://ecddrepository.org/en).
The World Health Organization takes this opportunity to renew to Member States and Associate Members the assurance of its highest consideration.
GENEVA, 11 July 2025
48th WHO EXPERT COMMITTEE ON DRUG DEPENDENCE
Provisional Agenda
----
Information Meeting (Virtual)
20 October 2025
10:00-13:00 CEST
1. Welcome and opening of the meeting
2. WHO presentations 2.1 Expert Committee on Drug Dependence 2.2 Science Division 2.3 Gender, Equity, and Human Rights 2.4 Traditional medicine
3. Presentations and statements from participants
48th WHO EXPERT COMMITTEE ON DRUG DEPENDENCE
Geneva, Switzerland
Provisional Agenda
----
Closed Session
20–22 October 2025
1. Procedural matters and updates 1.1 Opening of meeting and welcoming remarks 1.2 Introduction of participants 1.3 Statement of confidentiality 1.4 Declarations of interest 1.5 Election of Chair, Vice-Chair, and Rapporteur 1.6 Adoption of agenda
2. Updates on priorities from international agencies 2.1 Briefings from international agencies on their work on the public health dimension of the
world drug problem 2.1.1 WHO 2.1.2 UNODC 2.1.3 INCB
2.2 Updates on ECDD meeting recommendations and outcomes 2.2.1 Recommendations and outcomes of the 47th ECDD 2.2.2 Updates on substance surveillance
3. Critical reviews: Recommendations on the scope of international control 3.1 Coca leaf1
3.1.1 Coca leaf
3.2 Synthetic cannabinoids2 3.2.1 MDMB-FUBINACA
3.3 Novel synthetic opioids2 3.3.1 N-pyrrolidino isotonitazene (Isotonitazepyne) 3.3.2 N-Desethyl etonitazene
4. Finalization of meeting report
1 There has been a notification from a Party to the 1961 or the 1971 Convention concerning the scheduling of a
substance. 2 Information was brought to WHO’s attention that a substance is clandestinely manufactured, or especially serious risk
to public health and society, and of no recognized therapeutic use by any Party.
Annex II: List of focal points designated by Member States in previous years
Country Name Focal Point Job title Institution Email Last update
Afghanistan
Albania Linda Ternova Specialist
Regulation Sector of Pharmaceutical Market and Medical Devices Ministry of Health and Social Protection, Albania
Algeria Ghrieb Houria Doctor
Narcotics, Psychotropics and Chemical Precursors, General Direction of Pharmacy and Health Equipment, Algerian Health Ministry
Andorra Carla Lobaco Valls Technical Officer Department of Health Resources and Medicines [email protected]
Andorra Carme Pallarés Papaseit Department of Health Resources and Medicines [email protected]
Angola Ana Da Conceição Mamede General Director, National Institute for combating Drugs
Ministry of Health [email protected]
Antigua and Barbuda
Argentina G. Rebaldería Pharmacist
Director of Surveillance of Substances Subject to Special Control Argentinian Ministry of Health [email protected]
Armenia Hasmik Martirosyan Armenian Ministry of Health [email protected]
Australia
Narcotics Control Section Office of Drug Control Australian Government Department of Health and Aged Care
[email protected] 7/10/2024
Australia [email protected]
Austria Raphael Bayer Head of Division
Section VI, Department 6 Federal Ministry of Social Affairs, Health, Care and Consumer Protection
Azerbaijan Telman Suleyman Oglu Mammadhassanov [email protected]
Bahamas
Bahrain Samar Yousef Salem Senior Pharmacist Ministry of Health [email protected]
Bangladesh Habibur Rahman Khan Additional Secretary Health Services Division, Ministry of Health & Family Welfare [email protected]
Barbados Lindsay Bynoe Assistant Director for Drug Regulation Ministry of Health [email protected]
Belarus Aleksey Kralko Ministry of Health [email protected]
Belgium Lies Gremeaux Head of Unit illicit Drugs, Reitox National Focal Point
Epidemiology and Public Health, Sciensano, Ministry of Health
Belize
Benin Saturnin Bognon State-certified Pharmacist, Head of Pharmaceutical Establishments Department
Pharmaceutical Establishments Department [email protected]
Bhutan Dil Kumar Subba Department of Public Health, Ministry of Health [email protected]
Bolivia (Plurinational State of) H.E. Amb. Maira Mariela Macdonal Permanente Representative of the Plurinational State of Bolivia
[email protected]; [email protected] 7/27/2024
Bosnia and Herzegovina [email protected]; [email protected]
Annex II: List of focal points designated by Member States in previous years
Country Name Focal Point Job title Institution Email Last update
Bosnia and Herzegovina Sabina Šahman Department for Health, Ministr of the Civill Affairs of Bosnia and Herzegovina
Botswana Vivian Sebako Chief Pharmacist Department of Clinical Services, Ministry of Health and Wellness [email protected]
Brazil Renata de Morais Souza, Moema Luisa Silva Macedo Manager
Management of Controlled Products GPCON/GGMON/DIMON/ANVISA Controlled Substances Office Brazilian Health Regulatory Agency – ANVISA
Brazil Natalia Jorge e Costa International Affairs Office, Brazilian Health Regulatory Agency - ANVISA, AINTE/ GADIP/ANVISA
Brunei Darussalam Hajah Zanatul ‘Aini Haji Zainin (Ms) Acting Director of Pharmaceutical Services Department of Pharmaceutical Services, Ministry of Health [email protected]
Bulgaria Slaveyka Nikolova Chief Expert at the Health Promotion Department Health Promotion and Prophylaxis of the Diseases and Addictions Directorate
Bulgaria Alexander Panayotov Head of the National Focus Center Department
Mental Health and Addiction Prevention Directorate, National Center for Public Health and Analysis
Burkina Faso [email protected]
Burundi Israël Nimubona [email protected]
Cabo Verde Raquel Lopes Commission for the Coordination of Alcohol and Other Drugs, Ministerio da Saude e da Seguranca Social
[email protected] 8/30/2024
Cambodia Chhit Sophal Director Department of Mental and Substance Abuse, Ministry of Health [email protected]
Cameroon Ketchozo Loko Wilfried [email protected]
Canada
International Relations Unit, Office of Drug Policy and Science, Controlled Substances Directorate, Health Canada, Government of Canada
[email protected] 4/26/2024
Central African Republic
Chad Haoua Haroun Saker Deputy Director of Pharmacy and Medicine Ministry of Public Health [email protected]
Chile Javiera Erazo Leiva Advisor Department of Mental Health/DIPRECE, Ministry of Health [email protected]
China Zhendong HUA Deputy Director National Narcotics Laboratory [email protected]
China Yan ZHENG Official Office of National Narcotics Control Commission [email protected]
China Peng XU Senior Expert National Narcotics Laboratory [email protected]
Annex II: List of focal points designated by Member States in previous years
Country Name Focal Point Job title Institution Email Last update
Colombia Oscar Ricardo Santana
Observatorio de Drogas de Colombia Dirección de Políticas de Drogas y Actividades Relacionadas Ministerio de Justicia y del Derecho
[email protected]; [email protected] 7/16/2024
Colombia Nubia Esperanza Bautista Coordinadora del Grupo Convivencia Social y Ciudadanía
Dirección de Promoción y Prevención – Ministerio de Salud y Protección Social
Colombia Germán Andrés Calderón Velásquez Coordinador Grupo Interno de Trabajo de Asuntos Relacionados con las Drogas
Ministerio de Relaciones Exteriores [email protected]; [email protected]
Comoros
Cook Islands Tereapii Uka Central Policy and Planning Office [email protected]
Costa Rica Marchena Vasquez [email protected]
Côte d'Ivoire Ernest Zotoua [email protected]
Croatia Lidija Vugrinec Head of National Information Unit in the Field of Drugs and Behavioural Addictions and Internal Relations Department
Croation Institute of Public Health [email protected] 8/30/2024
Cuba
Cyprus John Kkolos Pharmacist Pharmaceutical Services, Ministry of Health [email protected]
Czechia Vlastimil Brandejs Inspectorate Department, Narcotic and Psychotropic Substances Ministry of Health
Democratic People's Republic of Korea Kim Jong Guk
Democratic Republic of the Congo Ghislaine Mbelu Kanyunya [email protected]
Denmark Kari Gragaasen Chief Consultant Head of Focal Point, Prevention, National Board of Health [email protected]
Djibouti
Dominica Laura Esprit Chief Medical Office Ministry of Health, Wellness and New Health Investment [email protected]
Dominica Anna Royer-Edmund Chief Pharmacist Ministry of Health, Wellness and New Health Investment [email protected]
Dominican Republic [email protected]
Dominican Republic Francisca Dalia Castillo Sanchez Head of the Assistive Technology Department
General Directorate of Medicines, Food and Health Products (DIGEMAPS), Ministry of Public Health
Ecuador Gabriel Ordonez Guzman Director nacional de Estrategias de Prevencion Y Control para Enfermedades no Transmisibles
Salud Mental Y Fenomeno Socioeconomico de las Drogas [email protected] 7/24/2024
Egypt Dr Samah Abdeleazik Kandil Ministry of Health and Population [email protected]; [email protected] 7/16/2024
El Salvador José Mauricio Bermúdez Recinos Focal Point of the Ministry of Health of El Salvador
Health Technology Department, Ministry of Health [email protected]
Equatorial Guinea
Annex II: List of focal points designated by Member States in previous years
Country Name Focal Point Job title Institution Email Last update
Eritrea Michael Girmay Haile [email protected]
Estonia Olga Kamp Inspector of pharmacovigilance, drugs and psychotropic substances, and the precursors
State Agency of Medicines, Ministry of Health [email protected]
Eswatini
Ethiopia Baharu Zewdie Moya [email protected]
Fiji Ilisabeta May Pesamino Chief Pharmacist Pharmaceutical & Biomedical Services/Ministry of Health & Medical Services
Finland Katja Pihlainen Finnish Medicines Agency, Ministry of Health [email protected]
France Luciano Amato Acting Head of Department
Regulation of narcotics and psychotropic substances, National Agency for the Safety of Medicines and Health Products
Gabon Okouyi Ndakissa
Directorate of Medicines and Pharmacy Ministry of Health [email protected]
Gambia
Georgia Ekaterine Paposhvili Senior Specialist
Division of Legal Circulation of Narcotic Drugs, LEPL State Regulation Agency for Medical Activities Ministry of Labour, Health and Social Affairs of Georgia
Germany Annette Hinze
Division 122 - Narcotics Law, Traffic in Narcotics, International Narcotic Drug Affairs Federal Ministry of Health
Ghana Martha Gyansa-Lutterodt Director Pharmaceutical Services, Ministry of Health [email protected]
Greece Dr Foteini Koulouri Head of General Directorate of Public Health and Quality of Life
Hellenic Ministry of Health [email protected] ; [email protected] 7/16/2024
Greece Avgerinos Nikolaos Psychiatrist, Programs Implementation Director
OKANA - Organisation Against Drugs Greece
[email protected] ; [email protected]
Greece Ms Anastasia Petroulia Legal Advisor to the Minister of Health Hellenic Ministry of Health [email protected]; [email protected] Will also attend the 47th ECDD meeting
Grenada
Guatemala José Miguel Solares Estrada Department of Regulation and Control of Related Pharmaceutical Products [email protected] 8/30/2024
Guatemala Alicia Elena Morgan Durán Section of Psychotropics, Narcotics, Imports and Exports [email protected] 8/30/2024
Guinea
Guinea-Bissau
Guyana
Haiti Marie Judith Robuste Roche Ministry of Health [email protected]
Honduras Alex Virgilio Santos Moreno General Director of the Honduran Institute for the Prevention of Alcoholism
Honduran Institute for the Prevention of Alcoholism, Drug Addiction and Drug Dependence (IHADFA)
Annex II: List of focal points designated by Member States in previous years
Country Name Focal Point Job title Institution Email Last update
Hungary Tímea Kahlesz Deputy Head of Department EMMI Pharmaceutical and Medical Technology Department [email protected]
Iceland Bjarni Sigurðsson Ministry of Health [email protected]
India Dr Anju Dhawan Professor and Head Department of Psychiatry, National Drug Dependence Treatment Centre, All India Institute of Medical Sciences
[email protected] 7/24/2024
Indonesia Agusdini Banun Saptaningsih Director of Pharmaceutical Production and Distribution
Directorate General of Pharmaceutical Care and Medical Devices, [email protected]
Iran (Islamic Republic of) Mina Azhoogh [email protected]
Iraq Emad Abdulrazzaq Abdulghani Ministry of Health [email protected]
Ireland Conor Brennan Department of Health [email protected]
Ireland Alan Bell Department of Health [email protected]
Israel Paola Rosca Head of the Addiction Treatment Department Ministry of Health [email protected]
Israel Tal Lavy
The Competent Authority for Narcotics, Psychotropics and Precursors Pharmaceutical Administration
Italy Pietro Canuzzi Head of Office 7, Central Narcotic Office Ministry of Health - Directorate general of Health Prevention [email protected] 7/26/2024
Jamaica Dr Jacquiline Bisasor McKenzie Chief Medical Officer Ministry of Health & Wellness [email protected] 7/5/2024
Jamaica Ms Uki Atkinson Research Analyst National Council on Drug Abuse (NCDA) [email protected] 7/5/2024
Japan Compliance and Narcotics Division, Pharmaceutical Safety and Environmental Health Bureau
Jordan Malak AlMahirah
Head of Narcotics, Psychotropic Substances and Chemical Precursors Department, Jordan Food and Drug Administration
Kazakhstan Prilutskaya Marina Republican Scientific and Practical Center of Mental Health [email protected]
Kenya Anthony Toroitich [email protected]
Kenya Simon Njuguna [email protected]
Kiribati Biribo Kararaiti Chief Pharmacist Ministry of Health and Medical Services [email protected]
Kuwait Ali Abdulmohsen Jaragh Head Control of Licenses for Narcotic Drugs and Psychotropic Substances Department
[email protected] 7/24/2024
Kyrgyzstan Kanyshai Damirbek Drug Trafficking Control Department, Ministry of Foreign Affairs [email protected]
Annex II: List of focal points designated by Member States in previous years
Country Name Focal Point Job title Institution Email Last update
Lao People's Democratic Republic Khatthanaphone Phandoangsy Head of Health Promotion and Nutrition Unit Department of Hygiene and Health Promotion, Ministry of Health [email protected]
Latvia Linda Veisberga Ministry of Health [email protected]
Lebanon Marie-Therese Matar Head of Narcotics Department Ministry of Public Health [email protected]
Lesotho Masello Sello [email protected]
Liberia Dr. Moses Ziah II Director Mental Health Unit Ministry of Health, Republic of Liberia [email protected]; [email protected]
Libya
Lithuania Rima Mačiūnienė Head of Drug Precursors Control and Risk Assessment Division
Drug Precursors Control and Risk Assessment Division, Drug, Tobacco and Alcohol Control Department
Luxembourg Alain Origer National Drug Coordinator Ministry of Health [email protected]
Madagascar Maximine Ravaoarimanana Director of Pharmacy Laboratories and Traditional Medicine [email protected]; [email protected]
Malawi Michael Udedi Assistant Director of Clinical Services (Mental Health and Substance Abuse) [email protected]
Malaysia Rohaida Binti Zakaria Senior Principal Assistant Director Pharmaceutical Services Division, Ministry of Health [email protected]
Maldives Aishath Mohamed Deputy Director General, Pharmaceuticals
Medicine and Therapeutic Goods Division, Maldives Food and Drug Authority [email protected]
Mali Mahamadou Ousmane Maiga [email protected]
Malta Victor P. Pace
Office of the Superintendence of Public Health, Department for Health Regulation [email protected]
Marshall Islands Julia Alfred Ministry of Health [email protected]
Mauritania Hamoud Fadel Yamohomed Director of Pharmacy and Laboratories Ministry of Health [email protected]
Mauritius Nitish Raj Sokool Officer-in-Charge Harm Reduction Unit, Ministry of Health and Wellness [email protected]
Mauritius Anil Jhugroo Advisor on Substance Abuse Ministry of Health and Wellness [email protected]
Mexico Angélica Juárez Ramírez Specialized Reviewer COFEPRIS representative, Federal Committee for Protection from Sanitary Risks
Micronesia (Federated States of) Benido Victor [email protected]
Monaco Isabelle Kessedjian Head of Division Pharmacy Inspector, Health Products Division [email protected]
Mongolia Luvsandagva Purevdorj [email protected]
Montenegro Jasna Sekulic Ministry of Health [email protected]
Morocco Hassan Elkarimi [email protected]
Annex II: List of focal points designated by Member States in previous years
Country Name Focal Point Job title Institution Email Last update
Morocco Jallal Toufiq
Professor of Psychiatry, Rabat Faculty of Medicine, Director of the National Centre on Drug Abuse Prevention, Treatment and Research, Director of the Moroccan Observatory on Drugs and Drugs Addictions
Mozambique Flavio Mandlate [email protected]
Myanmar Nanda Myo Aung Wan Program Manager/ Consultant Psychiatrist Drug Dependency Treatment and Research Unit, Ministry of Health and Sport
Namibia Ester Mvula Senior Pharmacist Ministry of Health & Social Services [email protected]
Nauru Richard Leona Chief Surgeon Ministry of Health [email protected]
Nepal
Netherlands Matthijs Geilenkirchen Nutrition, Health Protection and Prevention Department, Ministry of Health, Welfare and Sport
[email protected] 29 April 2024
New Zealand Group mail to be cc'ed [email protected] 7/10/2024
New Zealand Tania Jones Regulatory Practice and Analysis, Medsafe
[email protected] Confirmed 10/7/24
Nicaragua Karla Vanessa Delgado Martinez Director of Pharmacy Ministry of Health [email protected]
Niger Haoua Na Allah Alou [email protected]
Nigeria Wosilat Abdulhameed Deputy Director Federal Ministry of Health [email protected] 8/30/2024
Niue
North Macedonia
Norway Anne S. Onsgård Sagabråten Narcotic Drugs Control, Norwegian Medicines Agency [email protected]
Oman Dr. Mohammed Al-Rubaie, [email protected] 7/10/2024
Oman Dr Mahmood Al Abri [email protected] 7/10/2024
Oman Directorate General of Pharmaceutical Affairs and Drug control, Ministry of Health
Oman Drug Safety Center, Ministry of Health, Sultanate of Oman [email protected] 8/30/2024
Pakistan Rizwan Taj Professor Ministry of Health [email protected]
Palau Clarette Matlab Chief Pharmacist
Division of Ancillary Services, Bureau of Hospital and Clinical Services, Ministry of Health
Palau [email protected]
Palau Marla Ito [email protected]
Panama Dr Ricardo Goti, coordinateur du Programme de Santé Mentale
Ministère de la Santé du Panama [email protected] 7/16/2024
Annex II: List of focal points designated by Member States in previous years
Country Name Focal Point Job title Institution Email Last update
Papua New Guinea Vicky Wari Program Manager-Non Communicable Diseases
Public Health Division, National Department of Health [email protected]
Paraguay Blanca Galeano [email protected] 8/30/2024
Paraguay Zaira Francesca Stumpfs Bigarella [email protected]
Peru Judith Castañeda Alcántara Head of Functional Unit of Controlled Products
DIGEMID – General Directorate of Medicines, Supplies and Drugs [email protected] 7/26/2024
Philippines
Poland Michał Kidawa Polish Reitox Focal Point
Information Centre for Drugs and Drug Addiction (CINN) National Bureau for Drug Prevention [email protected]
Portugal Graça Vilar Director of Planning and Intervention Services Directorate
Intervention Service for Addictive Behaviours and Addictions General Directorate for Intervention on Addictive Behaviours and Dependencies SICAD
Puerto Rico
Qatar Majid Ali Al Abdulla Senior Consultant Psychiatrist
Director of addiction and CL at Hamad Medical Corporation Deputy Chairman of Mental Health Services, Hamad Medical Corporation
Republic of Korea Sang Hun Yeon Narcotics Policy Division of Ministry of Food and Drug Safety [email protected] 7/16/2024
Republic of Moldova Oleg Costachi
Standing Committee on Drugs Control, Agency for Medicines and Medical Devices
Romania Camelia Bunaciu Senior Advisor Ministry of Health [email protected]
Russian Federation Alyona Ryzova Deputy Head of the Unit for regulatory and leg Department for regulation of medicines and medical devices, Ministry of Health
[email protected] 7/11/2024
Rwanda
Saint Kitts and Nevis puerto rico
Saint Lucia Charlotte Emmanuel Coordinator of the Substance Abuse Advisory Council Secretariat
Substance Abuse Advisory Council Secretariat, Ministry of Health and Wellness [email protected]
Saint Lucia Paul Caleb Programme Officer
Substance Abuse Advisory Council Secretariat, Ministry of Health and Wellness [email protected]
Saint Vincent and the Grenadines
Samoa Robert Thomsen Assistant Chief Executive Officer HSPQA, Medical and Allied Division [email protected]
San Marino Claudio Muccioli Health Authority Director Health Authority [email protected]
Sao Tome and Principe
Annex II: List of focal points designated by Member States in previous years
Country Name Focal Point Job title Institution Email Last update
Saudi Arabia Adnan Alshammary
Administration of controlled preparations, Executive Management for Regulatory Affairs, Controlled Products Department, Regulatory Affairs Directorate, Drug Sector
Senegal Moussa DIALLO Pharmacist Inspector Pharmaceutical Regulatory Agency, Ministry of Health and Social Action [email protected]
Serbia Nataša Savić
Monitoring Centre for Drugs and Drug Addiction, Sector for Medicines and Medical Devices, Psychoactive Controlled Substances and Precursors, Ministry of Health
Seychelles
Sierra Leone
Singapore Ong Lay Tin Personal Assistant to Director (International Cooperation)
Senior Executive (International Cooperation) Public Health Group, Ministry of Health
[email protected] 04/07/2024 confiming no changes
Slovakia Peter Koreň Reitox National Focal Point
National Monitoring Centre for Drugs, Department of Anti-Drug Strategy Coordination and Drug Monitoring, Ministry of Health of the Slovak Republic
[email protected] 04/07/2024 confirming no changes
Slovenia Joze Hren Secretary Directorate of Public Health, Ministry of Health [email protected]
Solomon Islands Paul Orotaloa Head of Mental Health Services National Mental Health Service, Ministry of Health and Medical Services
Solomon Islands Stephen Araitewa Director Mental Health National Mental Health Service, Ministry of Health and Medical Services
Somalia
South Africa MG Molewa Ministry of Health [email protected]
South Sudan Moses Malual Deng Director General of Pharmaceuticals and Medical Supplies
Ministry of Health [email protected]
Spain Manuel Ibarra Head of Department Inspection & Enforcement
Spanish Agency of Medicines and Medical Products (AEMPS) [email protected]
Spain Lidia Fernandez Matellano
Narcotics and Psychotropic Substances Area, Pharmaceutical Inspection and Enforcement Department, Spanish Agency of Medicines and Medical Products (AEMPS)
Sri Lanka S.C. Wickramasinghe Deputy Director General (NCD) Ministry of Health [email protected]
Sudan
Annex II: List of focal points designated by Member States in previous years
Country Name Focal Point Job title Institution Email Last update
Suriname
Sweden Annika Borg
Ministry of Health and Social Affairs, Division for Public Health and Health Care [email protected] 4/8/2024
Switzerland Lucien Colliander
Federal Department of Home Affairs, Federal Office of Public Health, Division of International Affairs, Global Health Section
Switzerland Monika Joos Head of Division Narcotics Swissmedic, Swiss Agency for Therapeutic Products [email protected]
Syrian Arab Republic Ahmed Al-Salama Mental Health Directorate, Ministry of Health [email protected]
Tajikistan Salim Abdulazizov [email protected]
Thailand Sujinart Chantharakul Pharmacist
Narcotics Control Division (Standards and Regulations Sub-Division), Food and Drug Administration, Ministry of Public Health
Thailand Saranya Chavanich Pharmacist
Narcotics Control Division (Standards and Regulations Sub-Division), Food and Drug Administration, Ministry of Public Health
Thailand Korapin Na Ranong Expert on Narcotics Epidemiology
Narcotics Control Division Food and Drug Administration, Ministry of Public Health [email protected]
Thailand Raththar Benchapalanont Pharmacist
Narcotics Control Division Food and Drug Administration, Ministry of Public Health
Timor-Leste Soares Henriques Regulatory Affairs Pharmacist
Pharmacovigilance and Medicine Control Department, National Directorate for Pharmaceutical and Medicines, Ministry of Health
Togo Mouhoudine Yerima Centre National de Pharmacovigilance (CNPV)
[email protected]; [email protected]
Tokelau
Tonga Melenaite Mahe Principal Pharmacist Central Pharmacy and Medical Store, Old Vaiola, Ministry of Health [email protected]
Trinidad and Tobago Anesa Doodnath-Siboo Principal Pharmacist Ministry of Health [email protected]
Tunisia
Türkiye Elif Inci ERGONUL Head of Pharmacovigilance and Controlled Substances Department
Turkish Medicines and Medical Devices Agency, Ministry of Health
[email protected]; [email protected] 7/24/2024
Turkmenistan
Tuvalu
Uganda Hafsa Lukwata Head of Mental Health and Control of Substance Abuse
Mental Health and Control of Substance Abuse Division, Ministry of Health [email protected]
Annex II: List of focal points designated by Member States in previous years
Country Name Focal Point Job title Institution Email Last update
Ukraine Deputy Director Institute of Psychiatry, Forensic Psychiatric Examination and Drug Monitoring,
Ukraine Irina Pinchuk Director
Institute of Psychiatry of Taras Shevchenko National University of Kyiv, International Technology Transfer Center - Ukraine Head of ISSUP Ukraine National Chapter
Ukraine Yulia YACHNYK Clinical Psychologist Institute of Psychiatry, Taras Shevchenko National University of Kyiv
United Arab Emirates Alia Bin Hussain Head of Regulating Controlled substances Product & Precursor Chemicals Drug Department, Ministry of Health and Prevention
United Kingdom of Great Britain and Northern Ireland
Alberto Oteo Project Manager Drugs Research and Surveillance
Addiction and Inclusion Directorate, Office for Health Improvement & Disparities, Department of Health and Social Care
United Republic of Tanzania Suma Jairo Pharmacist Pharmaceutical Service Unit, Ministry of Health [email protected]
United States of America Edward Hawkins Senior Pharmacologist and International Drug Control Liaison
Center for Drug Evaluation and research, U.S. Food and Drug Administration
Uruguay Lorena Quintana Coordinator of the Addiction Prevention and Treatment Program
Ministry of Public Health [email protected] 8/2/2024
Uzbekistan Dr Azizbek Khamrakulov Head, Department of Inpatient and Specialized Care
Ministry of Health [email protected]
Uzbekistan Mr Zarif Ashurov Director Specialized Scientific and Mental Health Medical Center [email protected]
Vanuatu Jerry Iaruel Tafea Provincial Health Administrator Lenakel Health Office, Ministry of Health [email protected]
Venezuela (Bolivarian Republic of)
Viet Nam Mhin Tam Nguyen Regulatory Affair Consultant Ministry of Health [email protected]
Yemen
Zambia Nita Besa Head Clinical Care Chainama Hospital [email protected]
Zimbabwe Eneti Siyame Mental Health Manager Ministry of Health and Child Care [email protected]
20, AVENUE APPIA – CH-1211 GENÈVE 27 – SUISSE – TÉL. CENTRAL +41 22 791 2111 – FAX CENTRAL +41 22 791 3111 – WWW.WHO.INT
… PIÈCES JOINTES (2)
Réf. : C.L.22.2025
L’Organisation mondiale de la Santé (OMS) présente ses compliments aux États Membres et aux Membres associés et a le plaisir d’annoncer que la quarante-huitième réunion du Comité d’experts de la pharmacodépendance (ECDD) se tiendra du 20 au 22 octobre 2025 à Genève (Suisse). Étant donné que les réunions du Comité d’experts se tiennent à huis clos, la présente lettre circulaire vise à informer les États Membres de l’ordre du jour de la quarante-huitième
… réunion du Comité d’experts des substances psychoactives, qui figure à l’annexe I ci-jointe.
L’OMS est mandatée par les conventions internationales relatives au contrôle des drogues de 1961 et de 1971 pour formuler des recommandations à l’intention du Secrétaire général de l’Organisation des Nations Unies sur la nécessité d’un contrôle international des substances psychoactives et sur le niveau de celui-ci, suivant l’avis de son organe scientifique consultatif indépendant, le Comité d’experts de la pharmacodépendance. Pour déterminer si une substance psychoactive doit faire l’objet d’un contrôle international, le Comité d’experts de la pharmacodépendance se réunit chaque année pour examiner, d’une part, la capacité d’une substance à entraîner une dépendance et des dommages pour la santé publique et, d’autre part, ses applications thérapeutiques. Afin de procéder à cet examen et de prendre des décisions fondées sur des bases factuelles, le Comité d’experts évalue les substances psychoactives sélectionnées du point de vue médical, scientifique et de la santé publique en se fondant sur les informations les plus fiables.
Bien que les réunions se tiennent à huis clos, les États Membres et les Membres associés, sont invités à prendre part au processus d’examen en participant à une réunion d’information, qui aura lieu le 20 octobre 2025. Cette réunion d’information, qui se tiendra en ligne, permettra aux parties intéressées de connaître les activités actuelles et futures du secrétariat du Comité d’experts et de présenter des informations sur les substances à étudier afin que le Comité d’experts les examine à sa quarante-huitième réunion. Les informations relatives aux inscriptions seront disponibles en temps utile sur le site Web du Comité d’experts de la pharmacodépendance, à l’adresse : https://www.who.int/news-room/events/detail/2025/10/20/default-calendar/forty-eighth- expert-committee-on-drug-dependence.
C.L.22.2025 Page 2
Les États Membres et les Membres associés peuvent aussi contribuer au processus d’examen en fournissant des données actualisées et précises concernant les substances examinées par le Comité d’experts avant la réunion, comme par le passé et conformément aux dispositions de la publication « Directives pour l’examen par l’OMS des substances psychoactives aux fins d’un contrôle international » (EB126/2010/REC/1, annexe 6).1 À cette fin, et conformément à la pratique établie, un questionnaire sera envoyé aux États Membres et aux Membres associés pour réunir des informations sur l’utilisation légitime, l’usage nocif, le contrôle exercé au niveau national et l’impact que pourrait avoir le contrôle international pour chacune des substances à évaluer.
… L’annexe II de la présente lettre circulaire comporte une liste des points focaux nationaux officiellement désignés par les États Membres et les Membres associés les années précédentes pour fournir au Comité d’experts des informations propres à leur pays, à l’aide du questionnaire susmentionné. Si les informations relatives aux points focaux doivent être modifiées ou complétées, les États Membres et les Membres associés sont invités à en informer le secrétariat du Comité d’experts par courriel à l’adresse [email protected] d’ici au 18 juillet 2025, en indiquant en objet de leur message : « Point focal 48ECDD : (nom du pays) ».
Si la/les personne(s) figurant sur la liste est/sont toujours le(s) point(s) focal/aux chargé(s) de compléter le questionnaire transmis aux États Membres par le Comité d’experts cette année et si aucun ajout ni modification n’est apporté aux coordonnées des points focaux figurant sur la liste d’ici au 18 juillet 2025, ceux-ci recevront d’autres instructions du Secrétariat de l’OMS et pourront accéder directement aux questionnaires en ligne. Les réponses aux questionnaires complétés seront synthétisées dans un rapport dans le cadre du processus d’examen des substances psychoactives par le Comité d’experts à sa quarante-huitième réunion.
Outre le questionnaire, les États Membres et les Membres associés sont également invités à envoyer toute information supplémentaire utile (publiée ou non) dont ils disposent concernant les substances qui seront examinées à la quarante-septième réunion du Comité d’experts à l’adresse [email protected], en indiquant en objet de leur message : « Réf. : C.L.22.2025 ».
Toutes les recommandations formulées par le Comité d’experts de la pharmacodépendance (ECDD) à sa quarante-septième réunion, tenue en octobre 2024, ont été acceptées par la Commission des stupéfiants des Nations Unies à sa soixante-huitième session et l’ensemble des rapports techniques et recommandations du Comité d’experts sont disponibles dans son répertoire d’informations récemment mis en ligne à l’adresse https://ecddrepository.org/en.
L’Organisation mondiale de la Santé saisit cette occasion pour renouveler aux États Membres et aux Membres associés les assurances de sa très haute considération.
Genève, le 11 juillet 2025
1 https://apps.who.int/gb/ebwha/pdf_files/EB126-REC1/B126_REC1-fr.pdf#page=96.
QUARANTE-HUITIÈME RÉUNION DU COMITÉ D’EXPERTS DE LA PHARMACODÉPENDANCE
Ordre du jour provisoire
----
Séance d’information (en ligne)
20 octobre 2025
10 h 00-13 h 00 HNEC
1. Accueil et ouverture de la réunion
2. Exposés de l’OMS 2.1 Comité d’experts de la pharmacodépendance 2.2 Division des sciences 2.3 Genre, équité et droits humains 2.4 Médecine traditionnelle
4. Exposés et déclarations des participant(e)s
QUARANTE-HUITIÈME RÉUNION DU COMITÉ D’EXPERTS DE LA PHARMACODÉPENDANCE
Genève (Suisse)
Ordre du jour provisoire
----
Séance à huis clos
20-22 octobre 2025
1. Questions de procédure et mises à jour
1.1 Ouverture de la réunion et allocution de bienvenue 1.2 Présentation des participant(e)s 1.3 Engagement de confidentialité 1.4 Déclarations d’intérêts 1.5 Élection de la présidente ou du président, des vice-président(e)s et de la rapporteuse ou du
rapporteur 1.6 Adoption de l’ordre du jour
2. Informations actualisées sur les priorités des organismes internationaux
2.1 Exposés des organismes internationaux sur leurs travaux relatifs au problème mondial de la drogue sous l’angle de la santé publique 2.1.1 OMS 2.1.2 ONUDC 2.1.3 OICS
2.2 Mises à jour sur les réunions et les recommandations du Comité OMS d’experts de la pharmacodépendance 2.2.1 Recommandations et résultats de la quarante-septième réunion du Comité d’experts de
la pharmacodépendance 2.2.2 Mises à jour sur la surveillance des substances psychoactives
3. Examens critiques : recommandations sur le champ d’application du contrôle international
3.1 Feuille de coca1 3.1.1 Feuille de coca
3.2 Cannabinoïdes de synthèse2 3.2.1 MDMB-FUBINACA
3.3 Nouveaux opioïdes de synthèse2 3.3.1 N-pyrrolidino isotonitazène (isotonitazèpyne) 3.3.2 N-déséthyl-étonitazène
4. Achèvement du rapport de la réunion
1 Une notification a été soumise par une Partie à la Convention de 1961 ou à la Convention de 1971 au sujet de
l’inscription d’une substance. 2 L’attention de l’OMS a été appelée sur des informations selon lesquelles la substance est produite
clandestinement, présente un risque particulièrement grave pour la santé publique et la société et n’est considérée par aucune Partie comme ayant une utilité thérapeutique reconnue.
Annexe II : Liste des points focaux désignés par les États Membres les années précédentes
Pays Nom du point focal Titre du poste Institution Courriel Dernière mise à jour
Afghanistan
Afrique du Sud MG Molewa Ministry of Health [email protected]
Albanie Linda Ternova Specialist
Regulation Sector of Pharmaceutical Market and Medical Devices Ministry of Health and Social Protection, Albania
Algérie Ghrieb Houria Doctor
Narcotics, Psychotropics and Chemical Precursors, General Direction of Pharmacy and Health Equipment, Algerian Health Ministry
Allemagne Annette Hinze
Division 122 - Narcotics Law, Traffic in Narcotics, International Narcotic Drug Affairs Federal Ministry of Health
Andorre Carla Lobaco Valls Technical Officer Department of Health Resources and Medicines [email protected]
Andorre Carme Pallarés Papaseit Department of Health Resources and Medicines [email protected]
Angola Ana Da Conceição Mamede General Director, National Institute for combating Drugs
Ministry of Health [email protected]
Antigua-et-Barbuda
Arabie saoudite Adnan Alshammary
Administration of controlled preparations, Executive Management for Regulatory Affairs, Controlled Products Department, Regulatory Affairs Directorate, Drug Sector
Argentine G. Rebaldería Pharmacist Director of Surveillance of Substances Subject to Special Control Argentinian Ministry of Health
Arménie Hasmik Martirosyan Armenian Ministry of Health [email protected]
Australie
Narcotics Control Section Office of Drug Control Australian Government Department of Health and Aged Care
[email protected] 7/10/2024
Australie [email protected]
Autriche Raphael Bayer Head of Division
Section VI, Department 6 Federal Ministry of Social Affairs, Health, Care and Consumer Protection
Azerbaïdjan Telman Suleyman Oglu Mammadhassanov [email protected]
Bahamas
Bahreïn Samar Yousef Salem Senior Pharmacist Ministry of Health [email protected]
Bangladesh Habibur Rahman Khan Additional Secretary Health Services Division, Ministry of Health & Family Welfare [email protected]
Barbade Lindsay Bynoe Assistant Director for Drug Regulation Ministry of Health [email protected]
Bélarus Aleksey Kralko Ministry of Health [email protected]
Belgique Lies Gremeaux Head of Unit illicit Drugs, Reitox National Focal Point
Epidemiology and Public Health, Sciensano, Ministry of Health
Annexe II : Liste des points focaux désignés par les États Membres les années précédentes
Pays Nom du point focal Titre du poste Institution Courriel Dernière mise à jour
Belize
Bénin Saturnin Bognon State-certified Pharmacist, Head of Pharmaceutical Establishments Department
Pharmaceutical Establishments Department [email protected]
Bhoutan Dil Kumar Subba Department of Public Health, Ministry of Health [email protected]
Bolivie (État plurinational de) H.E. Amb. Maira Mariela Macdonal Permanente Representative of the Plurinational State of Bolivia
[email protected]; [email protected] 7/27/2024
Bosnie-Herzégovine [email protected]; [email protected]
Bosnie-Herzégovine Sabina Šahman Department for Health, Ministr of the Civill Affairs of Bosnia and Herzegovina
Botswana Vivian Sebako Chief Pharmacist Department of Clinical Services, Ministry of Health and Wellness [email protected]
Brésil Renata de Morais Souza, Moema Luisa Silva Macedo Manager
Management of Controlled Products GPCON/GGMON/DIMON/ANVISA Controlled Substances Office Brazilian Health Regulatory Agency – ANVISA
Brésil Natalia Jorge e Costa International Affairs Office, Brazilian Health Regulatory Agency - ANVISA, AINTE/ GADIP/ANVISA
Brunéi Darussalam Hajah Zanatul ‘Aini Haji Zainin (Ms) Acting Director of Pharmaceutical Services Department of Pharmaceutical Services, Ministry of Health [email protected]
Bulgarie Slaveyka Nikolova Chief Expert at the Health Promotion Department Health Promotion and Prophylaxis of the Diseases and Addictions Directorate
Bulgarie Alexander Panayotov Head of the National Focus Center Department
Mental Health and Addiction Prevention Directorate, National Center for Public Health and Analysis
Burkina Faso [email protected]
Burundi Israël Nimubona [email protected]
Cabo Verde Raquel Lopes Commission for the Coordination of Alcohol and Other Drugs, Ministerio da Saude e da Seguranca Social
[email protected] 8/30/2024
Cambodge Chhit Sophal Director Department of Mental and Substance Abuse, Ministry of Health [email protected]
Cameroun Ketchozo Loko Wilfried [email protected]
Canada
International Relations Unit, Office of Drug Policy and Science, Controlled Substances Directorate, Health Canada, Government of Canada
[email protected] 4/26/2024
Chili Javiera Erazo Leiva Advisor Department of Mental Health/DIPRECE, Ministry of Health [email protected]
Chine Peng XU Senior Expert National Narcotics Laboratory [email protected]
Chine Yan ZHENG Official Office of National Narcotics Control Commission [email protected]
Chine Zhendong HUA Deputy Director National Narcotics Laboratory [email protected]
Chypre John Kkolos Pharmacist Pharmaceutical Services, Ministry of Health [email protected]
Annexe II : Liste des points focaux désignés par les États Membres les années précédentes
Pays Nom du point focal Titre du poste Institution Courriel Dernière mise à jour
Colombie Oscar Ricardo Santana
Observatorio de Drogas de Colombia Dirección de Políticas de Drogas y Actividades Relacionadas Ministerio de Justicia y del Derecho
[email protected]; [email protected] 7/16/2024
Colombie Nubia Esperanza Bautista Coordinadora del Grupo Convivencia Social y Ciudadanía
Dirección de Promoción y Prevención – Ministerio de Salud y Protección Social
Colombie Germán Andrés Calderón Velásquez Coordinador Grupo Interno de Trabajo de Asuntos Relacionados con las Drogas
Ministerio de Relaciones Exteriores [email protected]; [email protected]
Comores
Costa Rica Marchena Vasquez [email protected]
Côte d'Ivoire Ernest Zotoua [email protected]
Croatie Lidija Vugrinec Head of National Information Unit in the Field of Drugs and Behavioural Addictions and Internal Relations Department
Croation Institute of Public Health [email protected] 8/30/2024
Cuba
Danemark Kari Gragaasen Chief Consultant Head of Focal Point, Prevention, National Board of Health [email protected]
Djibouti
Dominique Laura Esprit Chief Medical Office Ministry of Health, Wellness and New Health Investment [email protected]
Dominique Anna Royer-Edmund Chief Pharmacist Ministry of Health, Wellness and New Health Investment [email protected]
Égypte Dr Samah Abdeleazik Kandil Ministry of Health and Population [email protected]; [email protected] 7/16/2024
El Salvador José Mauricio Bermúdez Recinos Focal Point of the Ministry of Health of El Salvador
Health Technology Department, Ministry of Health [email protected]
Émirats arabes unis Alia Bin Hussain Head of Regulating Controlled substances Product & Precursor Chemicals Drug Department, Ministry of Health and Prevention
Équateur Gabriel Ordonez Guzman Director nacional de Estrategias de Prevencion Y Control para Enfermedades no
Salud Mental Y Fenomeno Socioeconomico de las Drogas
[email protected] 7/24/2024
Érythrée Michael Girmay Haile [email protected]
Espagne Manuel Ibarra Head of Department Inspection & Enforcement
Spanish Agency of Medicines and Medical Products (AEMPS) [email protected]
Espagne Lidia Fernandez Matellano
Narcotics and Psychotropic Substances Area, Pharmaceutical Inspection and Enforcement Department, Spanish Agency of Medicines and Medical Products (AEMPS)
Estonie Olga Kamp Inspector of pharmacovigilance, drugs and psychotropic substances, and the precursors
State Agency of Medicines, Ministry of Health [email protected]
Eswatini
États-Unis d’Amérique Edward Hawkins Senior Pharmacologist and International Drug Control Liaison
Center for Drug Evaluation and research, U.S. Food and Drug Administration
Éthiopie Baharu Zewdie Moya [email protected]
Fédération de Russie Alyona Ryzova
Deputy Head of the Unit for regulatory and legal regulation of pharmaceutical activities, regulation of narcotic drugs and psychotropic substances
Department for regulation of medicines and medical devices, Ministry of Health
[email protected] 7/11/2024
Annexe II : Liste des points focaux désignés par les États Membres les années précédentes
Pays Nom du point focal Titre du poste Institution Courriel Dernière mise à jour
Fidji Ilisabeta May Pesamino Chief Pharmacist Pharmaceutical & Biomedical Services/Ministry of Health & Medical Services
Finlande Katja Pihlainen Finnish Medicines Agency, Ministry of Health [email protected]
France Luciano Amato Acting Head of Department
Regulation of narcotics and psychotropic substances, National Agency for the Safety of Medicines and Health Products
Gabon Okouyi Ndakissa Directorate of Medicines and Pharmacy Ministry of Health
Gambie
Géorgie Ekaterine Paposhvili Senior Specialist
Division of Legal Circulation of Narcotic Drugs, LEPL State Regulation Agency for Medical Activities Ministry of Labour, Health and Social Affairs of Georgia
Ghana Martha Gyansa-Lutterodt Director Pharmaceutical Services, Ministry of Health [email protected]
Grèce Dr Foteini Koulouri Head of General Directorate of Public Health and Quality of Life
Hellenic Ministry of Health [email protected] ; [email protected] 7/16/2024
Grèce Avgerinos Nikolaos Psychiatrist, Programs Implementation Director
OKANA - Organisation Against Drugs Greece
[email protected] ; [email protected]
Grèce Ms Anastasia Petroulia Legal Advisor to the Minister of Health Hellenic Ministry of Health [email protected]; [email protected] Will also attend the 47th ECDD meeting
Grenade
Guatemala José Miguel Solares Estrada Department of Regulation and Control of Related Pharmaceutical Products [email protected] 8/30/2024
Guatemala Alicia Elena Morgan Durán Section of Psychotropics, Narcotics, Imports and Exports [email protected] 8/30/2024
Guinée
Guinée équatoriale
Guinée-Bissau
Guyana
Haïti Marie Judith Robuste Roche Ministry of Health [email protected]
Honduras Alex Virgilio Santos Moreno General Director of the Honduran Institute for the Prevention of Alcoholism
Honduran Institute for the Prevention of Alcoholism, Drug Addiction and Drug Dependence (IHADFA)
Hongrie Tímea Kahlesz Deputy Head of Department EMMI Pharmaceutical and Medical Technology Department [email protected]
Îles Cook Tereapii Uka Central Policy and Planning Office [email protected]
Îles Marshall Julia Alfred Ministry of Health [email protected]
Îles Salomon Paul Orotaloa Head of Mental Health Services National Mental Health Service, Ministry of Health and Medical Services
Îles Salomon Stephen Araitewa Director Mental Health National Mental Health Service, Ministry of Health and Medical Services
Inde Dr Anju Dhawan Professor and Head Department of Psychiatry, National Drug Dependence Treatment Centre, All India Institute of Medical Sciences
[email protected] 7/24/2024
Annexe II : Liste des points focaux désignés par les États Membres les années précédentes
Pays Nom du point focal Titre du poste Institution Courriel Dernière mise à jour
Indonésie Agusdini Banun Saptaningsih Director of Pharmaceutical Production and Distribution
Directorate General of Pharmaceutical Care and Medical Devices, [email protected]
Iran (République islamique d’) Mina Azhoogh [email protected]
Iraq Emad Abdulrazzaq Abdulghani Ministry of Health [email protected]
Irlande Conor Brennan Department of Health [email protected]
Irlande Alan Bell Department of Health [email protected]
Islande Bjarni Sigurðsson Ministry of Health [email protected]
Israël Paola Rosca Head of the Addiction Treatment Department
Ministry of Health [email protected]
Israël Tal Lavy
The Competent Authority for Narcotics, Psychotropics and Precursors Pharmaceutical Administration
Italie Pietro Canuzzi Head of Office 7, Central Narcotic Office Ministry of Health - Directorate general of Health Prevention [email protected] 7/26/2024
Jamaïque Dr Jacquiline Bisasor McKenzie Chief Medical Officer Ministry of Health & Wellness [email protected] 7/5/2024
Jamaïque Ms Uki Atkinson Research Analyst National Council on Drug Abuse (NCDA) [email protected] 7/5/2024
Japon Compliance and Narcotics Division, Pharmaceutical Safety and Environmental Health Bureau
Jordanie Malak AlMahirah
Head of Narcotics, Psychotropic Substances and Chemical Precursors Department, Jordan Food and Drug Administration
Kazakhstan Prilutskaya Marina Republican Scientific and Practical Center of Mental Health [email protected]
Kenya Anthony Toroitich [email protected]
Kenya Simon Njuguna [email protected]
Kirghizistan Kanyshai Damirbek Drug Trafficking Control Department, Ministry of Foreign Affairs [email protected]
Kiribati Biribo Kararaiti Chief Pharmacist Ministry of Health and Medical Services [email protected]
Koweït Ali Abdulmohsen Jaragh Head Control of Licenses for Narcotic Drugs and Psychotropic Substances Department
[email protected] 7/24/2024
Lesotho Masello Sello [email protected]
Lettonie Linda Veisberga Ministry of Health [email protected]
Liban Marie-Therese Matar Head of Narcotics Department Ministry of Public Health [email protected]
Libéria Dr. Moses Ziah II Director Mental Health Unit Ministry of Health, Republic of Liberia [email protected]; [email protected]
Libye
Lituanie Rima Mačiūnienė Head of Drug Precursors Control and Risk Assessment Division
Drug Precursors Control and Risk Assessment Division, Drug, Tobacco and Alcohol Control Department
Luxembourg Alain Origer National Drug Coordinator Ministry of Health [email protected]
Annexe II : Liste des points focaux désignés par les États Membres les années précédentes
Pays Nom du point focal Titre du poste Institution Courriel Dernière mise à jour
Macédoine du Nord
Madagascar Maximine Ravaoarimanana Director of Pharmacy Laboratories and Traditional Medicine [email protected]; [email protected]
Malaisie Rohaida Binti Zakaria Senior Principal Assistant Director Pharmaceutical Services Division, Ministry of Health [email protected]
Malawi Michael Udedi Assistant Director of Clinical Services (Mental Health and Substance Abuse) [email protected]
Maldives Aishath Mohamed Deputy Director General, Pharmaceuticals Medicine and Therapeutic Goods Division, Maldives Food and Drug Authority
Mali Mahamadou Ousmane Maiga [email protected]
Malte Victor P. Pace Office of the Superintendence of Public Health, Department for Health Regulation
Maroc Hassan Elkarimi [email protected]
Maroc Jallal Toufiq
Professor of Psychiatry, Rabat Faculty of Medicine, Director of the National Centre on Drug Abuse Prevention, Treatment and Research, Director of the Moroccan Observatory on Drugs and Drugs Addictions
Maurice Nitish Raj Sokool Officer-in-Charge Harm Reduction Unit, Ministry of Health and Wellness [email protected]
Maurice Anil Jhugroo Advisor on Substance Abuse Ministry of Health and Wellness [email protected]
Mauritanie Hamoud Fadel Yamohomed Director of Pharmacy and Laboratories Ministry of Health [email protected]
Mexique Angélica Juárez Ramírez Specialized Reviewer COFEPRIS representative, Federal Committee for Protection from Sanitary Risks
Micronésie (États fédérés de) Benido Victor [email protected]
Monaco Isabelle Kessedjian Head of Division Pharmacy Inspector, Health Products Division [email protected]
Mongolie Luvsandagva Purevdorj [email protected]
Monténégro Jasna Sekulic Ministry of Health [email protected]
Mozambique Flavio Mandlate [email protected]
Myanmar Nanda Myo Aung Wan Program Manager/ Consultant Psychiatrist Drug Dependency Treatment and Research Unit, Ministry of Health and Sport
Namibie Ester Mvula Senior Pharmacist Ministry of Health & Social Services [email protected]
Nauru Richard Leona Chief Surgeon Ministry of Health [email protected]
Népal
Nicaragua Karla Vanessa Delgado Martinez Director of Pharmacy Ministry of Health [email protected]
Niger Haoua Na Allah Alou [email protected]
Nigéria Wosilat Abdulhameed Deputy Director Federal Ministry of Health
[email protected] 8/30/2024
Nioué
Norvège Anne S. Onsgård Sagabråten Narcotic Drugs Control, Norwegian Medicines Agency [email protected]
Nouvelle-Zélande Group mail to be cc'ed [email protected] 7/10/2024
Annexe II : Liste des points focaux désignés par les États Membres les années précédentes
Pays Nom du point focal Titre du poste Institution Courriel Dernière mise à jour
Nouvelle-Zélande Tania Jones Regulatory Practice and Analysis, Medsafe
[email protected] Confirmed 10/7/24
Oman Dr. Mohammed Al-Rubaie, [email protected] 7/10/2024
Oman Dr Mahmood Al Abri [email protected] 7/10/2024
Oman Directorate General of Pharmaceutical Affairs and Drug control, Ministry of Health
Oman Drug Safety Center, Ministry of Health, Sultanate of Oman [email protected] 8/30/2024
Ouganda Hafsa Lukwata Head of Mental Health and Control of Substance Abuse
Mental Health and Control of Substance Abuse Division, Ministry of Health
Ouzbékistan Dr Azizbek Khamrakulov Head, Department of Inpatient and Specialized Care
Ministry of Health [email protected]
Ouzbékistan Mr Zarif Ashurov Director Specialized Scientific and Mental Health Medical Center [email protected]
Pakistan Rizwan Taj Professor Ministry of Health [email protected]
Palau Clarette Matlab Chief Pharmacist
Division of Ancillary Services, Bureau of Hospital and Clinical Services, Ministry of Health
Palau [email protected]
Palau Marla Ito [email protected]
Panama Dr Ricardo Goti, coordinateur du Programme de Santé Mentale
Ministère de la Santé du Panama [email protected] 7/16/2024
Papouasie-Nouvelle-Guinée Vicky Wari Program Manager-Non Communicable Diseases
Public Health Division, National Department of Health [email protected]
Paraguay Blanca Galeano [email protected] 8/30/2024
Paraguay Zaira Francesca Stumpfs Bigarella [email protected]
Pays-Bas Matthijs Geilenkirchen Nutrition, Health Protection and Prevention Department, Ministry of Health, Welfare and Sport
[email protected] 29 April 2024
Pérou Judith Castañeda Alcántara Head of Functional Unit of Controlled Products
DIGEMID – General Directorate of Medicines, Supplies and Drugs [email protected] 7/26/2024
Philippines
Pologne Michał Kidawa Polish Reitox Focal Point Information Centre for Drugs and Drug Addiction (CINN) National Bureau for Drug Prevention
Porto Rico
Portugal Graça Vilar Director of Planning and Intervention Services Directorate
Intervention Service for Addictive Behaviours and Addictions General Directorate for Intervention on Addictive Behaviours and Dependencies SICAD
Qatar Majid Ali Al Abdulla Senior Consultant Psychiatrist
Director of addiction and CL at Hamad Medical Corporation Deputy Chairman of Mental Health Services, Hamad Medical Corporation
République arabe syrienne Ahmed Al-Salama Mental Health Directorate, Ministry of Health [email protected]
Annexe II : Liste des points focaux désignés par les États Membres les années précédentes
Pays Nom du point focal Titre du poste Institution Courriel Dernière mise à jour
République centrafricaine
République de Corée Sang Hun Yeon Narcotics Policy Division of Ministry of Food and Drug Safety [email protected] 7/16/2024
République de Moldova Oleg Costachi
Standing Committee on Drugs Control, Agency for Medicines and Medical Devices
République démocratique du Congo Ghislaine Mbelu Kanyunya [email protected]
République démocratique populaire lao Khatthanaphone Phandoangsy Head of Health Promotion and Nutrition Unit Department of Hygiene and Health Promotion, Ministry of Health [email protected]
République dominicaine [email protected]
République dominicaine Francisca Dalia Castillo Sanchez Head of the Assistive Technology Department
General Directorate of Medicines, Food and Health Products (DIGEMAPS), Ministry of Public Health
République populaire démocratique de Corée
Kim Jong Guk
République-Unie de Tanzanie Suma Jairo Pharmacist Pharmaceutical Service Unit, Ministry of Health [email protected]
Roumanie Camelia Bunaciu Senior Advisor Ministry of Health [email protected]
Royaume-Uni de Grande-Bretagne et d’Irlande du Nord
Alberto Oteo Project Manager Drugs Research and Surveillance
Addiction and Inclusion Directorate, Office for Health Improvement & Disparities, Department of Health and Social Care
Rwanda
Sainte-Lucie Charlotte Emmanuel Coordinator of the Substance Abuse Advisory Council Secretariat
Substance Abuse Advisory Council Secretariat, Ministry of Health and Wellness
Sainte-Lucie Paul Caleb Programme Officer Substance Abuse Advisory Council Secretariat, Ministry of Health and Wellness
Saint-Kitts-et-Nevis puerto rico
Saint-Vincent-et-les-Grenadines
Samoa Robert Thomsen Assistant Chief Executive Officer HSPQA, Medical and Allied Division [email protected]
San Marin Claudio Muccioli Health Authority Director Health Authority [email protected]
Sao Tomé-et-Principe
Sénégal Moussa DIALLO Pharmacist Inspector Pharmaceutical Regulatory Agency, Ministry of Health and Social Action [email protected]
Serbie Nataša Savić
Monitoring Centre for Drugs and Drug Addiction, Sector for Medicines and Medical Devices, Psychoactive Controlled Substances and Precursors, Ministry of Health
Seychelles
Sierra Leone
Singapour Ong Lay Tin Personal Assistant to Director (International Cooperation)
Senior Executive (International Cooperation) Public Health Group, Ministry of Health
[email protected] 04/07/2024 confiming no changes
Annexe II : Liste des points focaux désignés par les États Membres les années précédentes
Pays Nom du point focal Titre du poste Institution Courriel Dernière mise à jour
Slovaquie Peter Koreň Reitox National Focal Point
National Monitoring Centre for Drugs, Department of Anti-Drug Strategy Coordination and Drug Monitoring, Ministry of Health of the Slovak Republic
[email protected] 04/07/2024 confirming no changes
Slovénie Joze Hren Secretary Directorate of Public Health, Ministry of Health [email protected]
Somalie
Soudan
Soudan du Sud Moses Malual Deng Director General of Pharmaceuticals and Medical Supplies
Ministry of Health [email protected]
Sri Lanka S.C. Wickramasinghe Deputy Director General (NCD) Ministry of Health [email protected]
Suède Annika Borg Ministry of Health and Social Affairs, Division for Public Health and Health Care
[email protected] 4/8/2024
Suisse Lucien Colliander
Federal Department of Home Affairs, Federal Office of Public Health, Division of International Affairs, Global Health Section
Suisse Monika Joos Head of Division Narcotics Swissmedic, Swiss Agency for Therapeutic Products [email protected]
Suriname
Tadjikistan Salim Abdulazizov [email protected]
Tchad Haoua Haroun Saker Deputy Director of Pharmacy and Medicine Ministry of Public Health [email protected]
Tchéquie Vlastimil Brandejs Inspectorate Department, Narcotic and Psychotropic Substances Ministry of Health
Thaïlande Sujinart Chantharakul Pharmacist
Narcotics Control Division (Standards and Regulations Sub-Division), Food and Drug Administration, Ministry of Public Health
Thaïlande Saranya Chavanich Pharmacist
Narcotics Control Division (Standards and Regulations Sub-Division), Food and Drug Administration, Ministry of Public Health
Thaïlande Korapin Na Ranong Expert on Narcotics Epidemiology Narcotics Control Division Food and Drug Administration, Ministry of Public Health
Thaïlande Raththar Benchapalanont Pharmacist Narcotics Control Division Food and Drug Administration, Ministry of Public Health
Timor-Leste Soares Henriques Regulatory Affairs Pharmacist
Pharmacovigilance and Medicine Control Department, National Directorate for Pharmaceutical and Medicines, Ministry of Health
Togo Mouhoudine Yerima Centre National de Pharmacovigilance (CNPV)
[email protected]; [email protected]
Tokélaou
Tonga Melenaite Mahe Principal Pharmacist Central Pharmacy and Medical Store, Old Vaiola, Ministry of Health [email protected]
Trinité-et-Tobago Anesa Doodnath-Siboo Principal Pharmacist Ministry of Health [email protected]
Annexe II : Liste des points focaux désignés par les États Membres les années précédentes
Pays Nom du point focal Titre du poste Institution Courriel Dernière mise à jour
Tunisie
Türkiye Elif Inci ERGONUL Head of Pharmacovigilance and Controlled Substances Department
Turkish Medicines and Medical Devices Agency, Ministry of Health
[email protected]; [email protected] 7/24/2024
Turkménistan
Tuvalu
Ukraine Deputy Director Institute of Psychiatry, Forensic Psychiatric Examination and Drug Monitoring,
Ukraine Irina Pinchuk Director
Institute of Psychiatry of Taras Shevchenko National University of Kyiv, International Technology Transfer Center - Ukraine Head of ISSUP Ukraine National Chapter
Ukraine Yulia YACHNYK Clinical Psychologist Institute of Psychiatry, Taras Shevchenko National University of Kyiv
Vanuatu Jerry Iaruel Tafea Provincial Health Administrator Lenakel Health Office, Ministry of Health [email protected]
Venezuela (République bolivarienne du)
Viet Nam Mhin Tam Nguyen Regulatory Affair Consultant Ministry of Health [email protected]
Yémen
Zambie Nita Besa Head Clinical Care Chainama Hospital [email protected]
Zimbabwe Eneti Siyame Mental Health Manager Ministry of Health and Child Care [email protected]
20, AVENUE APPIA – CH-1211 GENEVA 27 – SWITZERLAND – TEL CENTRAL +41 22 791 2111 – FAX CENTRAL +41 22 791 3111 – WWW.WHO.INT
... ПРИЛ: (2)
Всемирная организация здравоохранения
Organisation mondiale de la Santé • World Health Organization • Organización Mundial de la Salud
Ref.: C.L.22.2025
Всемирная организация здравоохранения (ВОЗ) свидетельствует свое уважение государствам-членам и ассоциированным членам и имеет честь сообщить, что 20–22 октября 2025 г. в Женеве, Швейцария, состоится 48-е совещание Комитета экспертов по лекарственной зависимости (КЭЛЗ). Поскольку совещания комитетов экспертов ВОЗ носят закрытый характер, настоящее письмо служит уведомлением государств-членов о повестке дня 48-го совещания КЭЛЗ,
… которая для справки приводится в файле приложения I к настоящему письму.
В соответствии с конвенциями о международном контроле над наркотиками 1961 г. и 1971 г. ВОЗ поручено на основе заключений ее независимого научно-консультативного органа – КЭЛЗ – представлять Генеральному секретарю ООН рекомендации в отношении необходимости и уровня международного контроля над психоактивными веществами. Для оценки целесообразности введения международного контроля над теми или иными психоактивными веществами КЭЛЗ проводит ежегодные совещания для рассмотрения способности таких веществ вызывать зависимость, провоцировать злоупотребление и причинять вред здоровью, а также способов их применения в терапевтических целях. В целях проведения такого анализа и принятия научно обоснованных решений КЭЛЗ проводит оценку отобранных психоактивных веществ с точки зрения медицины, науки и принципов общественного здравоохранения, используя наиболее точную имеющуюся информацию.
Хотя совещания КЭЛЗ носят закрытый характер, государствам-членам и ассоциированным членам предлагается внести свой вклад в аналитическую работу КЭЛЗ, приняв участие в информационном заседании 48-го совещания КЭЛЗ, которое состоится 20 октября 2025 г. В ходе информационного заседания, которое пройдет в виртуальном формате, заинтересованные стороны смогут узнать и прошлой и текущей деятельности Секретариата КЭЛЗ и представить на рассмотрение Комитета информацию о веществах, которые будут объектом анализа на его 48-м совещании. Информация о регистрации участников будет в установленном порядке размещена на веб-сайте КЭЛЗ по адресу https://www.who.int/news-room/events/detail/2025/10/20/default-calendar/forty-eighth-expert- committee-on-drug-dependence.
В соответствии со сложившейся практикой и положениями Руководства по выполнению ВОЗ оценки психоактивных веществ на предмет введения международного контроля (EB126/2010/REC1, приложение 6)1 государства-члены и ассоциированные члены могут также внести вклад в аналитическую работу КЭЛЗ, заблаговременно предоставив совещанию актуальную и точную информацию о рассматриваемых веществах. С этой целью государствам-членам и ассоциированным членам будет, как и раньше, направлена анкета для сбора информации
1 https://apps.who.int/gb/ebwha/pdf_files/EB126-REC1/B126_REC1-ru.pdf#page=114.
C.L.22.2025 стр. 2
о правомерном использовании, вредном использовании, статусе национального контроля и возможных последствиях введения международного контроля в отношении каждого из рассматриваемых веществ.
... В приложении II к настоящему циркулярному письму содержится список национальных координаторов, которые были официально назначены государствами-членами и ассоциированными членами в предыдущие годы и предоставляют КЭЛЗ информацию от своих стран путем заполнения вышеуказанной анкеты для государств-членов и ассоциированных членов. В случае необходимости внесения изменений или дополнений в информацию о координаторах государствам-членам предлагается сообщить об этом в секретариат КЭЛЗ при ВОЗ не позднее 18 июля 2025 г. по электронной почте на адрес [email protected], указав в теме сообщения “48ECDD Focal Point: (название страны на английском языке)”.
Если указанное в списке лицо остается официальным координатором государства-члена по заполнению анкеты КЭЛЗ в этом году и если до 18 июля 2025 г. в его контактную информацию не будет внесено никаких изменений или дополнений, Секретариат ВОЗ направит указанному в списке координатору дополнительные инструкции и предоставит непосредственный доступ к анкете в режиме онлайн. По итогам обработки анкет будет подготовлен доклад, который будет учитываться 48-м совещанием КЭЛЗ при рассмотрении соответствующих веществ.
Помимо анкеты государствам-членам и ассоциированным членам предлагается также направить любую значимую дополнительную информацию (опубликованную или неопубликованную) по рассматриваемым на 48-м совещании КЭЛЗ веществам на адрес электронной почты [email protected], указав в теме сообщения “Ref: C.L.22.2025”.
Комиссия ООН по наркотическим веществам на своем 68-м заседании приняла все рекомендации, вынесенные по итогам 47-го совещания КЭЛЗ, состоявшегося в октябре 2024 г., а все технические доклады и рекомендации КЭЛЗ размещены онлайн на веб-сайте нового Центра документации КЭЛЗ (https://ecddrepository.org/en).
Всемирная организация здравоохранения пользуется настоящей возможностью, чтобы вновь заверить государства-члены и ассоциированных членов в своем глубоком уважении.
ЖЕНЕВА, 11 июля 2025 г.
Всемирная организация здравоохранения
48-е СОВЕЩАНИЕ КОМИТЕТА ЭКСПЕРТОВ ВОЗ ПО ЛЕКАРСТВЕННОЙ ЗАВИСИМОСТИ
Предварительная повестка дня
----
Информационное заседание (виртуальный формат)
20 октября 2025 г.
10:00–13:00 ЦЕВ
1. Приветственная часть и открытие совещания
2. Выступления от ВОЗ
2.1. Комитет экспертов по лекарственной зависимости 2.2. Управление по научной работе 2.3. Департамент по вопросам гендерного равенства, прав человека
и справедливости в области здравоохранения 2.4. Центр по народной медицине
3. Выступления и заявления участников
Всемирная организация здравоохранения
48-е СОВЕЩАНИЕ КОМИТЕТА ЭКСПЕРТОВ ВОЗ ПО ЛЕКАРСТВЕННОЙ ЗАВИСИМОСТИ
Женева, Швейцария
Предварительная повестка дня
----
Закрытое заседание
20–22 октября 2025 г.
1. Процедурные вопросы и актуальная информация
1.1. Открытие совещания и приветственные выступления 1.2. Представление участников 1.3. Заявление о конфиденциальности 1.4. Декларации интересов 1.5. Выборы Председателя, заместителя Председателя и докладчика 1.6. Утверждение повестки дня
2. Обновленная информация международных учреждений о текущих приоритетах
2.1. Выступления представителей международных учреждений об их работе, связанной с медико-санитарными аспектами мировой проблемы наркотиков
2.1.1. ВОЗ 2.1.2. УНП ООН 2.1.3. МККН
2.2. Обновленная информация о рекомендациях и итогах совещания КЭЛЗ
2.2.1. Рекомендации и итоги 47-го совещания КЭЛЗ 2.2.2. Обновленная информация о надзоре за психоактивными веществами
Всемирная организация здравоохранения
3. Критический анализ: рекомендации относительно уровня международного контроля
3.1. Лист коки1
3.1.1. Лист коки
3.2. Синтетические каннабиноиды2
3.2.1. MDMB-FUBINACA
3.3. Новые синтетические опиоиды2
3.3.1. N-пирролидин-изотонитазен (изотонитазепин) 3.3.2. N-дезэтил-этонитазен
4. Доработка доклада о работе совещания
---
1 От одной из Сторон Конвенции 1961 г. или Конвенции 1971 г. было получено уведомление о внесении вещества в список.
2 До сведения ВОЗ была доведена информация о нелегальном изготовлении данного вещества либо о том, что оно представляет серьезную опасность для здоровья населения и общества и не имеет установленных показаний для применения в лечебных целях на территории ни одной из Сторон.
Приложение 2. Список национальных координаторов, назначенных государствами-членами в прошлые годы
Страна Имя/фамилия координатора Должность Учреждение Эл. почта Последнее обновление
Афганистан
Албания Linda Ternova Specialist
Regulation Sector of Pharmaceutical Market and Medical Devices Ministry of Health and Social Protection, Albania
Алжир Ghrieb Houria Doctor
Narcotics, Psychotropics and Chemical Precursors, General Direction of Pharmacy and Health Equipment, Algerian Health Ministry
Андорра Carla Lobaco Valls Technical Officer Department of Health Resources and Medicines [email protected]
Андорра Carme Pallarés Papaseit Department of Health Resources and Medicines [email protected]
Ангола Ana Da Conceição Mamede General Director, National Institute for combating Drugs
Ministry of Health [email protected]
Антигуа и Барбуда
Аргентина G. Rebaldería Pharmacist Director of Surveillance of Substances Subject to Special Control Argentinian Ministry of Health
Армения Hasmik Martirosyan Armenian Ministry of Health [email protected]
Приложение 2. Список национальных координаторов, назначенных государствами-членами в прошлые годы
Страна Имя/фамилия координатора Должность Учреждение Эл. почта Последнее обновление
Австралия Narcotics Control Section Office of Drug Control Australian Government Department of Health and Aged Care
[email protected] 10-07-24
Австралия [email protected]
Австрия Raphael Bayer Head of Division
Section VI, Department 6 Federal Ministry of Social Affairs, Health, Care and Consumer Protection
Азербайджан Telman Suleyman Oglu Mammadhassanov
Багамские Острова
Бахрейн Samar Yousef Salem Senior Pharmacist Ministry of Health [email protected]
Бангладеш Habibur Rahman Khan Additional Secretary Health Services Division, Ministry of Health & Family Welfare [email protected]
Барбадос Lindsay Bynoe Assistant Director for Drug Regulation Ministry of Health [email protected]
Беларусь Aleksey Kralko Ministry of Health [email protected]
Бельгия Lies Gremeaux Head of Unit illicit Drugs, Reitox National Focal Point
Epidemiology and Public Health, Sciensano, Ministry of Health
Белиз
Приложение 2. Список национальных координаторов, назначенных государствами-членами в прошлые годы
Страна Имя/фамилия координатора Должность Учреждение Эл. почта Последнее обновление
Бенин Saturnin Bognon State-certified Pharmacist, Head of Pharmaceutical Establishments Department
Pharmaceutical Establishments Department [email protected]
Бутан Dil Kumar Subba Department of Public Health, Ministry of Health [email protected]
Боливия (Многонациональное Государство)
H.E. Amb. Maira Mariela Macdonal Permanente Representative of the
Plurinational State of Bolivia [email protected]; [email protected] 27-07-24
Босния и Герцеговина [email protected]; [email protected]
Босния и Герцеговина Sabina Šahman Department for Health, Ministr of the Civill Affairs of Bosnia and Herzegovina
Ботсвана Vivian Sebako Chief Pharmacist Department of Clinical Services, Ministry of Health and Wellness [email protected]
Бразилия Renata de Morais Souza, Moema Luisa Silva Macedo Manager
Management of Controlled Products GPCON/GGMON/DIMON/ANVISA Controlled Substances Office Brazilian Health Regulatory Agency – ANVISA
Бразилия Natalia Jorge e Costa International Affairs Office, Brazilian Health Regulatory Agency – ANVISA, AINTE/ GADIP/ANVISA
Приложение 2. Список национальных координаторов, назначенных государствами-членами в прошлые годы
Страна Имя/фамилия координатора Должность Учреждение Эл. почта Последнее обновление
Бруней-Даруссалам Hajah Zanatul ‘Aini Haji Zainin (Ms)
Acting Director of Pharmaceutical Services
Department of Pharmaceutical Services, Ministry of Health [email protected]
Болгария Slaveyka Nikolova Chief Expert at the Health Promotion
Department Health Promotion and Prophylaxis of the Diseases and Addictions Directorate
Болгария Alexander Panayotov Head of the National Focus Center Department
Mental Health and Addiction Prevention Directorate, National Center for Public Health and Analysis
Буркина-Фасо [email protected]
Бурунди Israël Nimubona [email protected]
Кабо-Верде Raquel Lopes Commission for the Coordination of Alcohol and Other Drugs, Ministerio da Saude e da Seguranca Social
[email protected] 30-08-24
Камбоджа Chhit Sophal Director Department of Mental and Substance Abuse, Ministry of Health [email protected]
Камерун Ketchozo Loko Wilfried [email protected]
Приложение 2. Список национальных координаторов, назначенных государствами-членами в прошлые годы
Страна Имя/фамилия координатора Должность Учреждение Эл. почта Последнее обновление
Канада
International Relations Unit, Office of Drug Policy and Science, Controlled Substances Directorate, Health Canada, Government of Canada
[email protected] 26-04-24
Центральноафриканская Республика
Чад Haoua Haroun Saker Deputy Director of Pharmacy and Medicine Ministry of Public Health [email protected]
Чили Javiera Erazo Leiva Advisor Department of Mental Health/DIPRECE, Ministry of Health [email protected]
Китай Zhendong HUA Deputy Director National Narcotics Laboratory [email protected]
Китай Yan ZHENG Official Office of National Narcotics Control Commission [email protected]
Китай Peng XU Senior Expert National Narcotics Laboratory [email protected]
Колумбия Oscar Ricardo Santana Observatorio de Drogas de Colombia Dirección de Políticas de Drogas y Actividades Relacionadas Ministerio de Justicia y del Derecho
[email protected]; [email protected] 16-07-24
Приложение 2. Список национальных координаторов, назначенных государствами-членами в прошлые годы
Страна Имя/фамилия координатора Должность Учреждение Эл. почта Последнее обновление
Колумбия Nubia Esperanza Bautista Coordinadora del Grupo Convivencia Social y Ciudadanía
Dirección de Promoción y Prevención – Ministerio de Salud y Protección Social
Колумбия Germán Andrés Calderón Velásquez
Coordinador Grupo Interno de Trabajo de Asuntos Relacionados con las Drogas
Ministerio de Relaciones Exteriores [email protected]; [email protected]
Коморские Острова
Острова Кука Tereapii Uka Central Policy and Planning Office [email protected]
Коста-Рика Marchena Vasquez [email protected]
Кот-дʼИвуар Ernest Zotoua [email protected]
Хорватия Lidija Vugrinec
Head of National Information Unit in the Field of Drugs and Behavioural Addictions and Internal Relations Department
Croation Institute of Public Health [email protected] 30-08-24
Куба
Кипр John Kkolos Pharmacist Pharmaceutical Services, Ministry of Health [email protected]
Чехия Vlastimil Brandejs Inspectorate Department, Narcotic and Psychotropic Substances Ministry of Health
Приложение 2. Список национальных координаторов, назначенных государствами-членами в прошлые годы
Страна Имя/фамилия координатора Должность Учреждение Эл. почта Последнее обновление
Корейская Народно- Демократическая Республика
Kim Jong Guk
Демократическая Республика Конго Ghislaine Mbelu Kanyunya [email protected]
Дания Kari Gragaasen Chief Consultant Head of Focal Point, Prevention, National Board of Health [email protected]
Джибути
Доминика Laura Esprit Chief Medical Office Ministry of Health, Wellness and New Health Investment [email protected]
Доминика Anna Royer-Edmund Chief Pharmacist Ministry of Health, Wellness and New Health Investment [email protected]
Доминиканская Республика
Доминиканская Республика Francisca Dalia Castillo Sanchez Head of the Assistive
Technology Department
General Directorate of Medicines, Food and Health Products (DIGEMAPS), Ministry of Public Health
Эквадор Gabriel Ordonez Guzman
Director nacional de Estrategias de Prevencion Y Control para Enfermedades no Transmisibles
Salud Mental Y Fenomeno Socioeconomico de las Drogas [email protected] 24-07-24
Египет Dr Samah Abdeleazik Kandil Ministry of Health and Population [email protected]; [email protected] 16-07-24
Приложение 2. Список национальных координаторов, назначенных государствами-членами в прошлые годы
Страна Имя/фамилия координатора Должность Учреждение Эл. почта Последнее обновление
Сальвадор José Mauricio Bermúdez Recinos
Focal Point of the Ministry of Health of El Salvador
Health Technology Department, Ministry of Health [email protected]
Экваториальная Гвинея
Эритрея Michael Girmay Haile [email protected]
Эстония Olga Kamp
Inspector of pharmacovigilance, drugs and psychotropic substances, and the precursors
State Agency of Medicines, Ministry of Health [email protected]
Эсватини
Эфиопия Baharu Zewdie Moya [email protected]
Фиджи Ilisabeta May Pesamino Chief Pharmacist Pharmaceutical & Biomedical Services/Ministry of Health & Medical Services
Финляндия Katja Pihlainen Finnish Medicines Agency, Ministry of Health [email protected]
Франция Luciano Amato Acting Head of Department
Regulation of narcotics and psychotropic substances, National Agency for the Safety of Medicines and Health Products
Приложение 2. Список национальных координаторов, назначенных государствами-членами в прошлые годы
Страна Имя/фамилия координатора Должность Учреждение Эл. почта Последнее обновление
Габон Okouyi Ndakissa Directorate of Medicines and Pharmacy Ministry of Health
Гамбия
Грузия Ekaterine Paposhvili Senior Specialist
Division of Legal Circulation of Narcotic Drugs, LEPL State Regulation Agency for Medical Activities Ministry of Labour, Health and Social Affairs of Georgia
Германия Annette Hinze Division 122 - Narcotics Law, Traffic in Narcotics, International Narcotic Drug Affairs Federal Ministry of Health
Гана Martha Gyansa-Lutterodt Director Pharmaceutical Services, Ministry of Health [email protected]
Греция Dr Foteini Koulouri Head of General Directorate of Public Health and Quality of Life
Hellenic Ministry of Health [email protected] ; [email protected] 16-07-24
Греция Avgerinos Nikolaos Psychiatrist, Programs Implementation Director
OKANA - Organisation Against Drugs Greece
[email protected] ; [email protected]
Греция Ms Anastasia Petroulia Legal Advisor to the Minister of Health Hellenic Ministry of Health [email protected];
Will also attend the 47th ECDD meeting
Приложение 2. Список национальных координаторов, назначенных государствами-членами в прошлые годы
Страна Имя/фамилия координатора Должность Учреждение Эл. почта Последнее обновление
Гренада
Гватемала José Miguel Solares Estrada Department of Regulation and Control of Related Pharmaceutical Products
[email protected] 30-08-24
Гватемала Alicia Elena Morgan Durán Section of Psychotropics, Narcotics, Imports and Exports
[email protected] 30-08-24
Гвинея
Гвинея-Бисау
Гайана
Гаити Marie Judith Robuste Roche Ministry of Health [email protected]
Гондурас Alex Virgilio Santos Moreno General Director of the Honduran Institute for the Prevention of Alcoholism
Honduran Institute for the Prevention of Alcoholism, Drug Addiction and Drug Dependence (IHADFA)
Венгрия Tímea Kahlesz Deputy Head of Department
EMMI Pharmaceutical and Medical Technology Department [email protected]
Исландия Bjarni Sigurðsson Ministry of Health [email protected]
Индия Dr Anju Dhawan Professor and Head Department of Psychiatry, National Drug Dependence Treatment Centre, All India Institute of Medical Sciences
[email protected] 24-07-24
Приложение 2. Список национальных координаторов, назначенных государствами-членами в прошлые годы
Страна Имя/фамилия координатора Должность Учреждение Эл. почта Последнее обновление
Индонезия Agusdini Banun Saptaningsih Director of Pharmaceutical Production and Distribution
Directorate General of Pharmaceutical Care and Medical Devices,
Иран (Исламская Республика) Mina Azhoogh [email protected]
Ирак Emad Abdulrazzaq Abdulghani Ministry of Health [email protected]
Ирландия Conor Brennan Department of Health [email protected]
Ирландия Alan Bell Department of Health [email protected]
Израиль Paola Rosca Head of the Addiction Treatment Department Ministry of Health [email protected]
Израиль Tal Lavy The Competent Authority for Narcotics, Psychotropics and Precursors Pharmaceutical Administration
Италия Pietro Canuzzi Head of Office 7, Central Narcotic Office
Ministry of Health - Directorate general of Health Prevention [email protected] 26-07-24
Ямайка Dr Jacquiline Bisasor McKenzie Chief Medical Officer Ministry of Health & Wellness [email protected] 05-07-24
Ямайка Ms Uki Atkinson Research Analyst National Council on Drug Abuse (NCDA) [email protected] 05-07-24
Приложение 2. Список национальных координаторов, назначенных государствами-членами в прошлые годы
Страна Имя/фамилия координатора Должность Учреждение Эл. почта Последнее обновление
Япония Compliance and Narcotics Division, Pharmaceutical Safety and Environmental Health Bureau
Иордания Malak AlMahirah Head of Narcotics, Psychotropic Substances and Chemical Precursors Department, Jordan Food and Drug Administration
Казахстан Prilutskaya Marina Republican Scientific and Practical Center of Mental Health [email protected]
Кения Anthony Toroitich [email protected]
Кения Simon Njuguna [email protected]
Кирибати Biribo Kararaiti Chief Pharmacist Ministry of Health and Medical Services [email protected]
Кувейт Ali Abdulmohsen Jaragh Head Control of Licenses for Narcotic Drugs and Psychotropic Substances Department
[email protected] 24-07-24
Приложение 2. Список национальных координаторов, назначенных государствами-членами в прошлые годы
Страна Имя/фамилия координатора Должность Учреждение Эл. почта Последнее обновление
Кыргызстан Kanyshai Damirbek Drug Trafficking Control Department, Ministry of Foreign Affairs [email protected]
Лаосская Народно- Демократическая Республика
Khatthanaphone Phandoangsy Head of Health Promotion and Nutrition Unit
Department of Hygiene and Health Promotion, Ministry of Health [email protected]
Латвия Linda Veisberga Ministry of Health [email protected]
Ливан Marie-Therese Matar Head of Narcotics Department Ministry of Public Health [email protected]
Лесото Masello Sello [email protected]
Либерия Dr. Moses Ziah II Director Mental Health Unit Ministry of Health, Republic of Liberia [email protected]; [email protected]
Ливия
Литва Rima Mačiūnienė Head of Drug Precursors Control and Risk Assessment Division
Drug Precursors Control and Risk Assessment Division, Drug, Tobacco and Alcohol Control Department
Люксембург Alain Origer National Drug Coordinator Ministry of Health [email protected]
Мадагаскар Maximine Ravaoarimanana Director of Pharmacy Laboratories and Traditional Medicine
Приложение 2. Список национальных координаторов, назначенных государствами-членами в прошлые годы
Страна Имя/фамилия координатора Должность Учреждение Эл. почта Последнее обновление
Малави Michael Udedi Assistant Director of Clinical Services (Mental Health and Substance Abuse)
Малайзия Rohaida Binti Zakaria Senior Principal Assistant Director
Pharmaceutical Services Division, Ministry of Health [email protected]
Мальдивские Острова Aishath Mohamed Deputy Director General, Pharmaceuticals
Medicine and Therapeutic Goods Division, Maldives Food and Drug Authority
Мали Mahamadou Ousmane Maiga [email protected]
Мальта Victor P. Pace Office of the Superintendence of Public Health, Department for Health Regulation
Маршалловы Острова Julia Alfred Ministry of Health [email protected]
Мавритания Hamoud Fadel Yamohomed Director of Pharmacy and Laboratories Ministry of Health [email protected]
Маврикий Nitish Raj Sokool Officer-in-Charge Harm Reduction Unit, Ministry of Health and Wellness [email protected]
Маврикий Anil Jhugroo Advisor on Substance Abuse Ministry of Health and Wellness [email protected]
Приложение 2. Список национальных координаторов, назначенных государствами-членами в прошлые годы
Страна Имя/фамилия координатора Должность Учреждение Эл. почта Последнее обновление
Мексика Angélica Juárez Ramírez Specialized Reviewer COFEPRIS representative, Federal Committee for Protection from Sanitary Risks
Микронезия (Федеративные Штаты) Benido Victor [email protected]
Монако Isabelle Kessedjian Head of Division Pharmacy Inspector, Health Products Division [email protected]
Монголия Luvsandagva Purevdorj [email protected]
Черногория Jasna Sekulic Ministry of Health [email protected]
Марокко Hassan Elkarimi [email protected]
Марокко Jallal Toufiq
Professor of Psychiatry, Rabat Faculty of Medicine, Director of the National Centre on Drug Abuse Prevention, Treatment and Research, Director of the Moroccan Observatory on Drugs and Drugs Addictions
Мозамбик Flavio Mandlate [email protected]
Мьянма Nanda Myo Aung Wan Program Manager/ Consultant Psychiatrist
Drug Dependency Treatment and Research Unit, Ministry of Health and Sport
Намибия Ester Mvula Senior Pharmacist Ministry of Health & Social Services [email protected]
Приложение 2. Список национальных координаторов, назначенных государствами-членами в прошлые годы
Страна Имя/фамилия координатора Должность Учреждение Эл. почта Последнее обновление
Науру Richard Leona Chief Surgeon Ministry of Health [email protected]
Непал
Нидерланды (Королевство) Matthijs Geilenkirchen
Nutrition, Health Protection and Prevention Department, Ministry of Health, Welfare and Sport
[email protected] 29 April 2024
Новая Зеландия Group mail to be cc'ed [email protected] 10-07-24
Новая Зеландия Tania Jones Regulatory Practice and Analysis, Medsafe [email protected] Confirmed
10/7/24
Никарагуа Karla Vanessa Delgado Martinez Director of Pharmacy Ministry of Health [email protected]
Нигер Haoua Na Allah Alou [email protected]
Нигерия Wosilat Abdulhameed Deputy Director
Federal Ministry of Health
[email protected] 30-08-24
Ниуэ
Северная Македония
Норвегия Anne S. Onsgård Sagabråten Narcotic Drugs Control, Norwegian Medicines Agency [email protected]
Оман Dr. Mohammed Al-Rubaie [email protected] 10-07-24
Приложение 2. Список национальных координаторов, назначенных государствами-членами в прошлые годы
Страна Имя/фамилия координатора Должность Учреждение Эл. почта Последнее обновление
Оман Dr Mahmood Al Abri [email protected] 10-07-24
Оман
Directorate General of Pharmaceutical Affairs and Drug control, Ministry of Health
Оман Drug Safety Center, Ministry of Health, Sultanate of Oman [email protected] 30-08-24
Пакистан Rizwan Taj Professor Ministry of Health [email protected]
Палау Clarette Matlab Chief Pharmacist
Division of Ancillary Services, Bureau of Hospital and Clinical Services, Ministry of Health
Палау [email protected]
Палау Marla Ito [email protected]
Панама Dr Ricardo Goti, Coordinateur du Programme de Santé Mentale
Ministère de la Santé du Panama [email protected] 16-07-24
Папуа – Новая Гвинея Vicky Wari Program Manager-Non Communicable Diseases
Public Health Division, National Department of Health [email protected]
Парагвай Blanca Galeano [email protected] 30-08-24
Парагвай Zaira Francesca Stumpfs Bigarella
Приложение 2. Список национальных координаторов, назначенных государствами-членами в прошлые годы
Страна Имя/фамилия координатора Должность Учреждение Эл. почта Последнее обновление
Перу Judith Castañeda Alcántara Head of Functional Unit of Controlled Products
DIGEMID – General Directorate of Medicines, Supplies and Drugs [email protected] 26-07-24
Филиппины
Польша Michał Kidawa Polish Reitox Focal Point Information Centre for Drugs and Drug Addiction (CINN) National Bureau for Drug Prevention
Португалия Graça Vilar Director of Planning and Intervention Services Directorate
Intervention Service for Addictive Behaviours and Addictions General Directorate for Intervention on Addictive Behaviours and Dependencies SICAD
Пуэрто-Рико
Катар Majid Ali Al Abdulla Senior Consultant Psychiatrist
Director of addiction and CL at Hamad Medical Corporation Deputy Chairman of Mental Health Services, Hamad Medical Corporation
Республика Корея Sang Hun Yeon Narcotics Policy Division of Ministry of Food and Drug Safety [email protected] 16-07-24
Приложение 2. Список национальных координаторов, назначенных государствами-членами в прошлые годы
Страна Имя/фамилия координатора Должность Учреждение Эл. почта Последнее обновление
Республика Молдова Oleg Costachi Standing Committee on Drugs Control, Agency for Medicines and Medical Devices
Румыния Camelia Bunaciu Senior Advisor Ministry of Health [email protected]
Российская Федерация Alyona Ryzova
Deputy Head of the Unit for regulatory and legal regulation of pharmaceutical activities, regulation of narcotic drugs and psychotropic substances
Department for regulation of medicines and medical devices, Ministry of Health
[email protected] 11-07-24
Руанда
Сент-Китс и Невис puerto rico
Сент-Люсия Charlotte Emmanuel Coordinator of the Substance Abuse Advisory Council Secretariat
Substance Abuse Advisory Council Secretariat, Ministry of Health and Wellness
Сент-Люсия Paul Caleb Programme Officer Substance Abuse Advisory Council Secretariat, Ministry of Health and Wellness
Сент-Винсент и Гренадины
Самоа Robert Thomsen Assistant Chief Executive Officer HSPQA, Medical and Allied Division [email protected]
Приложение 2. Список национальных координаторов, назначенных государствами-членами в прошлые годы
Страна Имя/фамилия координатора Должность Учреждение Эл. почта Последнее обновление
Сан-Марино Claudio Muccioli Health Authority Director Health Authority [email protected]
Сан-Томе и Принсипи
Саудовская Аравия Adnan Alshammary
Administration of controlled preparations, Executive Management for Regulatory Affairs, Controlled Products Department, Regulatory Affairs Directorate, Drug Sector
Сенегал Moussa DIALLO Pharmacist Inspector Pharmaceutical Regulatory Agency, Ministry of Health and Social Action [email protected]
Сербия Nataša Savić
Monitoring Centre for Drugs and Drug Addiction, Sector for Medicines and Medical Devices, Psychoactive Controlled Substances and Precursors, Ministry of Health
Сейшельские Острова
Сьерра-Леоне
Приложение 2. Список национальных координаторов, назначенных государствами-членами в прошлые годы
Страна Имя/фамилия координатора Должность Учреждение Эл. почта Последнее обновление
Сингапур Ong Lay Tin Personal Assistant to Director (International Cooperation)
Senior Executive (International Cooperation) Public Health Group, Ministry of Health
[email protected] 04/07/2024 confiming no changes
Словакия Peter Koreň Reitox National Focal Point
National Monitoring Centre for Drugs, Department of Anti-Drug Strategy Coordination and Drug Monitoring, Ministry of Health of the Slovak Republic
[email protected] 04/07/2024 confirming no changes
Словения Joze Hren Secretary Directorate of Public Health, Ministry of Health [email protected]
Соломоновы Острова Paul Orotaloa Head of Mental Health Services
National Mental Health Service, Ministry of Health and Medical Services
Соломоновы Острова Stephen Araitewa Director Mental Health National Mental Health Service, Ministry of Health and Medical Services
Сомали
Южная Африка MG Molewa Ministry of Health [email protected]
Южный Судан Moses Malual Deng Director General of Pharmaceuticals and Medical Supplies
Ministry of Health [email protected]
Приложение 2. Список национальных координаторов, назначенных государствами-членами в прошлые годы
Страна Имя/фамилия координатора Должность Учреждение Эл. почта Последнее обновление
Испания Manuel Ibarra Head of Department Inspection & Enforcement
Spanish Agency of Medicines and Medical Products (AEMPS) [email protected]
Испания Lidia Fernandez Matellano
Narcotics and Psychotropic Substances Area, Pharmaceutical Inspection and Enforcement Department, Spanish Agency of Medicines and Medical Products (AEMPS)
Шри-Ланка S.C. Wickramasinghe Deputy Director General (NCD) Ministry of Health [email protected]
Судан
Суринам
Швеция Annika Borg Ministry of Health and Social Affairs, Division for Public Health and Health Care
[email protected] 08-04-24
Швейцария Lucien Colliander Federal Department of Home Affairs, Federal Office of Public Health, Division of International Affairs, Global Health Section
Швейцария Monika Joos Head of Division Narcotics Swissmedic, Swiss Agency for Therapeutic Products [email protected]
Приложение 2. Список национальных координаторов, назначенных государствами-членами в прошлые годы
Страна Имя/фамилия координатора Должность Учреждение Эл. почта Последнее обновление
Сирийская Арабская Республика Ahmed Al-Salama Mental Health Directorate,
Ministry of Health [email protected]
Таджикистан Salim Abdulazizov [email protected]
Таиланд Sujinart Chantharakul Pharmacist
Narcotics Control Division (Standards and Regulations Sub-Division), Food and Drug Administration, Ministry of Public Health
Таиланд Saranya Chavanich Pharmacist
Narcotics Control Division (Standards and Regulations Sub-Division), Food and Drug Administration, Ministry of Public Health
Таиланд Korapin Na Ranong Expert on Narcotics Epidemiology
Narcotics Control Division Food and Drug Administration, Ministry of Public Health
Таиланд Raththar Benchapalanont Pharmacist Narcotics Control Division Food and Drug Administration, Ministry of Public Health
Приложение 2. Список национальных координаторов, назначенных государствами-членами в прошлые годы
Страна Имя/фамилия координатора Должность Учреждение Эл. почта Последнее обновление
Тимор-Лешти Soares Henriques Regulatory Affairs Pharmacist
Pharmacovigilance and Medicine Control Department, National Directorate for Pharmaceutical and Medicines, Ministry of Health
Того Mouhoudine Yerima Centre National de Pharmacovigilance (CNPV) [email protected]; [email protected]
Токелау
Тонга Melenaite Mahe Principal Pharmacist Central Pharmacy and Medical Store, Old Vaiola, Ministry of Health [email protected]
Тринидад и Тобаго Anesa Doodnath-Siboo Principal Pharmacist Ministry of Health [email protected]
Тунис
Турция Elif Inci ERGONUL Head of Pharmacovigilance and Controlled Substances Department
Turkish Medicines and Medical Devices Agency, Ministry of Health
[email protected]; [email protected] 24-07-24
Туркменистан
Тувалу
Уганда Hafsa Lukwata Head of Mental Health and Control of Substance Abuse
Mental Health and Control of Substance Abuse Division, Ministry of Health
Приложение 2. Список национальных координаторов, назначенных государствами-членами в прошлые годы
Страна Имя/фамилия координатора Должность Учреждение Эл. почта Последнее обновление
Украина Deputy Director Institute of Psychiatry, Forensic Psychiatric Examination and Drug Monitoring,
Украина Irina Pinchuk Director
Institute of Psychiatry of Taras Shevchenko National University of Kyiv, International Technology Transfer Center – Ukraine Head of ISSUP Ukraine National Chapter
Украина Yulia YACHNYK Clinical Psychologist Institute of Psychiatry, Taras Shevchenko National University of Kyiv
Объединенные Арабские Эмираты Alia Bin Hussain Head of Regulating
Controlled substances
Product & Precursor Chemicals Drug Department, Ministry of Health and Prevention
Соединенное Королевство Великобритании и Северной Ирландии
Alberto Oteo Project Manager Drugs Research and Surveillance
Addiction and Inclusion Directorate, Office for Health Improvement & Disparities, Department of Health and Social Care
Объединенная Республика Танзания Suma Jairo Pharmacist Pharmaceutical Service Unit, Ministry
of Health [email protected]
Приложение 2. Список национальных координаторов, назначенных государствами-членами в прошлые годы
Страна Имя/фамилия координатора Должность Учреждение Эл. почта Последнее обновление
Соединенные Штаты Америки Edward Hawkins
Senior Pharmacologist and International Drug Control Liaison
Center for Drug Evaluation and research, U.S. Food and Drug Administration
Уругвай Lorena Quintana Coordinator of the Addiction Prevention and Treatment Program
Ministry of Public Health [email protected] 02-08-24
Узбекистан Dr Azizbek Khamrakulov Head, Department of Inpatient and Specialized Care
Ministry of Health [email protected]
Узбекистан Mr Zarif Ashurov Director Specialized Scientific and Mental Health Medical Center [email protected]
Вануату Jerry Iaruel Tafea Provincial Health Administrator
Lenakel Health Office, Ministry of Health [email protected]
Венесуэла (Боливарианская Республика)
Вьетнам Mhin Tam Nguyen Regulatory Affair Consultant Ministry of Health [email protected]
Йемен
Замбия Nita Besa Head Clinical Care Chainama Hospital [email protected]
Зимбабве Eneti Siyame Mental Health Manager Ministry of Health and Child Care [email protected]
20, AVENUE APPIA – CH-1211 GINEBRA 27 – SUIZA – TEL. CENTRALITA +41 22 791 2111 – FAX CENTRAL +41 22 791 3111 – WWW.WHO.INT/ES
… ANEXOS (2)
Ref.: C.L.22.2025
La Organización Mundial de la Salud (OMS) presenta sus respetos a los Estados Miembros
y los Miembros Asociados y se complace en anunciar que el Comité de Expertos en Farmacodependencia (en adelante, «el Comité de Expertos») celebrará su 48.ª reunión del 20 al 22 de octubre de 2025 en Ginebra (Suiza). Dado que las reuniones del Comité de Expertos de la OMS son a puerta cerrada, la presente carta sirve para notificar a los Estados Miembros el
… orden del día de su 48.ª reunión, que figura en el anexo I, adjunto a título de referencia.
En virtud de los tratados de fiscalización internacional de drogas de 1961 y 1971, la OMS tiene el mandato de formular recomendaciones al Secretario General de las Naciones Unidas sobre la necesidad y el nivel de fiscalización internacional de las sustancias psicoactivas, basándose en las orientaciones de su órgano de asesoramiento científico independiente, el Comité de Expertos en Farmacodependencia. Para evaluar si una determinada sustancia psicoactiva debe someterse a fiscalización internacional, el Comité de Expertos se reúne anualmente con el fin de examinar potencial de dicha sustancia para causar dependencia, abuso y efectos nocivos para la salud, así como sus posibles aplicaciones terapéuticas. A fin de realizar este examen y tomar decisiones basadas en la evidencia, el Comité de Expertos realiza evaluaciones médicas, científicas y de salud pública de las sustancias psicoactivas seleccionadas utilizando la mejor información disponible.
Aunque las reuniones son a puerta cerrada, se invita a los Estados Miembros y los Miembros Asociados a que contribuyan al proceso de examen del Comité de Expertos participando en la sesión de información de la 48.ª reunión del Comité, el 20 de octubre de 2025. La sesión de información, que se celebrará virtualmente, permitirá a las partes interesadas conocer las actividades presentes y futuras de la secretaría del Comité de Expertos, así como presentar información relativa a las sustancias que se someten a examen en las deliberaciones del Comité de Expertos en su 48.ª reunión. La información sobre la inscripción se publicará a su debido tiempo en el sitio web del Comité de Expertos: https://www.who.int/news- room/events/detail/2025/10/20/default-calendar/forty-eighth-expert-committee-on-drug- dependence.
…
C.L.22.2025 Página 2
Como en ocasiones anteriores y en consonancia con la publicación titulada «Orientaciones para el examen por la OMS de sustancias psicoactivas en el contexto de la fiscalización internacional» (EB126/2010/REC1, anexo 6),1 los Estados Miembros y los Miembros Asociados también pueden contribuir al proceso de examen del Comité de Expertos proporcionando información precisa y actualizada sobre las sustancias objeto de examen antes de la reunión. A tal fin, y siguiendo la práctica habitual, se enviará un cuestionario a los Estados Miembros y los Miembros Asociados para reunir información de los países sobre el uso legítimo, el uso nocivo, la situación relativa a la fiscalización nacional y los posibles efectos de la fiscalización internacional de cada sustancia objeto de examen.
… En el anexo II de la presente carta circular figura una lista de los puntos focales nacionales designados oficialmente por los Estados Miembros y los Miembros Asociados en años anteriores y que proporcionan información de los países al Comité de Expertos a través del cuestionario de Estados Miembros mencionado anteriormente. Si la información relativa a los puntos focales requiere modificaciones o enmiendas, se invita a los Estados Miembros y a los Miembros Asociados a que informen a la secretaría del Comité de Expertos de la OMS enviando un correo electrónico a la dirección [email protected], a más tardar el 18 de julio de 2025, con el asunto «48ECDD Focal Point: (Nombre del país)».
Si la persona de la lista sigue siendo el punto focal oficial con el que habrá que contactar este año para que rellene el cuestionario de Estados Miembros para el Comité de Expertos y no se han añadido o modificado los datos relativos al punto focal a fecha de 18 de julio de 2025, la Secretaría de la OMS dará al punto focal de la lista más instrucciones y acceso directo a los cuestionarios en línea. Los resultados de los cuestionarios se prepararán a modo de informe como parte del proceso de examen de sustancias por el Comité de Expertos en su 48.ª reunión.
Además del cuestionario, se alienta también a los Estados Miembros y a los Miembros Asociados a que proporcionen toda información adicional pertinente (publicada o no) sobre las sustancias que se examinarán en la 48.ª reunión del Comité de Expertos, enviando un mensaje de correo electrónico a la dirección [email protected] con el asunto «Ref: C.L.22.2025».
Todas las recomendaciones formuladas por la 47.ª reunión del Comité, que se celebró en octubre de 2024, fueron aceptadas por la Comisión de Estupefacientes de las Naciones Unidas en su 68.º periodo de sesiones y todos los informes técnicos y recomendaciones formuladas por el Comité de Expertos pueden consultarse en línea en el Repositorio de Información del Comité de Expertos (https://ecddrepository.org/en), puesto en marcha recientemente.
La Organización Mundial de la Salud aprovecha esta oportunidad para reiterar a los Estados Miembros y Miembros Asociados el testimonio de su más alta consideración.
GINEBRA, 11 de julio de 2025
1 https://apps.who.int/gb/ebwha/pdf_files/EB126-REC1/B126_REC1-sp.pdf#page=96.
48.ª REUNIÓN DEL COMITÉ DE EXPERTOS DE LA OMS EN FARMACODEPENDENCIA
Orden del día provisional
----
Reunión de información (virtual)
20 de octubre de 2025
10.00 - 13.00 horas (hora de verano de Europa central)
1. Bienvenida y apertura de la reunión
2. Ponencias de la OMS 2.1 Comité de Expertos en Farmacodependencia 2.2 División Científica 2.3 Género, Equidad y Derechos Humanos 2.4 Medicina tradicional
3. Ponencias y declaraciones de los participantes
48.ª REUNIÓN DEL COMITÉ DE EXPERTOS DE LA OMS EN FARMACODEPENDENCIA
Ginebra, Suiza
Orden del día provisional
----
Sesión a puerta cerrada
20-22 de octubre de 2025
1. Asuntos de procedimiento e información actualizada 1.1 Apertura de la reunión y palabras de bienvenida 1.2 Presentación de los participantes 1.3 Declaración de confidencialidad 1.4 Declaraciones de intereses 1.5 Elección de Presidente, Vicepresidente y Relator 1.6 Adopción del orden del día
2. Información actualizada de los organismos internacionales sobre sus prioridades 2.1 Sesiones informativas de los organismos internacionales sobre su labor en relación con la
dimensión de salud pública del problema mundial de las drogas 2.1.1 OMS 2.1.2 UNODC 2.1.3 JIFE
2.2 Información actualizada sobre las recomendaciones y resultados de las reuniones del Comité de Expertos
2.2.1 Recomendaciones y resultados de la 47.ª reunión del Comité de Expertos 2.2.2 Información actualizada sobre la vigilancia de sustancias
3. Exámenes críticos: recomendaciones sobre el alcance de la fiscalización internacional
3.1 Hoja de coca1 3.1.1 Hoja de coca
3.2 Cannabinoides sintéticos2 3.2.1 MDMB-FUBINACA
3.3 Nuevos opioides sintéticos2 3.3.1 N-pirrolidino isotonitaceno (isotonitacepina) 3.3.2 N-desetil etonitaceno
4. Finalización del informe de la reunión
1 Una Parte en la Convención de 1961 o en el Convenio de 1971 ha presentado una notificación relativa a la inclusión
de una sustancia en las listas.
2 Se ha señalado a la atención de la OMS información según la cual una sustancia se fabrica clandestinamente, constituye un riesgo especialmente grave para la salud pública y la sociedad y no tiene utilidad terapéutica reconocida por ninguna Parte.
Anexo II: Lista de puntos focales designados por los Estados Miembros en años anteriores
País Nombre del punto focal Cargo Institución Correo electrónico Última actualización
Afganistán
Albania Linda Ternova Specialist
Regulation Sector of Pharmaceutical Market and Medical Devices Ministry of Health and Social Protection, Albania
Alemania Annette Hinze
Division 122 - Narcotics Law, Traffic in Narcotics, International Narcotic Drug Affairs Federal Ministry of Health
Andorra Carla Lobaco Valls Technical Officer Department of Health Resources and Medicines
Andorra Carme Pallarés Papaseit Department of Health Resources and Medicines,
Angola Ana Da Conceição Mamede General Director, National Institute for combating Drugs
Ministry of Health [email protected]
Antigua y Barbuda
Arabia Saudita Adnan Alshammary
Administration of controlled preparations, Executive Management for Regulatory Affairs, Controlled Products Department, Regulatory Affairs Directorate, Drug Sector
Argelia Ghrieb Houria Doctor
Narcotics, Psychotropics and Chemical Precursors, General Direction of Pharmacy and Health Equipment, Algerian Health Ministry
Argentina G. Rebaldería Farmacéutico Director de Vigilancia de Sustancias Sujetas a Control Especial Ministerio de Salud de la Argentina
Armenia Hasmik Martirosyan Armenian Ministry of Health [email protected]
Australia
Narcotics Control Section Office of Drug Control Australian Government Department of Health and Aged Care
[email protected] 45483
Australia [email protected]
Austria Raphael Bayer Head of Division
Section VI, Department 6 Federal Ministry of Social Affairs, Health, Care and Consumer Protection
Azerbaiyán Telman Suleyman Oglu Mammadhassanov
Bahamas
Bahrein Samar Yousef Salem Senior Pharmacist Ministry of Health [email protected]
Bangladesh Habibur Rahman Khan Additional Secretary Health Services Division, Ministry of Health & Family Welfare
Barbados Lindsay Bynoe Assistant Director for Drug Regulation Ministry of Health [email protected]
Belarús Aleksey Kralko Ministry of Health [email protected]
Bélgica Lies Gremeaux Head of Unit illicit Drugs, Reitox National Focal Point
Epidemiology and Public Health, Sciensano, Ministry of Health
Belice
Benin Saturnin Bognon State-certified Pharmacist, Head of Pharmaceutical Establishments Department
Pharmaceutical Establishments Department
Anexo II: Lista de puntos focales designados por los Estados Miembros en años anteriores
País Nombre del punto focal Cargo Institución Correo electrónico Última actualización
Bhután Dil Kumar Subba Department of Public Health, Ministry of Health
Bolivia (Estado Plurinacional de) S.E. Emb. Maira Mariela Macdonal Representante Permantente del Estado Plurinacional de Bolivia
[email protected]; [email protected] 45500
Bosnia y Herzegovina [email protected]; [email protected]
Bosnia y Herzegovina Sabina Šahman Department for Health, Ministr of the Civill Affairs of Bosnia and
Botswana Vivian Sebako Chief Pharmacist Department of Clinical Services, Ministry of Health and Wellness
Brasil Renata de Morais Souza, Moema Luisa Silva Macedo
Manager
Management of Controlled Products GPCON/GGMON/DIMON/ANVISA Controlled Substances Office Brazilian Health Regulatory Agency – ANVISA
Brasil Natalia Jorge e Costa International Affairs Office, Brazilian Health Regulatory Agency - ANVISA, AINTE/ GADIP/ANVISA
Brunei Darussalam Hajah Zanatul ‘Aini Haji Zainin (Ms) Acting Director of Pharmaceutical Services Department of Pharmaceutical Services, Ministry of Health
Bulgaria Slaveyka Nikolova Chief Expert at the Health Promotion Department Health Promotion and Prophylaxis of the Diseases and Addictions Directorate
Bulgaria Alexander Panayotov Head of the National Focus Center Department
Mental Health and Addiction Prevention Directorate, National Center for Public Health and Analysis
Burkina Faso [email protected]
Burundi Israël Nimubona [email protected]
Cabo Verde Raquel Lopes Commission for the Coordination of Alcohol and Other Drugs, Ministerio da Saude e da Seguranca Social
[email protected] 45534
Camboya Chhit Sophal Director Department of Mental and Substance Abuse, Ministry of Health
Camerún Ketchozo Loko Wilfried [email protected]
Canadá
International Relations Unit, Office of Drug Policy and Science, Controlled Substances Directorate, Health Canada, Government of Canada
[email protected] 45408
Chad Haoua Haroun Saker Deputy Director of Pharmacy and Medicine Ministry of Public Health [email protected]
Chequia Vlastimil Brandejs Inspectorate Department, Narcotic and Psychotropic Substances Ministry of Health
Chile Javiera Erazo Leiva Asesora Departamento de Salud Mental/DIPRECE, Ministerio de Salud
China Zhendong HUA Deputy Director National Narcotics Laboratory [email protected]
China Yan ZHENG Official Office of National Narcotics Control Commission
China Peng XU Senior Expert National Narcotics Laboratory [email protected]
Chipre John Kkolos Pharmacist Pharmaceutical Services, Ministry of Health
Colombia Oscar Ricardo Santana
Observatorio de Drogas de Colombia Dirección de Políticas de Drogas y Actividades Relacionadas Ministerio de Justicia y del Derecho
[email protected]; [email protected] 45489
Colombia Nubia Esperanza Bautista Coordinadora del Grupo Convivencia Social y Ciudadanía
Dirección de Promoción y Prevención – Ministerio de Salud y Protección Social
Anexo II: Lista de puntos focales designados por los Estados Miembros en años anteriores
País Nombre del punto focal Cargo Institución Correo electrónico Última actualización
Colombia Germán Andrés Calderón Velásquez Coordinador Grupo Interno de Trabajo de Asuntos Relacionados con las Drogas
Ministerio de Relaciones Exteriores [email protected]; [email protected]
Comoras
Costa Rica Marchena Vasquez [email protected]
Côte d’Ivoire Ernest Zotoua [email protected]
Croacia Lidija Vugrinec Head of National Information Unit in the Field of Drugs and Behavioural Addictions and Internal Relations Department
Croation Institute of Public Health [email protected] 45534
Cuba
Dinamarca Kari Gragaasen Chief Consultant Head of Focal Point, Prevention, National Board of Health
Djibouti
Dominica Laura Esprit Chief Medical Office Ministry of Health, Wellness and New Health Investment
Dominica Anna Royer-Edmund Chief Pharmacist Ministry of Health, Wellness and New Health Investment
Ecuador Gabriel Ordonez Guzman Director nacional de Estrategias de Prevencion Y Control para Enfermedades no Transmisibles
Salud Mental Y Fenomeno Socioeconomico de las Drogas
[email protected] 45497
Egipto Dr Samah Abdeleazik Kandil Ministry of Health and Population [email protected]; [email protected] 45489
El Salvador José Mauricio Bermúdez Recinos Punto focal del Ministerio de Salud de El Salvador
Dirección de Tecnologías Sanitarias Ministerio de Salud
Emiratos Árabes Unidos Alia Bin Hussain Head of Regulating Controlled substances Product & Precursor Chemicals Drug Department, Ministry of Health and Prevention
Eritrea Michael Girmay Haile [email protected]
Eslovaquia Peter Koreň Reitox National Focal Point
National Monitoring Centre for Drugs, Department of Anti-Drug Strategy Coordination and Drug Monitoring, Ministry of Health of the Slovak Republic
[email protected] 04/07/2024 confirming no changes
Eslovenia Joze Hren Secretary Directorate of Public Health, Ministry of Health
España Manuel Ibarra Jefe del Departamento de Inspección y Control de Medicamentos
Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
España Lidia Fernandez Matellano
Area de Estupefacientes y Psicótropos Departamento de Inspección y Control de Medicamentos Agencia Española de Medicamentos y Productos
Estados Unidos de América Edward Hawkins Senior Pharmacologist and International Drug Control Liaison
Center for Drug Evaluation and research, U.S. Food and Drug Administration
Estonia Olga Kamp Inspector of pharmacovigilance, drugs and psychotropic substances, and the
State Agency of Medicines, Ministry of Health
Eswatini
Etiopía Baharu Zewdie Moya [email protected]
Federación de Rusia Alyona Ryzova
Deputy Head of the Unit for regulatory and legal regulation of pharmaceutical activities, regulation of narcotic drugs and psychotropic substances
Department for regulation of medicines and medical devices, Ministry of Health
[email protected] 45484
Fiji Ilisabeta May Pesamino Chief Pharmacist Pharmaceutical & Biomedical Services/Ministry of Health & Medical Services
Filipinas
Finlandia Katja Pihlainen Finnish Medicines Agency, Ministry of Health
Anexo II: Lista de puntos focales designados por los Estados Miembros en años anteriores
País Nombre del punto focal Cargo Institución Correo electrónico Última actualización
Francia Luciano Amato Acting Head of Department
Regulation of narcotics and psychotropic substances, National Agency for the Safety of Medicines and Health Products
Gabón Okouyi Ndakissa
Directorate of Medicines and Pharmacy Ministry of Health
Gambia
Georgia Ekaterine Paposhvili Senior Specialist
Division of Legal Circulation of Narcotic Drugs, LEPL State Regulation Agency for Medical Activities Ministry of Labour, Health and Social Affairs of Georgia
Ghana Martha Gyansa-Lutterodt Director Pharmaceutical Services, Ministry of Health
Granada
Grecia Dr Foteini Koulouri Head of General Directorate of Public Health and Quality of Life
Hellenic Ministry of Health [email protected] ; [email protected] 45489
Grecia Avgerinos Nikolaos Psychiatrist, Programs Implementation Director
OKANA - Organisation Against Drugs Greece
[email protected] ; [email protected]
Grecia Ms Anastasia Petroulia Legal Advisor to the Minister of Health Hellenic Ministry of Health [email protected]; [email protected] will also attend the 47th ECDD meeting
Guatemala José Miguel Solares Estrada Departmento de Regulación y Control de Productos Farmacéuticos y Afines
[email protected] 45534
Guatemala Alicia Elena Morgan Durán Sección de Sicotrópicos, Estupefacientes, Importaciones y Exportaciones
[email protected] 45534
Guinea Guinea Ecuatorial Guinea-Bissau Guyana Haití Marie Judith Robuste Roche Ministry of Health [email protected]
Honduras Alex Virgilio Santos Moreno Director General del Instituto Hondureño para la Prevención del Alcoholismo
Instituto Hondureño para la Prevención del Alcoholismo, Drogadicción y Farmacodependencias (IHADFA)
Hungría Tímea Kahlesz Deputy Head of Department EMMI Pharmaceutical and Medical Technology Department
India Dr Anju Dhawan Professor and Head Department of Psychiatry, National Drug Dependence Treatment Centre, All India Institute of Medical Sciences
Anju Dhawan <[email protected]> 45497
Indonesia Agusdini Banun Saptaningsih Director of Pharmaceutical Production and Distribution
Directorate General of Pharmaceutical Care and Medical
Irán (República Islámica del) Mina Azhoogh [email protected]
Iraq Emad Abdulrazzaq Abdulghani Ministry of Health [email protected]
Irlanda Conor Brennan Department of Health [email protected]
Irlanda Alan Bell Department of Health [email protected]
Islandia Bjarni Sigurðsson Ministry of Health [email protected]
Islas Cook Tereapii Uka Central Policy and Planning Office [email protected]
Islas Marshall Julia Alfred Ministry of Health [email protected]
Islas Salomón Paul Orotaloa Head of Mental Health Services National Mental Health Service, Ministry of Health and Medical Services
Anexo II: Lista de puntos focales designados por los Estados Miembros en años anteriores
País Nombre del punto focal Cargo Institución Correo electrónico Última actualización
Islas Salomón Stephen Araitewa Director Mental Health National Mental Health Service, Ministry of Health and Medical Services
Israel Paola Rosca Head of the Addiction Treatment Department
Ministry of Health [email protected]
Israel Tal Lavy
The Competent Authority for Narcotics, Psychotropics and Precursors Pharmaceutical Administration
Italia Pietro Canuzzi Head of Office 7, Central Narcotic Office Ministry of Health - Directorate general of Health Prevention
[email protected] 45499
Jamaica Dr Jacquiline Bisasor McKenzie Chief Medical Officer Ministry of Health & Wellness [email protected] 45478
Jamaica Ms Uki Atkinson Research Analyst National Council on Drug Abuse (NCDA)
[email protected] 45478
Japón Compliance and Narcotics Division, Pharmaceutical Safety and Environmental Health Bureau
Jordania Malak AlMahirah
Head of Narcotics, Psychotropic Substances and Chemical Precursors Department, Jordan Food and Drug Administration
Kazajstán Prilutskaya Marina Republican Scientific and Practical Center of Mental Health
Kenya Anthony Toroitich [email protected]
Kenya Simon Njuguna [email protected]
Kirguistán Kanyshai Damirbek Drug Trafficking Control Department, Ministry of Foreign Affairs
Kiribati Biribo Kararaiti Chief Pharmacist Ministry of Health and Medical Services
Kuwait Ali Abdulmohsen Jaragh Head Control of Licenses for Narcotic Drugs and Psychotropic Substances Department
[email protected] 45497
Lesotho Masello Sello [email protected]
Letonia Linda Veisberga Ministry of Health [email protected]
Líbano Marie-Therese Matar Head of Narcotics Department Ministry of Public Health [email protected]
Liberia Dr. Moses Ziah II Director Mental Health Unit Ministry of Health, Republic of Liberia
[email protected]; [email protected]
Libia
Lituania Rima Mačiūnienė Head of Drug Precursors Control and Risk Assessment Division
Drug Precursors Control and Risk Assessment Division, Drug, Tobacco and Alcohol Control Department
Luxemburgo Alain Origer National Drug Coordinator Ministry of Health [email protected]
Macedonia del Norte
Madagascar Maximine Ravaoarimanana Director of Pharmacy Laboratories and Traditional Medicine
[email protected]; [email protected]
Malasia Rohaida Binti Zakaria Senior Principal Assistant Director Pharmaceutical Services Division, Ministry of Health
Malawi Michael Udedi Assistant Director of Clinical Services (Mental Health and Substance Abuse)
Maldivas Aishath Mohamed Deputy Director General, Pharmaceuticals
Medicine and Therapeutic Goods Division, Maldives Food and Drug Authority
Malí Mahamadou Ousmane Maiga [email protected]
Anexo II: Lista de puntos focales designados por los Estados Miembros en años anteriores
País Nombre del punto focal Cargo Institución Correo electrónico Última actualización
Malta Victor P. Pace
Office of the Superintendence of Public Health, Department for Health Regulation
Marruecos Hassan Elkarimi [email protected]
Marruecos Jallal Toufiq
Professor of Psychiatry, Rabat Faculty of Medicine, Director of the National Centre on Drug Abuse Prevention, Treatment and Research, Director of the Moroccan Observatory on Drugs and Drugs Addictions
Mauricio Nitish Raj Sokool Officer-in-Charge Harm Reduction Unit, Ministry of Health and Wellness
Mauricio Anil Jhugroo Advisor on Substance Abuse Ministry of Health and Wellness [email protected]
Mauritania Hamoud Fadel Yamohomed Director of Pharmacy and Laboratories Ministry of Health [email protected]
México Angélica Juárez Ramírez Consultora especializada Representante de COFEPRIS, Comisión Federal para la Protección contra Riesgos Sanitarios
Micronesia (Estados Federados de) Benido Victor [email protected]
Mónaco Isabelle Kessedjian Head of Division Pharmacy Inspector, Health Products Division
Mongolia Luvsandagva Purevdorj [email protected]
Montenegro Jasna Sekulic Ministry of Health [email protected]
Mozambique Flavio Mandlate [email protected]
Myanmar Nanda Myo Aung Wan Program Manager/ Consultant Psychiatrist Drug Dependency Treatment and Research Unit, Ministry of Health and Sport
Namibia Ester Mvula Senior Pharmacist Ministry of Health & Social Services [email protected]
Nauru Richard Leona Chief Surgeon Ministry of Health [email protected]
Nepal
Nicaragua Karla Vanessa Delgado Martinez Directora de Farmacia Ministerio de Salud [email protected]
Níger Haoua Na Allah Alou [email protected]
Nigeria Wosilat Abdulhameed Deputy Director Federal Ministry of Health
[email protected] 45534
Niue
Noruega Anne S. Onsgård Sagabråten Narcotic Drugs Control, Norwegian Medicines Agency
Nueva Zelandia Group mail to be cc'ed [email protected] 45483
Nueva Zelandia Tania Jones Regulatory Practice and Analysis, Medsafe
[email protected] confirmed 10/7/24
Omán Dr. Mohammed Al-Rubaie, [email protected] 45483
Omán Dr Mahmood Al Abri [email protected] 45483
Omán Directorate General of Pharmaceutical Affairs and Drug control,
Omán Drug Safety Center, Ministry of Health, Sultanate of Oman
[email protected] 45534
Países Bajos Matthijs Geilenkirchen Nutrition, Health Protection and Prevention Department, Ministry of Health, Welfare and Sport
[email protected] 29 April 2024
Pakistán Rizwan Taj Professor Ministry of Health [email protected]
Anexo II: Lista de puntos focales designados por los Estados Miembros en años anteriores
País Nombre del punto focal Cargo Institución Correo electrónico Última actualización
Palau Clarette Matlab Chief Pharmacist
Division of Ancillary Services, Bureau of Hospital and Clinical Services, Ministry of Health
Palau [email protected]
Palau Marla Ito [email protected]
Panamá Dr. Ricardo Goti, Coordinador del Programa Salud Mental Ministerio de Salud de Panamá [email protected] 45489
Papua Nueva Guinea Vicky Wari Program Manager-Non Communicable Diseases
Public Health Division, National Department of Health
Paraguay Blanca Galeano [email protected] 45534
Paraguay Zaira Francesca Stumpfs Bigarella [email protected]
Perú Judith Castañeda Alcántara Jefa de la Unidad Funcional de Productos Controlados
DIGEMID - Dirección General de Medicamentos, Insumos y Drogas
[email protected] 45499
Polonia Michał Kidawa Polish Reitox Focal Point
Information Centre for Drugs and Drug Addiction (CINN) National Bureau for Drug Prevention
Portugal Graça Vilar Director of Planning and Intervention Services Directorate
Intervention Service for Addictive Behaviours and Addictions General Directorate for Intervention on Addictive Behaviours and Dependencies SICAD
Puerto Rico
Qatar Majid Ali Al Abdulla Senior Consultant Psychiatrist
Director of addiction and CL at Hamad Medical Corporation Deputy Chairman of Mental Health Services, Hamad Medical Corporation
Reino Unido de Gran Bretaña e Irlanda del Norte
Alberto Oteo Project Manager Drugs Research and Surveillance
Addiction and Inclusion Directorate, Office for Health Improvement & Disparities, Department of Health and Social
República Árabe Siria Ahmed Al-Salama Mental Health Directorate, Ministry of Health
República Centroafricana
República de Corea Sang Hun Yeon Narcotics Policy Division of Ministry of Food and Drug Safety
[email protected] 45489
República de Moldova Oleg Costachi Standing Committee on Drugs Control, Agency for Medicines and Medical
República Democrática del Congo Ghislaine Mbelu Kanyunya [email protected]
República Democrática Popular Lao Khatthanaphone Phandoangsy Head of Health Promotion and Nutrition Unit
Department of Hygiene and Health Promotion, Ministry of Health
República Dominicana [email protected]
República Dominicana Francisca Dalia Castillo Sanchez Jefa del Departamento de Tecnología Sanitaria
Dirección General de Medicamentos, Alimentos y Productos Sanitarios (DIGEMAPS), Ministerio de Salud Pública
República Popular Democrática de Corea Kim Jong Guk
República Unida de Tanzanía Suma Jairo Pharmacist Pharmaceutical Service Unit, Ministry of Health
Rumanía Camelia Bunaciu Senior Advisor Ministry of Health [email protected]
Rwanda
Saint Kitts y Nevis puerto rico
Samoa Robert Thomsen Assistant Chief Executive Officer HSPQA, Medical and Allied Division [email protected]
Anexo II: Lista de puntos focales designados por los Estados Miembros en años anteriores
País Nombre del punto focal Cargo Institución Correo electrónico Última actualización
San Marino Claudio Muccioli Health Authority Director Health Authority [email protected]
San Vicente y las Granadinas
Santa Lucía Charlotte Emmanuel Coordinator of the Substance Abuse Advisory Council Secretariat
Substance Abuse Advisory Council Secretariat, Ministry of Health and Wellness
Santa Lucía Paul Caleb Programme Officer
Substance Abuse Advisory Council Secretariat, Ministry of Health and Wellness
Santo Tomé y Príncipe
Senegal Moussa DIALLO Pharmacist Inspector Pharmaceutical Regulatory Agency, Ministry of Health and Social Action
Serbia Nataša Savić
Monitoring Centre for Drugs and Drug Addiction, Sector for Medicines and Medical Devices, Psychoactive Controlled Substances and Precursors, Ministry of Health
Seychelles Sierra Leona
Singapur Ong Lay Tin Personal Assistant to Director (International Cooperation)
Senior Executive (International Cooperation) Public Health Group, Ministry of Health
[email protected] 04/07/2024 confiming no changes
Somalia
Sri Lanka S.C. Wickramasinghe Deputy Director General (NCD) Ministry of Health [email protected]
Sudáfrica MG Molewa Ministry of Health [email protected]
Sudán
Sudán del Sur Moses Malual Deng Director General of Pharmaceuticals and Medical Supplies
Ministry of Health [email protected]
Suecia Annika Borg
Ministry of Health and Social Affairs, Division for Public Health and Health Care
[email protected] 45390
Suiza Lucien Colliander
Federal Department of Home Affairs, Federal Office of Public Health, Division of International Affairs, Global Health Section
Suiza Monika Joos Head of Division Narcotics Swissmedic, Swiss Agency for Therapeutic Products
Suriname
Tailandia Sujinart Chantharakul Pharmacist
Narcotics Control Division (Standards and Regulations Sub-Division), Food and Drug Administration, Ministry of Public Health
Tailandia Saranya Chavanich Pharmacist
Narcotics Control Division (Standards and Regulations Sub-Division), Food and Drug Administration, Ministry of Public Health
Tailandia Korapin Na Ranong Expert on Narcotics Epidemiology
Narcotics Control Division Food and Drug Administration, Ministry of Public Health
Tailandia Raththar Benchapalanont Pharmacist
Narcotics Control Division Food and Drug Administration, Ministry of Public Health
Tayikistán Salim Abdulazizov [email protected]
Anexo II: Lista de puntos focales designados por los Estados Miembros en años anteriores
País Nombre del punto focal Cargo Institución Correo electrónico Última actualización
Timor-Leste Soares Henriques Regulatory Affairs Pharmacist
Pharmacovigilance and Medicine Control Department, National Directorate for Pharmaceutical and Medicines, Ministry of Health
Togo Mouhoudine Yerima Centre National de Pharmacovigilance (CNPV)
[email protected];[email protected]
Tokelau
Tonga Melenaite Mahe Principal Pharmacist Central Pharmacy and Medical Store, Old Vaiola, Ministry of Health
Trinidad y Tabago Anesa Doodnath-Siboo Principal Pharmacist Ministry of Health [email protected] Túnez
Türkiye Elif Inci ERGONUL Head of Pharmacovigilance and Controlled Substances Department
Turkish Medicines and Medical Devices Agency, Ministry of Health
[email protected] , [email protected] 45497
Turkmenistán Tuvalu
Ucrania Deputy Director Institute of Psychiatry, Forensic Psychiatric Examination and Drug Monitoring,
Ucrania Irina Pinchuk Director
Institute of Psychiatry of Taras Shevchenko National University of Kyiv, International Technology Transfer Center - Ukraine Head of ISSUP Ukraine National Chapter
Ucrania Yulia YACHNYK Clinical Psychologist Institute of Psychiatry, Taras Shevchenko National University of Kyiv
Uganda Hafsa Lukwata Head of Mental Health and Control of Substance Abuse
Mental Health and Control of Substance Abuse Division, Ministry of Health
Uruguay Lorena Quintana Coordinadora del Programa de prevención y tratamiento de adicciones
Ministerio de Salud Pública [email protected] 45506
Uzbekistán Dr Azizbek Khamrakulov Head, Department of Inpatient and Specialized Care
Ministry of Health [email protected]
Uzbekistán Mr Zarif Ashurov Director Specialized Scientific and Mental Health Medical Center
Vanuatu Jerry Iaruel Tafea Provincial Health Administrator Lenakel Health Office, Ministry of Health
Venezuela (República Bolivariana de)
Viet Nam Mhin Tam Nguyen Regulatory Affair Consultant Ministry of Health [email protected]
Yemen
Zambia Nita Besa Head Clinical Care Chainama Hospital [email protected]
Zimbabwe Eneti Siyame Mental Health Manager Ministry of Health and Child Care [email protected]